Radiation-induced Nanoparticle Formation as Novel Means of in Vivo / in Vitro Dosimetry by Subramaniam Pushpavanam, Karthik (Author) et al.
  
Radiation-induced Nanoparticle Formation as Novel Means of in Vivo / in Vitro 
Dosimetry 
by 
Karthik Subramaniam Pushpavanam 
 
 
 
 
 
A Dissertation Presented in Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
Approved April 2019 by the 
Graduate Supervisory Committee: 
 
Kaushal Rege, Chair 
Stephen Sapareto 
Brent Nannenga 
Matthew Green 
Bin Mu 
 
 
 
 
ARIZONA STATE UNIVERSITY 
May 2019
i 
 
ABSTRACT 
 
Rapid development of new technology has significantly disrupted the way radiotherapy is 
planned and delivered. These processes involve delivering high radiation doses to the target 
tumor while minimizing dose to the surrounding healthy tissue. However, with rapid 
implementation of these new technologies, there is a need for the detection of prescribed 
ionizing radiation for radioprotection of the patient and quality assurance of the technique 
employed. Most available clinical sensors are subjected to various limitations including 
requirement of extensive training, loss of readout with sequential measurements, sensitivity to 
light and post-irradiation wait time prior to analysis. Considering these disadvantages, there is 
still a need for a sensor that can be fabricated with ease and still operate effectively in predicting 
the delivered radiation dose. 
  
The dissertation discusses the development of a sensor that changes color upon exposure to 
therapeutic levels of ionizing radiation used during routine radiotherapy. The underlying 
principle behind the sensor is based on the formation of gold nanoparticles from its colorless 
precursor salt solution upon exposure to ionizing radiation. Exposure to ionizing radiation 
generates free radicals which reduce ionic gold to its zerovalent gold form which further 
nucleate and mature into nanoparticles. The generation of these nanoparticles render a change 
in color from colorless to a maroon/pink depending on the intensity of incident ionizing 
radiation. The shade and the intensity of the color developed is used to quantitatively and 
qualitatively predict the prescribed radiation dose.  
 
ii 
 
The dissertation further describes the applicability of sensor to detect a wide range of ionizing 
radiation including high energy photons, protons, electrons and emissions from radioactive 
isotopes while remaining insensitive to non-ionizing radiation. The sensor was further 
augmented with a capability to differentiate regions that are irradiated and non-irradiated in 
two dimensions. The dissertation further describes the ability of the sensor to predict dose 
deposition in all three dimensions. The efficacy of the sensor to predict the prescribed dose 
delivered to canine patients undergoing radiotherapy was also demonstrated. All these taken 
together demonstrate the potential of this technology to be translatable to the clinic to ensure 
patient safety during routine radiotherapy. 
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Chapter 1 INTRODUCTION 
 
Radiation therapy or Radiotherapy (RT), using ionizing radiation (X-rays and gamma 
rays), is a first line of treatment for several types of cancer diseases, although protons and 
low atomic weight ions are also used (Hardon therapy).1 External-beam radiotherapy 
(EBRT) is commonly employed in the clinic, although other methods including 
brachytherapy, intra-operatory radiation therapy (IORT) and metabolic radiation therapy 
are also used.1 The cumulative dose delivered depends on the type of cancer and often 
ranges between 20 and 70 Gy (1 Gy = 1 Joule of radiation energy absorbed / kg of matter). 
In conventional procedures, the cumulative dose is delivered over several fractions with a 
typical dose close to 2 Gy. The entire treatment lasts several weeks, with up to five fractions 
delivered every week. Several variations of fractionated radiotherapy have been explored 
in order to maximize the efficiency of treatment and facilitate patient tolerance. A dose 
range of 0.5-1.8 Gy is employed in hyperfractionated radiotherapy2, 3. In hypofractionated 
radiotherapy, doses ranging from 3-10 Gy, which are higher than the conventional 2 Gy 
dose, are delivered4. This has been made possible by advanced methods including 
volumetric-modulated arc therapy (VMAT). In addition, stereotactic RT, which is a kind 
of EBRT, has been employed in conjunction with imaging to deliver higher radiation doses, 
between 6 and 25 Gy1, specifically to well-defined small tumors in a single treatment or 
smaller number of fractions.5  
  
Although radiotherapy possesses several advantages for cancer treatment, radiation-
induced toxicity and tissue damage are causes for concern. For example, radiation-induced 
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fatigue, skin problems, proctitis6, esophagitis7, osteonecrosis8 and other complications 
have been reported. Clinical cases of accidental overdose9 and inaccurate dosing10  due to 
errors in machine calibration have been reported. In addition, cases of overdose due to error 
have also been known to occur11. These issues highlight the importance of appropriately 
dosing cancerous tumors so as to avert any adverse effects of radiation-induced toxicity.  
 
Several technologies have been investigated for monitoring and quantifying ionizing 
radiation in order to potentially facilitate accurate dosing in patients. For example, small 
ionization chambers, silicon diodes, metal-oxide semiconductor field effect transistors 
(MOSFETs), thermo-luminescent dosimeters (TLDs), optically stimulated luminescence 
dosimeters (OSLDs), diamonds and films are used for radiation dose determination. 
Existing dosimeters can be classified into non-implantable devices for in vivo 
measurements and implantable devices for measurements inside the target in the body. 
Non-implantable systems find application in procedures using standard fractions of ≈2 Gy 
per session of fractionated radiotherapy. Diodes, TLDs, films and some MOSFETs are the 
most commonly used non-implantable systems, and are often used for entry dose 
measurement. On the other hand, implantable dosimeters are introduced into the body via 
natural cavities or less commonly, directly into target tissues12; the reader is referred to 
other excellent papers on this for a more detailed discussion1. Most of these devices require 
electrical or optical connections for readout and are often cumbersome to use. Even in case 
of optical fibers, there is a need to shield optical connections as a result of the Cherenkov 
light produced13. In light of the above limitations, there is an urgent need to develop simple 
yet robust systems that can address existing challenges with radiation sensing and 
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dosimetry for clinical applications. Here, we review the latest developments in molecular 
and nanoscale systems for sensing ionizing radiation, with a particular focus on use in 
cancer radiotherapy applications. To our knowledge, this is the first comprehensive review 
on molecular and nanoscale dosimeters for application in clinical radiotherapy. 
 
1.1 Molecular Systems  
 
1.1.1 Small Molecule Systems 
 
Emission of light from fluorescent molecules depends on the chemistry of the molecules 
and their local environment.14. Radio-fluorogenic co-polymerization is a process in which 
a non-fluorescent active monomer is incorporated into a growing polymer chain resulting 
in fluorescence of the long chain. The polymerization itself is triggered by the free radicals 
generated upon irradiation with ionizing radiation. Warman et al. described a two-
component monomer system which includes an acrylate-based supporting molecule and a 
functional non-fluorescent active molecule, N-(1-pyrenyl)maleimide (MPy), for radiation 
sensing.15 The supporting non-fluorescent medium (methyl methacrylate/tertiary-butyl 
acrylate) polymerizes, incorporating the active molecule MPy into the growing polymer 
chain, in turn making it fluorescent.16 This incorporation of the active molecule in the 
polymer chain prevents diffusion and can render information on the spatial distribution of 
the dose. Limited diffusion of the active probe reduces false positives post-irradiation 
which can help define complex radiation profiles delivered. This approach of radio-
fluorogenic co-polymerization (RFCP) has been shown to be applicable to a wide range of 
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ionizing radiation sources including 192Ir radioisotope, cobalt gamma ray source, electron 
beam and proton beams.17-20 The fluorescence signal reached a steady state after three 
minutes and was reported to be stable for at least three hours. However, approximately 
60 % loss in signal was seen after a period of 28 days. This loss was attributed to the 
diffusion of air into the dosimeter, which was responsible for quenching the pyrene 
fluorescence; diffusion of the fluorescent product out of the irradiated region was not 
deemed to be a cause for this loss.20 Even though RFCP-based dosimeters measure doses 
as low 2 Gy, the need to carefully handle toxic and flammable acrylates can be a limitation 
of these systems. In addition, it is difficult to obtain real time information, which may limit 
the ultimate application of such systems during routine radiotherapy.20   
 
Benevides et al. used the principle of degradation of fluorescent molecules as a “turn-off” 
sensor for detecting radiation. Briefly, rhodamine 6G and fluorescein dyes were embedded 
in water-containing agarose hydrogels.21 Upon irradiation, water molecules release free 
radicals which have oxidizing and reducing properties.22 Upon reaction with free radicals, 
the dyes lose their fluorescence properties and act as an indicator of applied radiation 
dose21.  Radiolytic species generated in water have short lifespans, which decreases the 
probability of interaction between the free radical and the fluorophore. To achieve 
enhanced sensitivities, the lifetime of radiolytic species was increased by the addition of 
NaCl. Cl2− radicals generated through high energy irradiation have longer life times which 
led to the detection of radiation doses between 40 and 200 Gy with a resolution of 20 Gy.21 
Han et al. improved upon these fluorescence systems by developing a sensor that can detect 
radiation levels down to 0.01 Gy by using 4,4′-di(1H-phenanthro[9,10-d]imidazol-2-
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yl)biphenyl (DPI-BP).23 This detection capability can be relevant in a clinical setting in 
order to accurately target cancerous tumors with γ-radiation during therapy. DPI-BP, when 
solubilized in either chloroform or dichloromethane, demonstrated a strong fluorescence 
signal; iodinated and brominated solvents were not useful since DPI-BP did not fluoresce 
in them. These chlorine-based solvents result in the formation of HCl upon irradiation with 
ionizing radiation. This, in turn, is thought to enhance aggregation of DPI-BP due to 
intermolecular π–π stacking, leading to detectable quenching of the original fluorescence 
signal. This signal decay was used as a measure of radiation dose. A 5 % decrease in the 
emission of DPI-BP was seen for a radiation dose as small as 0.1 Gy and complete 
quenching was observed at a dose of 3 Gy. The strong quenching indicates the capability 
of the system for sensing low doses of ionizing radiation. Additionally, the original signal 
could be recovered by the addition of a strong base like NaOH which deprotonates HCl. In 
order to verify the need of HCl, other solvents including DMF, DMSO, THF and toluene 
were used without detectable changes in fluorescence even at a dose of 100 Gy. Further 
investigations may be necessary to determine the toxicity of these molecules for in vivo 
settings, particularly given the need for chlorinated solvents and formation of HCl.  
 
A novel fluorescence technique that is based on aggregation-induced fluorescence 
emission of silole compounds was recently developed for the detection of gamma ray 
radiation.24  In this system, the silole compound, containing a positively charged 
ammonium group, shows minimal emission in aqueous solutions. The solution however 
becomes strongly emissive upon mixing with either polymers or amphiphilic molecules 
that contain negatively charged moieties, which can induce the aggregation of the silole. 
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In one version, the silole molecule was mixed with a polyelectrolyte containing sulfone 
groups (−SO2−) in the main chain and −COONa groups in the side chain. Upon exposure 
to gamma ray radiation, the polymer degrades by the release of SO2 due to the relative 
weakness of C−S bonds in the main chain. The electrostatic and hydrophobic interactions 
between silole and polymer in turn weaken, inhibiting the aggregation of the silole 
compound. As a result, the solution containing the silole compound and polymer is weakly 
emissive after gamma-ray exposure. The decrease in intensity is used as a measure of 
radiation dose. The fluorescent complex did not lose its intensity for up to two days. In this 
case, a minimum dose of 130 Gy was needed for the sensor to work effectively. A “turn-
on” fluorescence sensor was subsequently developed by the same group due to the 
relatively high radiation dose required to observe a detectable change in the previous 
version.25  The synthesized molecular sensor consists of a 3,3′-dimethyl-3H-indole 
functional group on a tetraphenylethylene derivative dissolved in halogenated solvents 
including CHCl3 or CH2Cl2. This system is weakly emissive in chloroform and 
dichloromethane. Following irradiation with gamma rays, these solvents produce HCl, 
which results in protonation of the molecular sensor. This protonated molecule 
demonstrates poor solubility in the solvents used, which results in its aggregation and a 
concomitant increase in fluorescence (“turn-on”). The limit of detection of this system was 
shown to be as low 0.023 Gy. A different molecular sensor with a dual-band emissive 
response was developed by dissolving 4-(1H-phenanthro[9,10-d]imidazol-2-yl)-N,N-
diphenylaniline (PI-DPA) in chloroform.26 PI-DPA tends to self-assemble into fibers upon 
interaction with HCl that is generated upon irradiation. Formation of these fibers quenches 
the existing fluorescence intensity and brings about a new fluorescence band at a longer 
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wavelength. These two signals, along with the photoconductive property of the nanofibers, 
were predicted to assist in developing a multimodal sensor in the detection of ionizing 
radiation. The sensor was projected to detect radiation doses as low as 0.006 Gy. These 
stimuli-responsive small molecules could potentially be applied for routine ex vivo (skin) 
radiotherapy due to their sensitivity and fast response. However, potential toxicity issues 
of these small-molecule sensors as well as the solvent will have to be determined prior to 
in vivo dosimetry.  
 
1.1.2 Polymer-Based Systems 
 
Most polymer systems used for the purpose of radiation sensing are based on the principle 
of modification of the polymer structure / chain length either through cross-linking or by 
scission of the backbone by ionizing radiation27. This, in turn, results in changes in the 
physicochemical properties (e.g. color changes or change in electrical conductivity) of the 
polymer used28. Initial studies on polymer thin films were based on poly(p-phenylene 
vinylene)28; changes in electrical conductivity, optical density and photoluminescence 
were observed upon exposure to X-ray irradiation. However, these changes in polymer 
properties were typically observed at high radiation doses (>1 kGy), which necessitated 
the need for polymer-based systems that were responsive to lower radiation doses. Poly (2-
methoxy-5-(2′-ethyl-hexyloxy)-1,4-phenylene vinylene) (MEH-PPV) is one of the most 
widely studied polymer systems for detecting lower doses of ionizing radiation29. Two sets 
of formulations, MEH-PPV dissolved in chloroform and spin-coated MEH-PPV on a glass 
substrate as a thin film, were investigated. Upon gamma irradiation using a 1.25 MeV 60Co 
source, MEH-PPV in chloroform showed significant spectral shifts at 38 Gy, while MEH-
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PPV films were insensitive to doses as high as 114 Gy. The enhanced response could be 
attributed to the release of .Cl radicals in solution which degrade the polymer leading to a 
loss of conjugation. Further investigation into free radical-based polymer degradation was 
carried out using Fukui indices. 30  The .Cl radicals attack the vinyl bonds in the polymer 
backbone leading to chain scission and eventual loss of electronic conjugation. The effect 
of different halogenated solvents and their role in degradation of MEH-PPV was also 
investigated.31 At doses as low as 1 Gy, the polymer, dissolved in bromoform and 
diiodomethane/dichloromethane, showed blue shifts in absorbance spectra compared to the 
0 Gy condition. Significant shifts were obtained when the solvent contained higher 
amounts of halogen atoms. Studies with the polymer dissolved in toluene solvent showed 
no significant response at 30 Gy, which indicated the need for halogenated solvents in this 
system. Lower concentrations of the polymer were deemed to enhance the sensitivity of 
the dosimeter. This could be explained by the fact that at lower concentrations, the polymer 
is better solvated increasing the probability of reaction between the free radical and the 
polymer backbone. However, at higher concentrations, polymer aggregation can hinder the 
reaction between the radicals and the polymer, which lowers the efficacy of the detection 
performance. In addition to gamma radiation MEH-PPV also was shown to be responsive 
to a proton flux of 1013 ions cm−2 irradiation which can make this a versatile system for 
radiation sensing.32 As with previous systems, biocompatibility of the polymers, solvents, 
and by-products of the sensing reaction will need to be elucidated before considering 
translation to human applications.  
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High Z (atomic number) elements are known to enhance the sensitivity to lower radiation 
doses. 33, 34  Based on this background, composites containing inorganic compounds within 
polymer hosts were studied for gamma scintillation. Upon irradiation, the high Z material 
attenuates high-energy photons resulting in the formation of an electron-hole pair. These 
pairs are transferred to the polymers where radiative decay occurs.35  A luminescent 
polymer P-PPV and high Z materials including 1,3-diiodobenzene (DIB) and BiI3 were 
blended together with a solid polymer matrix consisting of poly(trimethylolpropane 
trimethylacrylate) (TMPTMA).35 The scintillation lifetimes of the nanocomposites were 
comparable to commonly employed scintillants LaCl3 and LaBr3 36 even though the 
scintillation efficiencies were found to be lower with the current formulation. A similar 
nanocomposite for detecting radiation using fluorescence resonance energy transfer 
(FRET)37 was developed. Poly[9-hexyl-9-(20-ethylhexyl)-fluorene] (HEH-PF), a blue 
light-emitting polymer, was mixed with red light emitting polymer DCM (4-
(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran). DIB was added to 
this mixture in order to enhance radiation absorption efficiency; the mixture was 
subsequently formulated into a thin film. This ternary composite showed radiation 
sensitivity for doses lower than 50 Gy based on photoluminescence readout.  
 
An unavoidable effect of photon beam radiotherapy is the potential scattering of the dose 
outside the treatment beam.38 These scattered doses of magnitudes lower than 1 Gy can 
induce unintended secondary effects in patients39. However, MEH-PPV based dosimeters 
do not typically respond to doses lower than 1 Gy40. Detection limits were improved by 
using an organometallic polymer 1,1’-bis(ethynyl)-4,4’–biphenyl (DEBP) with a platinum 
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metal center as a potential radiation dosimeter41. Pt-DEBP dissolved in chloroform was 
used further for dosimetry studies. Structural changes in Pt-DEBP arise due to Cl. free 
radical attack on the triple bond on the polymer chain and increase in molecular weight due 
to recombination of the oligomeric fragments42. A concomitant change in the absorbance 
spectra is detected above 1 Gy as a result of structural modification on the polymer. The 
polymer system displayed fluorescence properties due to its conjugated nature and π→π* 
absorption41.  The presence of a transition metal (Pt) renders unique structural, optical and 
electronic properties to the polymer. An importance feature is the presence of a delocalized 
π-conjugated electron cloud which extends and reaches the metal center from the polymeric 
backbone40. Chlorine incorporation reduces the spin density on Pt, thereby increasing the 
output fluorescence signal. This system, which uses the photoluminescence emission ratio 
at 420 nm and 398 nm, could detect doses between 0.1-1 Gy.  
1.1.3 Single-Crystal Systems 
 
Dielectric and wide-band gap semiconductor materials have been traditionally employed 
as scintillator materials43 and in radiation detection 44. Thermalized electrons and holes are 
generated in the scintillator lattice upon irradiation with a high-energy photon beam. 
Recombination of these electron-hole pairs lead to luminescence which is converted into 
an electrical signal through a photodetector.43 The use of room-temperature synthesis 
protocols has made organic molecules attractive alternatives to inorganic scintillators45. 
Organic semiconducting single crystals (OSSCs) including 4-hydroxycyanobenzene 
(4HCB) and 1,8-naphthaleneimide (NTI) demonstrate tissue equivalent properties, and are 
attractive as direct X ray detectors46. These crystals, along with organic polymers (PDMS, 
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poly(dimethylsiloxane) and PEDOT:PSS, 
poly(ethylenedioxythiophene):poly(styrenesulfonate)) as substrates, were able to convert 
incoming 35 kV photons from an X-ray source directly to an electrical signal. The 
longevity of 4HCB crystals was investigated by (1) irradiation to a total dose of 2.1 kGy 
and (2) aging for a month. The electrical response of the sensor was reliable despite this 
significant strain. Anisotropic crystals of 4HCB require alignment of the crystal and 
electrode in order to manipulate charge carrier transport properties. However, 1D crystals 
are of practical interest because they possess only one single crystallographic direction that 
can be electrically accessed. Needle-shaped crystals (1D) of 1,5-dinitronaphthalene (DNN) 
were studied for their electrical response under irradiation.45 Rubrene crystals were used 
based on the hypothesis that charge mobility might affect the sensitivity of the crystals to 
X-ray irradiation 47; charge mobility of rubrene crystals is higher than that of DNN crystals 
by approximately two orders of magnitude. However, rubrene crystals showed lower 
sensitivities and slower response times for detecting ionizing radiation compared to 
DNN47. DNN could detect doses as low as 20 mGy s−1 while rubrene had to be irradiated 
with 120 mGy s−1 in order to achieve a similar electrical output. This demonstrated that the 
higher charge mobility might not be sufficient to achieve enhanced performance for 
radiation detection.  
 
With flexible devices and wearable technology drawing a lot of attention, a wearable 
flexible detector with poly (ethylene terephthalate) (PET) as substrate and 4HCB crystals 
as the active ingredient was fabricated.48 Repeated bending did not seem to affect the 
electrical performance of the device making them feasible for active-wear radiation 
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detectors. A minimum dose of 50 μGy s−1 was able to trigger detection. The sensitivity of 
the above flexible device is comparable to an existing amorphous selenium detector. Such 
flexible detectors could be useful in routine entry and exit dose measurements during 
radiotherapy.  
 
1.2 Nanoparticle Systems 
  
1.2.1 Quantum Dot (QD) Systems 
 
Quantum dots are semiconductor nanoparticles (1–100 nm and demonstrate strong light 
absorption and luminescence properties).49 The electronic and optical characteristics of 
quantum dots are determined by their size and shape; larger sized dots are known to emit 
longer wavelengths while smaller dots emit shorter wavelengths. Quantum dots based on 
CdSe/ZnS have been investigated as neutron detectors.50 However, commercially available 
inorganic compounds possess low solubilities in organic and polymeric matrices, which 
can limit their use. Their preparation in inorganic matrices, including sol-gels, results in 
the formation of non-transparent materials, which can lower their efficiency as scintillating 
devices. Colloidal quantum dots (cQDs), which are dispersible in aqueous media, were 
subsequently mixed with lithiated gels to form a transparent QD gel composite and tested 
with a Po-210 alpha source. The scintillation pulse detected upon comparison with 
background radiation signal showed a performance similar to existing inorganic 
scintillators. Withers et al. reported the effect of 137Cs gamma irradiation on 
photoluminescence properties of CdSe/ZnS colloidal quantum dots.51, 52 Upon gamma 
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irradiation using 1.17 and 1.33 MeV energy photon beams, a decrease in fluorescence of 
the composite was observed at a dose as low as 0.1 Gy. At higher doses (10 Gy) the 
fluorescence intensity is halved with respect to the 0 Gy control sample. Based on this, the 
authors proposed that cQDs could be used as sensors to report for cumulative radiation 
doses. Colloidal quantum dots were subjected to a cumulative dose of 140 krad (1.4 kGy) 
using a 0.662 MeV beam; it was found that 50 % of the original optical output was lost 
after an exposure of 11.5 krad (115 Gy). The dose at which cQDs lost their signal was 
significantly higher than conventional NaI:Tl scintillator crystals, which lose their light 
output after an exposure to 5 Gy. Hypothetically, radiation hardness of cQDs can make 
them versatile for longer-term use in clinical applications without having to replace the 
dosimeter after every treatment. Using hexane as the solvent for cQD synthesis resulted in 
aggregation during prolonged storage.52 Water-dispersible CdSe-CdS-Cd0.5Zn0.5S-ZnS 
core-shell colloidal quantum dots were therefore developed in order to potentially eliminate 
limitations with other cQD systems.53 A linear emission behavior with radiation was 
observed between 0.05–3 Gy, making this system a potential candidate for detecting doses 
used in fractionated radiotherapy.  
 
Colloidal quantum dots can suffer from irreversible aggregation leading to loss in 
fluorescence properties54. In order to overcome this challenge, cQDs were cast in a polymer 
matrix and the resulting composites were used as scintillators. Dispersion in a polymeric 
matrix also serves the purpose of maintaining the efficiency of cQDs while potentially 
lowering the costs of synthesis by using lower amounts of the inorganic scintillator55. A 
dosimeter in which CdSe/ZnS QDs were impregnated in a porous glass matrix was 
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fabricated; etching with hydrofluoric acid resulted in in an increase in pore size of the 
matrix. In addition to being sturdy and transparent, the matrix contained cavities to hold 
guest molecules that were also kept apart in order to prevent self-quenching56. Scintillation 
output of the nanocomposite was compared to that of rhodamine B laser dye under alpha 
irradiation (243-244Cm as radiation source). Colloidal QDs were able to convert the incoming 
alpha radiation (243-244Cm) to visible photons, but their scintillation output was lower than 
that seen with conventional rhodamine B laser dye. The output variation between the two 
systems was attributed to the photon transport efficiency described by their Stokes shift; 
the laser dye has an inherent Stokes shift while cQDs do not exhibit such a phenomenon57. 
Thus, engineering the Stokes shift in quantum dots can likely lead to more sensitive 
dosimeters. Radiotherapy involves photon beams with various energies ranging from keV 
to MeV. This warrants the development of dosimeters that can function at both ends of the 
energy spectrum58. The above cQD nanocomposites demonstrated an improvement in 
energy resolution by a factor of 2 when compared to standard NaI crystal (irradiation with 
a 59 keV Americium or 241Am source) 56. 
 
Size effects of CdSe/ZnS quantum dots were studied using a 1 MeV gamma radiation 
source59. Colloidal quantum dots (3.3 nm) showed a degradation of up to 30 % in original 
fluorescence emission, while larger particles showed complete recovery of their original 
emission properties 24 h after exposure to 5 Gy dose.60 In a system developed by Crone 
and coworkers, CdSe-ZnSe cQDs were dispersed in an organic scintillator (poly[2-
methoxy-5-(2′-ethylhexyloxy)-p-phenylene vinylene]61 Ionizing radiation generates 
excitations in the cQDs and these excitations are transferred to the organic host by FRET. 
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Cathode luminescence (CL) experiments were carried out on a composite spin-coated on 
gold-coated sapphire substrates in order to probe scintillation performance. At a volume 
fraction of 0.15, the cQD showed twice the CL intensity compared to pure MEH-PPV. 
Interestingly, further increase to 0.21 volume fraction led to a significant decrease in CL 
intensity. Aggregation of the cQDs at higher volume fractions can lead to an increase in 
non-radiative recombination and poor performance of the sensor, which indicates the need 
for uniform dispersion of cQDs in the matrix.  
 
In addition to CdSe quantum dots, CdTe QDs have also been investigated for x-ray 
scintillation and imaging62. A lower cost reusable detector was recently developed by Gaur 
et.al in which CdTe/CdS quantum dots were impregnated within porous silica63. The high 
surface area of the silica allows for larger entrapment of the colloidal particles. Upon 
irradiation, the QDs are oxidized and lose their emission intensity. X-ray radiation doses 
as high as 1 Mrad (10 kGy) were required to decrease the peak emission intensity by half. 
The nanoparticles show a near-complete recovery of peak intensity when treated with a 
thiol-rich solution for 25 min post X-ray irradiation, while partial recovery was observed 
post γ-irradiation, indicating differential mechanisms by which the quantum dots interact 
with radiation of different energies.  
 
Detailed studies on the mechanisms behind radiation-induced scintillation, and 
energy/dose rate dependency will be necessary to investigate the potential use of QDs in 
clinical radiation dosimetry. The relatively high cost associated with the use of such 
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systems and toxicity of quantum dots may also limit their use as implantable dosimeters in 
vivo. 64 
 
1.2.2 Plasmonic Nanoparticles 
 
Surface plasmon resonance (SPR) properties of plasmonic nanoparticles including gold 
and silver nanoparticles, have made them attractive in a number of biomedical applications 
65-67. Nanoparticles ranging in size from 1 to 100 nm have been found to preferentially 
accumulate at the tumor site and are widely employed as imaging agents in oncology 67. 
Very recently Dou et al demonstrated that optimally sized gold nanoparticles enhances 
real-time CT imaging and radiotherapy68. Oscillating surface plasmons in these 
nanoparticles can enhance surface-enhanced Raman scattering (SERS), resulting in 
increased efficiencies for chemical and biological sensing69. Alanine powder and alanine 
blended with polymeric binders have been investigated as dosimeters for ionizing 
radiation70, which induces the formation of stable free radicals in the amino acid. These 
free radicals are detected using electron spin resonance (ESR)71. The intensity of the ESR 
signal is proportional to the amount of free radicals generated, and this measure is used as 
a reporter for radiation dose 70, 72. Such systems are widely used in biological dosimetry 
applications and also serve as a reference system for other commercial dosimeters73. 
However, alanine dosimeters typically demonstrate reduced sensitivities when beam 
energies of the order of keV are employed. The sensitivity of alanine systems to X-rays 
can be enhanced by doping with high Z micro-scale materials74. Incorporating plasmonic 
nanoparticles within the matrix improved the dose enhancement factor, which is the ratio 
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between the mass absorption coefficient of the nanocomposite to that of pure alanine75, 76. 
Upon exposure to X-rays, metallic nanoparticles contribute to enhanced generation of free 
radicals within the alanine matrix75. Pre-synthesized silver nanoparticles were added to an 
aqueous solution of alanine before drying at 40oC to yield nanocomposite powders75. These 
nanocomposites, when irradiated with a 90 keV beam, displayed enhanced peak-to-peak 
amplitude of the ESR spectra when compared with a pure alanine dosimeter. Interestingly, 
increasing the nanoparticle concentration from 0.01% Ag NPs to 1% Ag NPs decreased 
the DEF which could be attributed to particle agglomeration at higher concentrations. 
Similar responses were observed when gold nanoparticles were employed76. These 
nanocomposites exhibit homogeneity, nanoparticle size stability and improved sensitivity 
with a linear response between 1-50 Gy. However, ESR is a sophisticated detection method 
that requires trained professionals. This can be a limitation in translating this technology 
towards clinical radiotherapy.      
1.2.3 Carbon Nanotubes 
 
Carbon nanotubes (CNTs) were first investigated for detecting ionizing radiation as part of 
field effect transistors (FETs)77. Shifts in threshold voltage upon irradiation of these 
CNTFETs were used as a measure of ionizing irradiation. CNTFETs had similar dosimetry 
characteristics to already existing MOSFETs and showed longevity upon repeated 
exposure to radiation. Thickness of the silicon dioxide layer in the CNTFETs affects the 
sensitivity of the device, which is similar to that seen in conventional MOSFETs. A parallel 
plate ionization chamber using CNTs was developed in order to overcome this drawback 
78; the parallel plate orientation allows for the insertion of CNTs into the working chamber. 
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The sensor demonstrated a near linear response from 2 - 600 MU (1 MU = 1 cGy in water), 
when both 6 and 15 MV photon beams were employed.  
 
A system using low density carbon fiber sheets sandwiched in between 
polymethylmethacrylate (PMMA) holders 79 was developed in order to potentially 
overcome attenuation of radiation dose by the sensor; copper electrodes were used as 
electrical contacts to complete the circuit. Absorption of ionizing radiation by the carbon 
fiber film generates electron pairs, which move in opposite directions under the influence 
of an initial current and reinforces the current. The change in current is used as an indirect 
measure of the radiation dose. A linear response between 100 and 600 MU (1–6 Gy) dose 
range indicates potential utility for dosimetry in fractionated radiotherapy.  
 
SCNTs have also been shown to be responsive to proton irradiation80. Proton irradiation 
(1011 protons/cm2) induces trapped charges in SiO2 on which the CNTs are deposited. 
These charges in turn affect the resistivity of the CNTs which is used as a measure of 
radiation dose. A polymer composite containing multiwalled carbon nanotubes (MCNTs) 
was recently developed for detecting γ radiation81.  Conductive MCNTs were dispersed in 
a non-conductive poly(olefin sulfone) matrix (Figure 4). Upon irradiation, the polymer 
network depolymerizes leading to a better contact between the MCNTs. This leads to 
enhanced electrical conductivity which is detected by amperometry. Doses as low as 50 
Gy were detected using this method. An advantage of CNT based dosimeters for radiation 
sensing applications includes real time dose response unlike passive sensors (TLDs) which 
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have to be processed and analyzed. Subsequent generations of CNT devices may possess 
the versatility required for clinical dosimetry.  
 
1.2.4 Metal Organic Frameworks 
 
Metal organic frameworks (MOFs) are crystalline materials that contain metal clusters 
linked by coordinating organic groups; these organic groups are fluorescent and are often 
excellent scintillators. This imparts fluorescence properties to MOFs upon exposure to 
ionizing radiation, and the change in luminescence can be used as a measure of the radiation 
dose. Flexibility of synthesis and ability to modulate the scintillation properties make 
MOFs attractive materials for radiation dosimetry.  
 
Several MOFs with zinc (Zn) have been evaluated for radioluminescence82. These MOFs 
were synthesized using solvothermal reaction of ZnII metal ion and stilbene dicarboxylic 
acid (SDCH2) in either N,N-dimethylformamide (DMF)/N,N-diethylformamide (DEF). 
The synthesized powdered MOFs were exposed to high-energy protons and alpha particles 
and characterized using ion-beam-induced luminescence spectroscopy (IBIL). The 
observed luminescence was similar to that seen in case of existing commercial scintillators. 
The Stokes shifts relative to the fluorescence excitation maxima for the MOFs were 
significantly large, minimizing an overlap between optical absorption and IBIL emission. 
This limited self-absorption resulting from the large Stokes shifts can lead to a new class 
of scintillators. These crystalline materials displayed enhanced radiation hardness and 
could potentially be stable for routine use with minimal concerns over radiation-induced 
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degradation. IBIL spectra were significantly different for MOFs with two different linkers: 
4,4′-biphenyldicarboxylic acid (H2BPDC) and 2,6-naphthalenedicarboxylic acid 
(H2NDC).83 BPDC2- displays a superimposable photoluminescence/IBIL emission spectra 
while a new 476nm IBIL emission peak was observed for NDC2-. BPDC2- upon excitation 
conforms to a planar geometry inhibiting formation of a dimeric species. NDC2-, on the 
other hand, readily forms excimer species in both ground and excited states due to 
intermolecular interaction.  
 
X-ray induced scintillation was also demonstrated using MOFs with Hf/Zr as the nodes 
and anthracene as the connecting ligand (Figure 5A)84; high atomic numbers metal ions 
were chosen because of their ability to absorb X-ray irradiation. These MOFs when 
exposed to X-ray radiation in the 20-200keV range resulted in the ejection of fast electrons 
following absorption of high energy photons (Figure 5B). These electrons interact with the 
anthracene linker leading to the generation of luminescence from their excited states, which 
is used as a measure of ionizing radiation. Doses as low as 0.25 μGy could be sensed by 
these materials dispersed in aqueous media. Hf-MOF displayed enhanced 
radioluminescence signal due to higher X ray scattering cross section as compared to that 
of the Zr-MOF.   
 
MOFs may be interesting candidates for a new class of radiation sensing materials because 
of their tenability. The availability of a large library of metal ions and organic linkers 
indicates the possibility of several combinations. Although very low doses can be sensed, 
linearity in the radio-therapeutic range has to be demonstrated before they could be further 
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used for real time dosimetry in the clinic. Factors including biocompatibility and 
stability/performance in biological solutions have to be studied before any potential 
application in vivo.  
 
1.3 Conclusions 
 
 
Several molecules and nanoscale systems are being investigated as radiation dosimeters 
with potential applications in fractionated radiotherapy. Some nano- and molecular scale 
sensors may demonstrate potential for clinical translation including for implantable 
applications, but additional studies on stability, sensitivity, reproducibility, toxicity, and/or 
biocompatibility are necessary. Most studies so far have typically been carried out with 
systems wherein the dosimeter does not come in direct contact with tissues and only the 
peripheral dose delivered is measured. Subsequent generations of dosimeters should be 
non-toxic, deliverable to the site of interest, be able to detect radiation doses in real time, 
and be able to provide a simple and quick readout. These advances have the potential to 
greatly improve treatment tolerance, safety and potentially, outcomes for patients 
undergoing radiotherapy.  
 
In this thesis, a dosimeter based on the formation of colored dispersions of plasmonic (gold) 
nanoparticles from colorless solutions of gold ions upon exposure to ionizing radiation is 
demonstrated.  
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Chapter 2 POLYPEPTIDE-FACILITATED FORMATION OF BIMETALLIC 
PLASMONIC NANOPARTICLES IN PRESENCE OF IONIZING RADIATION  
2.1 Introduction 
 
Ionizing radiation has widespread application that ranges from medical application in the 
form of diagnostic imaging and cancer therapy to military uses85-87. A critical aspect of 
these applications is the level of exposure which determines the acute response of 
incidentally exposed organs (in therapy) or of personnel (in warfare or nuclear energy 
industry). A wide variety of dosimeters are available to detect radiation exposure, including 
one-dimensional ion-chambers and three-dimensional polymer gels88, 89. Portability and 
conformability make potential liquid-phase dosimeters attractive, although development of 
effective liquid dosimeters has been limited to embedding dyes in a polymer-rich matrix90. 
These systems however tend to fade over time leading to a loss of signal91.  
 
Engineered systems that undergo a clearly visible color change in response to ionizing 
radiation can be employed as rapid, portable detectors, since they do not require 
sophisticated secondary analyses. In particular, plasmonic nanoparticles are attractive as 
indicators since they demonstrate a range of colors, depending on concentration and 
yield92. We previously demonstrated that irradiating gold salt solutions (in absence of 
silver), together with C2ELP molecules, resulted in the formation of gold nanoparticles93. 
In this system, high energy X-ray radiation results in the formation of both oxidizing (OH°) 
as well as reducing species (e-aq, H°) following radiolysis of water94. Reducing free radicals 
facilitate reduction of metal ions (Mn+, where n is the valency) to zero-valent metal ions 
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(M0) which then nucleate and grow into nanoparticles. C2ELP likely aids these processes 
by means of spontaneous metal ion reduction, nanoparticle stabilization, and nanoparticle 
templating due to the presence of cysteines95, 96. Although this approach is promising, gold 
nanoparticle formation was seen for doses in the 175-1000 Gy range. Here, we report that 
plasmonic nanoparticles can be generated from gold-silver bimetallic precursor solutions 
in presence of significantly lower doses (25-100 Gy), and can therefore be used as 
colorimetric reporters of elevated levels ionizing radiation.  
 
2.2 Materials and Methods 
 
Materials.  Gold(III) chloride trihydrate (HAuCl4·3H2O) was purchased from Sigma-
Aldrich. Isopropyl alcohol (IPA) (99.5%) was purchased from EMD. Silver Nitrate 
(AgNO3) and dithiothreitol (DTT) were purchased from Fisher Scientific. All chemicals 
were used as received from the respective manufacturers without any additional 
purification. 
 
Synthesis, Expression, and Purification of Cysteine containing Elastin-Like 
Polypeptides (ELPs). The elastin-like polypeptide used in the study, MVSACRGPG-(VG 
VPGVGVPGVGVPGVGVPGVGVPG)8-(VGVPGVG VPGVG VPGCG VPGVG 
VPG)2-WP, was generated using recursive directional ligation97, 98. This ELP contains two 
cysteines in the polypeptide repeat sequence and is labeled as C2ELP. The oligonucleotide 
encoding the ELP was cloned in a pUC19 plasmid. Further cloning in pET25b+ expression 
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vector at the sfiI site was carried out. The polypeptide was expressed in Escherichia coli 
BLR(DE3) (Novagen), purified, lyophilized, and stored at 4°C using methods described 
previously98. 
 
Preparation of C2ELP Samples for Irradiation with Ionizing Radiation. Lyophilized 
C2ELP was dissolved in nanopure water (18.2 MΩ cm resistivity) in order to form 1 mg / 
mL solutions. DTT was then added to the C2ELP solution (equal weight ratio of DTT to 
C2ELP) in order to reduce the cysteines in the polypeptide chain. The solution was mixed 
for 1 hour under constant rotation at 4°C after which, the DTT was removed from the 
dissolved ELP via dialysis through a 10 kDa molecular weight cut off (MWCO) membrane. 
Dialysis was carried out for a maximum of 20 hours under constant rotation at 4°C. 
Reduced C2ELP samples were stored at 4°C prior to use.  
 
Sample Preparation and Irradiation with Ionizing Radiation. Samples for irradiation 
were comprised of HAuCl4 (50 µL of 1 × 10−2 M), AgNO3 (15 µL of 1 × 10−2 M), C2ELP 
(200 µL of 1 mg/ml), and isopropyl alcohol (IPA) (600 µL of 0.4 M). In all cases, samples 
were mixed immediately prior to irradiation. All ionizing irradiation experiments were 
conducted at Banner-MD Anderson Cancer Center in Gilbert, AZ. A Truebeam linear 
accelerator was used to irradiate the samples with different doses at a dose rate of 15 
Gy/minute. The radiation beam is a 6 MeV photon beam produced by the linear accelerator. 
The solutions were irradiated with doses of 25, 50 and 100 Gy. After irradiation, all samples 
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were transported back to ASU in Tempe, AZ (approximately 15 miles; 20-30 minutes 
travel time) and characterized at 72 h after irradiation to allow for nanoparticle formation. 
 
Absorbance Spectroscopy. Absorbance values of the control (0 Gy) and irradiated 
samples were measured using a BioTek Synergy 2 plate reader in concert with Gen5 
software. The absorbance spectrum was determined from 300 to 995 nm, with a step size 
of 5 nm, using 150 μL sample in each well of a 96-well plate. Absorbance measurements 
were carried out at 72 hours following X-ray irradiation. Nanopure water was used as the 
blank in all cases, and the presence of an absorbance peak between 500-600 nm was used 
as an indicator of nanoparticle formation. 
 
Particle Size Determination. Hydrodynamic sizes of the irradiated samples were 
determined using dynamic light scattering (DLS), which was carried out with a DLS 
Particle Sizer (Corrvus Advanced Optical Instruments) in concert with a Zetasizer Nano 
instrument. Samples (40 μL) were pipetted into a square 1 mL cuvette and placed into the 
instrument for analysis.  
 
Transmission Electron Microscopy (TEM) and Elemental Analyses (EDX). 
Transmission electron microscopy (TEM) visualization was carried out using a JEOL-
2010F instrument. Specimen samples for TEM were prepared by casting a drop of the 
nanoparticle dispersion onto a carbon film on a copper mesh grid, followed by drying in 
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air, and air-dried samples were visualized by TEM. EDX analysis was performed on the 
nanoparticles using a JEOL-JEM-2000FX instrument.  
 
2.3 Results and Discussion 
 
In this study, we investigated polypeptide-mediated formation of bimetallic gold-silver (i.e. 
bimetallic) plasmonic nanoparticles as a colorimetric (visual) reporter of ionizing radiation 
(X-Rays). Radiation-induced hydrolysis results in the formation of free radicals which can 
reduce metal ions to form metal nanoparticles from their corresponding salt solutions93 
(Figure 2.1). Formation of bimetallic gold-silver nanoparticle dispersions is a simple, 
colorimetric (visual) indicator of ionizing radiation, since plasmonic nanoparticles absorb 
light in the visual region of the light absorption spectrum.  
 
 
 
 
 
Ionizing 
Radiation 
H2 M
C2ELP 
M
e
-
 
H° 
OH° 
Figure 2.1 Skeleton reaction that shows radiolysis of water followed by reduction of metal 
salts by H* and e- resulting in the formation of zerovalent metal atoms. The metal atoms 
nucleate and grow to form bimetallic nanoparticles under the current conditions employed.
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The reporter system investigated in the current study consists of three components, namely, 
isopropyl alcohol, metal salts, and a biomimetic polypeptide (C2ELP). Isopropyl alcohol 
enhances metal nanoparticle yield in three ways: (1) it converts oxidizing hydroxyl radicals 
into isopropyl radicals which are reducing in nature and facilitate the reduction of metal 
ions (i.e. Mn+) to metal nanoparticles, (2) it scavenges oxidizing agents and therefore 
prevents re-oxidation of M0 (zerovalent metal ion) to Mn+ (metal ions), and (3) it consumes 
hydroxyl radicals, and reduces the reaction between hydroxyl radicals and other free radical 
species99, 100. C2ELPs101, 102 were employed since thiols present in cysteines can facilitate 
metal nanoparticle formation and / or capping98. In addition, amide bonds, which are an 
integral part of the polypeptide backbone, can also stabilize nanoparticles through N-H 
bonds103.  
 
In order to establish conditions for colorimetric detection / reporting of ionizing radiation, 
we investigated conditions under which spontaneous nanoparticle formation could not be 
observed. We first investigated varying concentrations of silver salt and C2ELP at a fixed 
gold salt concentration of 0.57 mM. A silver salt concentration of 0.173 mM was deemed 
as an optimal condition at which spontaneous nanoparticle formation was not visually 
observed for a period of 72 h. Increasing the silver salt concentration beyond this condition 
resulted in spontaneous nanoparticle formation in the absence of radiation as seen from the 
characteristic spectral peaks in Figure 2.2.   
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Figure 2.2 Average (n=3) absorbance spectra of C2ELP (1 mg/ml) and gold-silver 
bimetallic solutions when exposed to varying concentrations of silver salt at 0 Gy at a pH 
5-6. A silver salt concentration of 0.173 mM was used for further experiments due to 
observation of only a very weak spectral band compared to higher concentrations.      
 
Increasing the polypeptide concentration above 1 mg / ml resulted in a concomitant 
increase in the dispersion color intensity indicating the formation of plasmonic 
nanoparticles (Figure 2.3). It is likely that increasing the polypeptide concentration 
increases the reducing activity and favors spontaneous nucleation and growth. In addition 
to silver salt and C2ELP concentrations, we investigated the role of solution pH, since pH 
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has been shown to be an important factor determining nanoparticle synthesis104. Figure 2.4 
indicates that spontaneous nanoparticle formation is observed under conditions of basic 
pH. This is consistent with previous findings, which indicate that higher pH conditions can 
result in rapid reduction, likely due to the higher concentrations of OH- ions under these 
conditions105, 106. Spontaneous nanoparticle formation was not seen under conditions of 
lower pH i.e. pH = 5-6. This pH condition was therefore chosen for subsequent studies.  
 
 
Figure 2.3 Average (n=3) absorbance spectra of C2ELP and gold-silver bimetallic 
solutions when exposed to varying concentrations of C2ELP at 0 Gy at pH 5-6. A C2ELP 
concentration of 1 mg/ml was used for further experiments due to observation of a minimal 
spectral band compared to higher concentrations.      
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Figure 2.4 Average (n=3) absorbance spectra of C2ELP (1 mg/ml) and gold-silver 
bimetallic solutions when exposed to acidic and basic pH conditions at 0 Gy (no 
irradiation). Absorbance spectra indicate spontaneous nanoparticle formation under 
conditions of basic pH, while nanoparticle formation is not seen for pH ranges of 2-6.     
 
Following identification of operating conditions that did not result in spontaneous 
nanoparticle formation, the metal salt-C2ELP solution was subjected to different doses of 
ionizing radiation in order to determine the minimum dose required for inducing a visible 
color change. No change in color was observed in samples not subjected to X-Ray radiation 
(Figure 2.5A). In addition, color change was not seen in samples irradiated with X-ray 
doses in the 0-20 Gy range. The minimum dose required for inducing a visual color change 
with the gold-silver bimetallic system was 25 Gy (Figure 2.5 B). Higher radiation doses 
of 100 Gy resulted in further intensification of the color in the liquid nanoparticle 
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dispersions (Figure 2.5 C & D), while no significant change in the intensity of color was 
observed for the system irradiated with a dose of 50 Gy. This is likely due to generation of 
higher number of reducing species at higher radiation doses (i.e. 100 Gy) which, in turn, 
lead to greater reduction of metal ions to their respective zerovalent metal forms. In these 
cases, the color change was seen three days after X-Ray irradiation. The peak absorbance 
value was maximum in the 100 Gy case, which is consistent with high yields that may be 
expected at higher radiation doses. This is also a reflection of the color intensity, which 
was highest for the 100 Gy case.  
 
 
Figure 2.5 Visible, colorimetric detection of ionizing radiation as reported by the 
formation of plasmonic bimetallic nanoparticles. Formation of bimetallic nanoparticles 
was facilitated by C2ELP (1 mg/mL; pH 5-6) at different radiation doses. (A) 0 Gy, (B) 25 
Gy, (C) 50 Gy and (D) 100 Gy. A visible change in color can be seen for samples irradiated 
with 25, 50, and 100 Gy. 
 
Optical density is a straightforward method for detection and quantification of plasmonic 
nanoparticle dispersions, and is often used as a surrogate for concentration. Pure gold and 
silver nanoparticles demonstrate absorbance peaks at 510-570 and 400-530 nm, 
respectively107, 108. In the absence of X-ray radiation, C2ELP molecules were not able to 
A B D C 
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reduce metal salts to the extent that a significant plasmonic peak could be observed in the 
absorption spectrum (Figure 2.6A). However, in presence of 25, 50 and 100 Gy X-ray 
radiation doses, absorbance peaks were seen between 500-600 nm three days after 
irradiation, indicating formation of plasmonic nanoparticles. These spectra are consistent 
with those for bimetallic gold-silver dispersions observed previously in the literature109. A 
reduction in the width of the absorption peak was observed with increasing radiation dose. 
This narrowing is likely an indication of lower nanoparticle polydispersity at higher 
radiation doses110.  
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Figure 2.6 (A) Average absorbance spectra (n = 9) of C2ELP and gold-silver bimetallic 
solutions in presence of C2ELP and (B) Average absorbance spectra (n = 3) of gold-silver 
bimetallic solutions irradiated in absence of C2ELP with 0 Gy (control), 25 Gy, 50 Gy, and 
100 Gy. X-ray radiation indicate nanoparticle formation in case of irradiated samples in 
presence of C2ELP. Absence of absorbance peak indicates no stable nanoparticles formed 
verifying the need for C2ELP. 
 
Dynamic light scattering (DLS) measurements indicated that nanoparticles with 
hydrodynamic diameters ranging from 80-110 nm were formed in these studies (Figure 
2.7). Previous studies, including ours, indicate that higher radiation doses lead to the 
formation of smaller sized particles 93, 99, 111. At higher radiation doses, the ratio of the 
unreduced metal ions to the reduced zerovalent metal is likely low, due to higher efficacy 
of free radical formation. The concentrations of the reduced zerovalent metal ions, and 
subsequently nanoclusters (nucleus for metal nanoparticle formation), tend to be higher 
than the unreduced metal ions in solution. Further aggregation is likely inhibited due to the 
presence of the capping agent. At lower doses of X-Ray radiation, the number (or 
concentration) of unreduced metal ions is higher than the number of metallic nuclei formed. 
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Thus, the unreduced ions likely tend to aggregate with the nucleus formed and result in 
larger sized particles on an average. 
 
 
Figure 2.7 Hydrodynamic diameters, determined by dynamic light scattering (DLS), of 
nanoparticles formed as a function of radiation dose (n=3). Data indicate mean absorbance 
values from n = 3 readings ± one standard deviation. Average hydrodynamic diameter is 
seen to decrease modestly with increasing radiation dose. The line connecting individual 
data points is included for visualization alone.  
 
X-ray irradiated and non-irradiated control samples were imaged using transmission 
electron microscopy (TEM) in order to visualize the bimetallic nanoparticles formed under 
different conditions. The core sizes of nanoparticles, as visualized using TEM, ranged from 
15 to 90 nm in the different cases studied (Figure 2.8), while the average core sizes 
typically range from 10-20 nm. The control (0 Gy) did result in the formation of 
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nanoparticles, indicating that the C2ELP molecules were capable of reducing metal ions 
and thereby templating nanoparticles in absence of radiation as seen previously93. This is 
likely due to the presence of the amide backbone in the ELP chain, along with the presence 
of arginine (A), which contains an amine moiety. These moieties can stabilize the 
nanoparticles formed due to the reduction of metal salts in the presence of tryptophan (W) 
residues which is known to be a powerful reducing agent for metal salts112, 113. However, it 
is important to note that neither peaks in the absorption spectrum (Figure 2.6A), nor 
significant color changes (Figure 2.5A) were observed in the case of C2ELP-bimetallic 
metal solutions not subjected to X-Ray radiation. These observations indicate that in 
absence of radiation, C2ELP did not result in high enough yields of nanoparticles to be 
identified visually and / or spectroscopically. Irradiating aqueous solutions of gold-silver 
bimetallic metal salts in presence of C2ELP resulted in formation of plasmonic 
nanoparticles due to the additional reducing activity following radiolysis of water. These 
higher nanoparticle yields could be identified visually due to the color change (Figure 2.5) 
as well as the characteristic UV-visible absorbance spectra (Figure 2.6). A precipitate was 
visually observed when the metal salts were irradiated in absence of C2ELP while the 
solution remained colorless and no peaks were seen in the the UV-Vis light absorption 
between 300 and 990 nm (Figure 2.6B). This confirms that C2ELP is necessary as a 
stabilizing agent for overcoming aggregation of the metal atoms formed during radiolysis.  
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Figure 2.8 Transmission electron microscopy (TEM) images of plasmonic nanoparticles 
formed under irradiation. (A) control (0 Gy) and samples irradiated with (B) 25 Gy, (C) 50 
Gy and (D) 100 Gy X-Ray radiation. Scale bar = 20 nm for (A) and (B), and 50 nm for (C) 
and (D). 
 
Elemental analyses were carried out in order to determine the composition of the plasmonic 
nanoparticles formed. Heterogeneity in the elemental composition was observed among 
different nanoparticles investigated (n ≥ 3 nanoparticles), and nanoparticles individually 
enriched in either gold or silver were seen (Figure 2.9A-B). The synthesis of such 
bimetallic clusters has been shown to proceed by a progressive reduction of metal ions 
during radiolysis and growth of the nanoparticles (Figure 2.10). During radiolysis the 
reducing free radicals react with gold and silver metal ions and reduce them to their 
zerovalent states114. The lesser noble metal (silver in this case) transfers electrons to the 
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more noble metal (gold in this case) which results in reduction of the latter from Au3+ to 
Au0 species. Electron transfer is made possible due to the differences in electronegativity 
as Au is more electronegative than Ag. The electron relay from Ag to Au is also possible 
between the different valence states of the gold ions (i.e. +1 and +3)111.  
 
 
 
 
Figure 2.9 Elemental analyses of plasmonic nanoparticles (n ≥ 3) indicates presence of 
both gold and silver. Heterogeneity among nanoparticles is observed with some particles 
being enriched in silver (A) and others rich in gold (B).      
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Figure 2.10 Schematic of bimetallic nanoparticle formation during radiolysis involving 
inter-metal electron transfer. 
 
To further verify the need for a bimetallic system, solutions containing either silver alone 
or gold alone were irradiated separately (Figure 2.11). The maximum absorbance values 
were similar to the bimetallic condition (between 500-600 nm for Au salt and 400-500 nm 
for Ag salt). Following baseline and offset corrections (i.e. maximum absorbance at the 
corresponding wavelengths – absorbance at 900 nm), it was observed that the yields of the 
bimetallic nanoparticles were higher than those for the individual metal (Au or Ag) 
nanoparticles alone. This further provides support to our hypothesis that the presence of a 
small amount of silver ions facilitates nanoparticle formation at lower doses as those 
required for gold salt alone (≥ 175 Gy).  
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Figure 2.11 Average values of peak absorbance (n = 3) observed after C2ELP and 
monometallic (Au or Ag) / bimetallic (Au and Ag) solutions were irradiated with 0 Gy 
(control), 25 Gy, 50 Gy, and 100 Gy X-ray radiation. Error bars indicate standard deviation. 
Overall increase in the average absorbance values likely indicate higher yields of bimetallic 
nanoparticles formed for a given radiation dose. Asterisks (*) indicate p-values < 0.05 for 
Au-Ag system compared to Au/Ag alone control systems, as determined using Student’s t-
test; p-values < 0.05 are considered statistically significant. 
 
2.4 Conclusions 
In conclusion, we report that radiation-induced nanoparticle formation from a mixture of 
gold-silver metal salts, scavenging agents, and cysteine-containing elastin-like 
polypeptides can be employed as a reporter for elevated doses of ionizing radiation, 25 Gy 
and higher. Even though nanoparticle formation was observed using TEM for non-
irradiated (0 Gy) samples, visible color changes was observed only in case of irradiated 
samples, indicating a colorimetric response to radiation. Future work will involve an 
investigation into engineering the polypeptide, as well as optimizing operating conditions 
in order to further enhance the sensitivity of this simple detection system. It is anticipated 
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that these studies can advance the field of conformable and portable radiation detectors for 
various applications in healthcare, defense and space exploration.  
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Chapter 3 A COLORIMETRIC PLASMONIC NANOSENSOR FOR DOSIMETRY 
OF THERAPEUTIC LEVELS OF IONIZING RADIATION 
3.1 Introduction 
Radiation therapy is a common primary treatment modality for multiple malignancies, 
including cancers of the head and neck, breast, lung, prostate, and rectum.115 Depending 
on the disease, cumulative radiation doses ranging from 20 and 70 Gy are often employed 
for therapeutic use. Diseased tissue and normal organ radiation sensitivities also vary.116 In 
order to maximize disease treatment relative to radiation-induced side-effects, various 
methods of delivery including hyperfractionation (0.5-1.8 Gy), conventional fractionation 
(1.8-2.2 Gy), and hypofractionation (3-10 Gy)115 have been explored. These delivery 
methods explore different regimes of radiation sensitivity in order to maximize tumor cell 
killing while optimizing treatment times.115  
 
Despite obvious advantages with radiotherapy, there can be significant radiation-induced 
toxicity in tissues.117 For example, radiation-induced proctitis can be of significant 
morbidity for patients undergoing prostate or endometrial cancer treatment. For centrally 
located lung cancer radiotherapy, the esophagus can be incidentally irradiated during 
treatments, resulting in esophagitis. In head and neck treatments, radiation of salivary gland 
or pharyngeal tumors can induce radiation-induced osteonecrosis. Another concern during 
radiotherapy is the motion of the patient as well as the natural peristalsis of internal organs. 
These issues highlight the importance of appropriately dosing cancerous tumors while 
sparing the normal tissue in order to prevent significant morbidity that arises from radiation 
toxicity.   
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Following several transformative advances since its inception in the late 19th century,118 
radiation therapy has become a complex process aimed at maximizing the dose delivered 
to the tumor environment while sparing normal tissue of unnecessary radiation. This has 
led to the development of image-guided and intensity-modulated radiation therapy.119 The 
process of treatment planning requires initial simulation followed by verification of dose 
delivery with anthropomorphic phantoms which simulate human tissue with more or less 
homogeneous, polymeric materials.120 The accuracy of the planning is determined using 
either anthropomorphic phantoms or 3D dosimeters.119,121,122 During treatment, actual dose 
delivery can be verified with a combination of entry, exit or luminal dose 
measurements,120,123,124 in a process called in vivo dosimetry. Administered in vivo doses 
can be measured with diodes (surface or implantable), thermoluminescent detectors 
(TLDs), or other scintillating detectors.120,123,124 However, these detectors are either 
invasive, difficult to handle (due to fragility or sensitivity to heat and light), require 
separate read-out device, or measure surface doses only.  TLDs are typically laborious to 
use and require repeated calibration, while diodes suffer from angular, energy and dose 
rate-dependent responses.125 Although MOSFETs can overcome some of these limitations, 
they typically require highly stable power supplies.126 In addition, these dosimeters require 
sophisticated and expensive fabrication processes in many cases. In light of these 
considerations, there is still a need for the development of robust and simple sensors in 
order to assist / replace existing dosimeters that can be employed during sessions of 
fractionated radiotherapy.127, 128 
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Unique optical properties associated with plasmonic nanoparticles129 have led to 
investigation of different metal nanoparticles in imaging, hyperthermia, drug delivery, and 
sensing applications.67, 130, 131 Of particular relevance to imaging and sensing is the 
observation that dispersions of plasmonic nanoparticles display different colors depending 
on the size of the particles. Metallic nanoparticles are synthesized using a wide range of 
wet chemistry66, 132 and radiation133 based techniques. Current radiation-based methods 
require high doses, use of complex polymers / polypeptides, scavengers and / or inert 
atmospheres to engender nanoparticle synthesis.93, 134, 135 To our knowledge, none of these 
methods are based on dose ranges employed in fractionated radiotherapies.  
 
In this work, we exploited lipid surfactant-templated formation of colored dispersions of 
gold nanoparticles from colorless metal salts as a facile, visual and quantitative indicator 
of therapeutic levels of ionizing radiation (X-rays) for application in radiation dosimetry. 
This plasmonic nanosensor can detect radiation doses as low as 0.5 Gy, and exhibit a linear 
response for doses relevant in therapeutic administration of fractionated radiotherapy (0.5 
– 2 Gy). Modulating the concentration and chemistry of the templating lipid surfactant 
results in linear response in different dose ranges, which demonstrates the versatility of the 
plasmonic radiation nanosensor in a variety of radiotherapy applications. 
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3.2 Materials and Methods  
Materials. Gold(III) chloride trihydrate (HAuCl4·3H2O), trimethyloctylammonium 
bromide (C8TAB) (≥ 98%), dodecyltrimethylammonium bromide (C12TAB) (≥ 98%) and 
L-Ascorbic acid (AA) were purchased from Sigma-Aldrich. Cetyl trimethylammonium 
bromide (C16TAB) was purchased from MP chemicals. All chemicals were used as 
received from the manufacturer without any additional purification. 
  
Sample Preparation for Irradiation. First, 30µL of 0.01 M HAuCl4 were mixed with 600 
µL of 0.05 M Cx=8,12,16TAB. Upon addition of 30 µL (0.196 mM), 300 µL (1.96 mM), 600 
µL (3.92 mM approximated as 4mM) and 900 µL (5.88 mM or ~5.9 mM) of 0.01 M L-
Ascorbic acid, the solution turned colorless after shaking; the concentrations of ascorbic 
acid were thus varied in order to examine its effect on nanoparticle formation. Unless 
specifically mentioned, the volume of AA used is 900 µL. The measured pH of the 
precursor solution was typically between 2.9 and 3.1. Samples were prepared at Banner-
MD Anderson Cancer Center, Gilbert, AZ prior to radiation. 
  
Radiation Conditions. A Varian TrueBeam linear accelerator was used to irradiate 
samples at a dose rate of 15.6 Gy/min. The samples containing surfactant at a concentration 
of 20 mM and 10 mM were radiated at doses of 0 (control), 1.1, 3.2, 5.3, 10.5, 15.8, 26.3, 
36.9 and 47.4 Gy. These are reported as 0, 1, 3, 5, 10, 16, 26, 37 and 47 Gy respectively in 
the article. The samples containing surfactant at a concentration 2 mM and 4 mM were 
irradiated with 0 (control), 0.5, 1, 1.5, 2, 2.5, 3, 5, 7.5, 10, 12.5 and 15 Gy. After irradiation 
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the samples were transported back to Arizona State University in Tempe, AZ (one-way 
travel time of approximately 20-30 minutes). At a dose rate of 15.6 Gy / min, most doses 
take seconds to administer to a sample, and the highest dose (47 Gy) takes a little over 3 
minutes. 
  
Absorbance Spectroscopy. Absorbance profiles of the radiated and the control samples 
were measured using a BioTek Synergy 2 plate reader. Absorbance values from 150 µL of 
sample were measured from 300 to 900 nm with a step size of 10 nm in a 96 well plate. 
Nanopure water (18.2 MΩcm) was used as a blank in all cases. The absorbance was 
corrected for offset by subtracting A900 nm and the presence of a peak (or peaks) between 
500 and 700 nm was used as an indicator for gold nanoparticle formation. 
 
Determination of Critical Micellar Concentration (CMC). Pyrene (60 µL of 2 x 10-5M) 
in acetone was added to 20 ml glass vials. Upon acetone evaporation, 2ml of C16TAB of 
varying concentrations was added and stirred for 6 hours at room temperature. To achieve 
the similar conditions as the irradiation experiments, 30µL of 10mM gold salt + 600µL of 
the above prepared C16TAB + 900µL of 10mM ascorbic acid were mixed. A fluorescence 
spectrophotometer with an excitation scan range of 300 – 360 nm and an emission 
wavelength of 390 nm was used. Ratio of I337/I334 determined as a function of the surfactant 
concentration was used to calculate the CMC using pyrene as the probe based on methods 
described in the literature136. 
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Dynamic Light Scattering (DLS) Measurements. 50 μL of the sample was transferred 
into a cuvette and placed into a Zetasizer Nano instrument. The software was set up to carry 
out measurements with autocorrelation. Thereafter, the average diameter values, along with 
the polydispersity index (PDI), were recorded based on the software readout. 
 
Transmission Electron Microscopy (TEM). Samples for TEM were prepared by casting 
a drop of the solution onto a carbon film on a copper mesh grid. The samples were then 
dried in air. The above process was repeated several times to ensure good coverage. Dried 
samples were visualized using a CM200-FEG instrument operating at 200 kV. 
 
Endorectal Balloon Studies. Prostate immobilization treatment (endorectal) balloon 
device kit was purchased from Radiadyne. The nanosensor (1.503 mL) containing 20mM 
C16TAB was introduced into the inflatable balloon through the stem using a syringe. After 
irradiation with the corresponding dose, the liquid was drawn out and the absorbance was 
measured using a UV-visible spectrometer. 
 
Prostate Phantom Experiments. CIRS tissue equivalent prostate phantom was aligned at 
the center of the prostate volume on the Philips RT CT table with CT room aligning lasers. 
Three radio opaque markers were placed at the isocenter of the radiation beams. The 
endorectal balloon was inflated to a known volume of 50 ml following insertion into the 
phantom. CT scan imaging was executed on the phantom with 1 mm image thickness and 
1 mm spacing to total of 150 images. After scanning, they were exported to a Philips 
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Pinnacle treatment planning system. The prostate, rectum and the capsules were contoured 
and a treatment plan was generated for a 6MV radiation beam. A prescribed dose of 1 Gy 
to a 95% isodose encompassing the entire prostate was simulated. Pinnacle’s Collapsed 
Cone Convolution Superposition (CCCS) algorithm was used to compute the dose to the 
prostate in the phantom. 
 
3.3 Results and Discussion 
Facile radiation sensors have the potential to transform treatment methods and planning in 
clinical radiotherapy by verifying the precise delivery of doses to the intended site of action 
with minimal damage to surrounding tissues. Here, we report studies on a simple 
colorimetric, liquid-phase plasmonic nanosensor that can detect therapeutic levels of 
ionizing radiation. X-rays, in concert with templating lipid micelles, induced the formation 
of colored dispersions of gold nanoparticles from a colorless gold salt solution, thereby 
resulting in a visible indicator of ionizing radiation.  
 
Several molecular design considerations were employed in order to develop the plasmonic 
nanosensor for detecting therapeutic doses (broadly 0.5 -10 Gy) of ionizing radiation. The 
basic working principle behind the plasmonic nanosensor involves reduction of colorless 
gold ions to gold nanoparticles (colored) by generating zerovalent (Au(0)) ions in order to 
facilitate nanoparticle nucleation and growth. Gold ions typically exist in a trivalent state 
(Au(III)) in metal salts, and we first sought to convert these ions to monovalent gold ions 
(Au(I)). This is because the reduction of Au(I) to Au(0) is thermodynamically favored over 
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the reduction of Au(III) to Au(0) due to the higher standard reduction potential of the 
former.137 Au(I) has an electronic configuration of 4f145d10 and requires a single electron 
for conversion (reduction) to Au(0),138 which then grow to form nanoparticles. 
 
In the current plasmonic nanosensor, the electron transfer required for reducing Au(I) to 
Au(0) is facilitated by splitting water into free radicals following exposure to ionizing 
radiation (X-rays). Water splitting by ionizing radiation generates three key free radicals, 
two of which, e- and H., are reducing, and the other (˙OH.) is oxidizing in nature.93 Ascorbic 
acid is an antioxidant and is capable of removing the oxidizing OH. radicals, which can 
inhibit nanoparticle formation. Finally, CxTAB (x=8, 12, 16) surfactants were employed 
for their ability to template gold nanoparticles.139 Taken together, a colorless metal salt 
precursor solution consisting of a mixture of auric chloride (HAuCl4), L-ascorbic acid (AA) 
and cetyl (C16), dodecyl (C12), or octyl (C8) trimethylammonium bromide (Cx; x=16/12/8TAB) 
surfactant molecules (Figure 3.1; please see the Experimental Section for more details),140, 
141 form the key constituents of the novel plasmonic nanosensor for detecting ionizing 
radiation as described in the following sections. 
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Figure 3.1 Schematic depicting the reaction progress after addition of various components 
in the plasmonic nanosensor for ionizing radiation. The concept for this figure was adapted 
from [142]. HAuCl4 salt solution is yellow in color, but changes to orange upon addition of 
CxTAB. Addition to ascorbic acid results in the formation of a colorless solution forming 
the precursor solution for the plasmonic nanosensor. Irradiation with ionizing radiation 
(e.g. X-rays shown as hν) results in the formation of colored dispersions of gold 
nanoparticle. The color of gold nanoparticle dispersions (AuNPs) can vary in color 
depending on the size of the nanoparticles. 
 
CxTAB and HAuCl4 (gold salt) were first mixed leading to the formation of AuIIIBr4-. 
HAuCl4 (Au(III)) shows a prominent light absorption peak at 340 nm, which shifts to 400 
nm after addition of C16TAB, likely due to the exchange of a weaker chloride ion by a 
stronger bromide ion (Figures 3.2 A and B, Figure 3.1).138 The shift in the absorption 
peak can also be seen visually as a color change from yellow to orange. Ascorbic acid 
reduces Au(III) to Au(I) in a two-electron, step-reduction reaction,138 and addition of the 
acid to an orange-colored solution of HAuCl4 and C16TAB renders it colorless with no 
observable peaks between 300 and 999 nm (Figure 3.2 C, Figure 3.1). This mixture of 
CxTAB, ascorbic acid, and HAuCl4 is employed as the precursor solution of the plasmonic 
radiation nanosensor. It has been shown that addition of up to 5 molar equivalent excess 
ascorbic acid does not result in the formation of zerovalent gold or Au(0) species, which 
can be partly attributed to the lower oxidation potential of the acid in presence of 
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Figure 3.2 UV-Visible spectral profiles of (A) HAuCl4 (Circles) (B) HAuCl4 + C16TAB 
(Diamonds), (C) HAuCl4 + C16TAB + Ascorbic Acid (Squares) and (D) HAuCl4 + Ascorbic 
Acid (AA) (Triangles). 
C16TAB.143 However, a characteristic peak in the range of 500-600 nm corresponding to 
gold nanoparticles is observed if ascorbic acid is directly reacted with the gold salt in the 
absence of C16TAB (Figure 3.2 D),138 indicating spontaneous formation of nanoparticles 
in absence of the lipid surfactant under the conditions employed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We next optimized the concentration of ascorbic acid (AA) in the presence of the surfactant 
(C16TAB) and gold salt employed in the precursor solution for the plasmonic nanosensor; 
the maximal dose of 47 Gy was delivered in order to study the effect of ascorbic acid on 
nanoparticle formation (Figure 3.3). A marked increase in nanoparticle formation is 
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observed when excess AA is used, and the effect saturates at 600 µL of 0.01 M (4 mM AA) 
(Figure 3.3). Although saturation was observed when 4 mM AA were used, we used ~5.9 
mM AA for all subsequent experiments in order to ensure adequate quenching of OH. 
radicals which can reduce the yield of nanoparticles generated. Control experiments with 
(1) gold salt (HAuCl4) alone, (2) gold salt + C16TAB and (3) gold salt + C12TAB were also 
carried out in presence of different X-ray doses, but in absence of ascorbic acid. 
Absorbance profiles of the samples were measured after 7 hours, and the absence of peaks 
from 500-900 nm indicated the absence of plasmonic (gold) nanoparticles (Figure 3.4). 
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Figure 3.3 (A) UV-Vis spectra of varying ascorbic acid volumes along with gold and 
C16TAB irradiated at 47 Gy. (B) Maximum absorbance values of samples containing 
varying concentrations of ascorbic acid. A significant increase in the absorbance peak 
intensity is observed at ~ 520 nm when the amount of ascorbic acid is increased, indicating 
an increase in the formation of gold nanoparticles.  
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Figure 3.4 Absorbance spectra of (A) gold salt (0.196 mM) (B) gold salt (0.196 mM) + 
C16TAB (20 mM) (C) gold salt (0.196 mM) + C12TAB (20 mM). Nanoparticle formation 
is not observed in the absence of ascorbic acid signifying its importance in the plasmonic 
nanosensor system.   
 
Next, we investigated the efficacy of three cationic surfactants, C8TAB, C12TAB, and 
C16TAB, for inducing nanoparticle formation in presence of different doses of ionizing 
radiation (Figure 3.5). All three surfactants have trimethyl ammonium moieties as the head 
group and bromide as the counter ions; only the lipid chain length was varied as C8, C12, 
and C16 in these molecules and a concentration of 20 mM was employed for each lipid. As 
stated previously, a large number of e-aq and H. radicals are generated following exposure 
of the solution to X-rays which facilitate the conversion of Au+ ions to their zerovalent Au0 
state.99 The Au0 species act as seeds upon which further nucleation and coalescence occurs. 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
300 500 700 900
A
bs
or
ba
nc
e 
(A
.U
)
Wavelength (nm)
0Gy
1Gy
3Gy
5Gy
10Gy
16Gy
26Gy
37Gy
47Gy
C 
55 
 
This, in turn, leads to an increase in size and eventual formation of nanoparticles, which 
are stabilized by surfactant molecules. Formation of these plasmonic nanoparticles imparts 
a burgundy / maroon color to the dispersion; the intensity of the color increases with an 
increase in radiation dose applied (Figure 3.6).  
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Figure 3.5 UV-Vis absorption spectra of the control (0 Gy) and X-ray irradiated samples 
containing (A) C16TAB, (B) C12TAB and (C) C8TAB after 7 hours. The concentration of 
each lipid surfactant was 20 mM. 
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Nanoparticle formation was seen as early as 1 h following irradiation in many cases, 
although 2 h were required for samples irradiated with lower doses (1, 3 and 5 Gy) (Figure 
3.7). No significant differences in absorbance intensity were observed thereafter until a 
period of 7 hours, which was the maximum duration investigated in these cases. 
Nanoparticle formation was observed at radiation doses as low as 1 Gy, which is well 
within the range of doses employed for radiotherapy.144 While C16TAB or C12TAB were 
effective at templating nanoparticle formation even at low doses (1-5 Gy), C8TAB did not 
show any propensity for templating nanoparticle formation even at the highest radiation 
dose (47 Gy) employed. C12TAB-templated gold nanoparticles exhibited unique spectral 
profiles under ionizing radiation; two spectral peaks - one between 500 and 550 nm and 
    0                1               3               5              10             16             26              37             47 
E 
 
Figure 3.6 Optical images of samples containing different C16TAB and C12TAB 
concentrations irradiated with a range of X-ray doses (Gy) (A) 2 mM C16TAB, (B) 4mM 
C16TAB, (C) 10mM C16TAB, (D) 20mM C16TAB and (E) 20mM C12TAB 2 hours post X-
ray irradiation. The corresponding X-ray radiation dose leading to the observed visual 
color change is indicated below each sample in Gray (Gy).  
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another between 650 and 800 nm - were seen (Figure 3.5 B). This is in contrast to C16TAB 
which exhibited only a single peak between 500 and 600 nm (Figure 3.5 A). The linear 
response of absorbance due to nanoparticle formation, seen between 5-37 Gy, was 
significantly more pronounced for C16TAB than that for C12TAB (Figure 3.8). Although 
nanoparticle formation was seen in the 1-5 Gy range, the absorbance of the dispersions 
under these conditions did not fall in the linear range (5-37 Gy), which indicated that the 
nanosensor was not sensitive at these lower doses. Given these findings, we focused our 
subsequent studies mainly on the C16TAB lipid surfactant in order to further optimize the 
nanosensor. 
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Figure 3.7 Kinetics of gold nanoparticle formation following exposure to different doses 
of ionizing radiation (0-47 Gy) for (A) C16TAB, (B) C12TAB and (C) C8TAB. Maximum 
(peak) absorbance values, typically between 450 nm and 650 nm, are plotted as a function 
of time following irradiation. The maximal value is reached at 1 h in most cases, but 
requires up to 2 h for lower doses. The value remains unchanged over a period of 7 h.  
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The critical micelle concentration (CMC) of C16TAB is reported to be approximately 1 
mM.145 Using the pyrene fluorescence assay, we determined the CMC of C16TAB in the 
nanosensor precursor solution (i.e. gold salt and ascorbic acid in deionized water) to be 
~0.39 mM, which was slightly lower than ~0.88 mM determined in deionized (DI) water 
(Figure 3.9). Pre-micellar aggregates are thought to exist when C16TAB concentration is 
lower than 7.4 mM, while stable micelles are observed at higher concentrations of the lipid 
Figure 3.8 Maximum absorbance vs. radiation dose (Gy) after 2 hours of X-ray irradiation. 
C16TAB (red filled squares, solid line) and C12TAB (orange open circles, dotted line) 
surfactants. C8TAB (green triangles, dotted line) does not show any response to radiation.
The lipid concentration was 20 mM in all cases. 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0 5 10 15 20 25 30 35 40 45 50
M
a
x
im
u
m
 A
b
so
rb
a
n
ce
 (
A
.U
.)
Dose (Gy)
C16TAB
C12TAB
C8TAB
64 
 
surfactant.146 It has been previously suggested that smaller, pre-micellar aggregates can 
facilitate enhanced catalytic activity of Fe(III) and promote oxidation of sulphanilic acid 
compared to fully matured micelles, likely due to the increased ratio of the reactant species 
to the surfactant molecules.147 We therefore hypothesized that increasing the ratio of the 
metallic species (Au+) to the aggregate (pre-micellar / micellar) C16TAB species will lead 
to greater propensity for nanoparticle formation upon exposure to ionizing radiation and 
therefore increased sensitivity of the resulting nanosensor at lower radiation doses. Based 
on the assumption that the number of aggregate species increases with lipid 
concentration,146 we next investigated different concentrations of C16TAB (0.7 mM, 2 mM, 
4 mM and 10 mM) in the nanosensor, while keeping the concentrations of gold ions and 
ascorbic acid constant. 
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Use of C16TAB concentrations below its CMC in the nanosensor precursor solution 
resulted in spontaneous formation of gold nanoparticles in absence of ionizing radiation; 
gold nanoparticle formation can be seen from the characteristic absorbance peak of the 
dispersion in Figures 3.9 and 3.10. However, the propensity for spontaneous nanoparticle 
formation is significantly reduced or lost at concentrations well above the CMC. A distinct 
color change can be observed for radiation doses as low as 0.5 Gy at a C16TAB 
concentration of 2mM, which is above the CMC of the lipid surfactant (Figures 3.6A and 
3.11). A linear response was observed for radiation doses ranging from 0.5 to 2 Gy under 
these conditions (Figure 3.12). As the concentration of C16TAB increases (4, 10, 20 mM), 
the radiation dose required to template nanoparticle formation also increases (Figures 3.6 
and 3.11). Furthermore, the color of the nanoparticle dispersion formed is significantly 
different in cases of 2mM C16TAB (blue-violet) compared to that observed in cases of 4 
mM (bluish-red), 10 mM (red / pink) and 20 mM (burgundy / maroon) C16TAB, likely 
indicating different sizes of nanoparticles formed under these conditions. An increase in 
color intensity is observed with increasing radiation dose (Figures 3.5 and 3.6), which 
allows for dose quantification using absorbance measurements. While it is most desired 
that the nanosensor is sensitive to therapeutic doses used in conventional and 
Figure 3.9 Determination of the critical micelle concentration (CMC) value for C16TAB 
in the nanosensor precursor solution (‘C16TAB + Au + AA’ in the legend) and DI Water 
(‘C16TAB’ in the legend) using the pyrene fluorescence assay. The intensity ratio of I337/I334
was plotted as a function of the lipid surfactant concentration and the CMC value was 
determined from the mid-point as shown in the figure. The dashed lines are for 
visualization alone. n = 2 independent experiments. Spontaneous nanoparticle formation 
was seen with the nanosensor precursor solution at 0.1 mM resulting in increased 
fluorescence intensity at this condition. As seen in the figure, the CMC of C16TAB was 
~0.88 mM and that for C16TAB in the nanosensor precursor solution was ~0.39 mM.  
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hyperfractionated radiotherapy (~0.5-2.0 Gy) as seen in the case of 2mM C16TAB, results 
with different concentrations of the lipid surfactant indicate that the response of the 
plasmonic nanosensor can be tuned by simply modifying the concentration of the lipid 
surfactant. Such visual colorimetric sensors possess significant advantages of convenience 
and likely, cost, over those that employ fluorescence changes or electron spin resonance 
measurements for detecting ionizing radiation. 
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Figure 3.10 Absorbance spectra of precursor monovalent gold salt solutions under 
conditions of no radiation (i.e. 0 Gy) in presence of different concentrations of (A) C16TAB 
and (B) C12TAB (C) C8TAB recorded after 10 minutes of incubation. Spontaneous 
nanoparticle formation was seen at 0.2 mM for all lipid surfactants, as indicated by the 
characteristic absorbance peak of gold nanoparticles at ~520 nm. In contrast, no 
nanoparticle formation was observed at a lipid concentration of 20 mM for up to 7 h. 
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Figure 3.11 Maximum absorbance vs. wavelength for different concentrations of C16TAB 
after a duration of 2 hours post irradiation with different doses of X-rays. (A) 2mM (B) 
4mM (C) 10mM (D) 20mM C16TAB.  
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Figure 3.12 Maximum absorbance vs. radiation dose for varying concentrations of C16TAB 
2 hours post X-ray irradiation. Red filled diamonds, solid line: 2 mM C16TAB, Orange 
filled circles, dashed line: 4 mM C16TAB, Green filled triangles, solid line: 10 mM 
C16TAB, and Blue filled squares, dashed line: 20mM C16TAB.  
 
 
Free radicals generated upon radiolysis of water are thought to be localized in finite 
volumes called spurs.148 These spurs can expand, diffuse, and simultaneously, react, 
leading to the formation of molecular products. These highly reactive free radicals have 
very short lifetimes of  ~10-7 – 10-6 s at 25oC.148 Reaction volumes consisting of nanoscale 
features can facilitate enhanced reaction kinetics and ensure efficient utilization of these 
free radicals for the formation of nanoparticles.149 In case of the current plasmonic 
nanosensor, this was achieved by the use of amphiphilic molecules that self-assemble into 
micelles above their respective critical micellar concentrations (CMCs). A strong 
interaction is possible between the positively charged head group of the lipid surfactant 
micelles and the negatively charged AuCl4- ions (Figure 3.1).150 This interaction can lead 
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to incorporation of AuCl4- ions in the water-rich Stern layer leading to the formation of a 
‘nanoreactor’.149, 150 However, spontaneous formation of nanoparticles (i.e. in absence of 
ionizing radiation) was seen when concentrations of C16TAB were lower than the CMC 
(Figure 3.10). We hypothesize that spontaneous nanoparticle formation observed at lower 
concentrations of the surfactant is likely due to negligible steric hindrance between the 
surfactant and ascorbic acid;22 absence of these barriers results in nanoparticle growth 
which can be observed spectroscopically.151 It is only when the concentrations of C12TAB 
and C16TAB are higher than the CMC, that no spontaneous formation of gold nanoparticles 
is seen in the precursor solution, and ionizing radiation is required to induce nanoparticle 
formation. Of the three lipid surfactants, only the concentration of C8TAB was significantly 
below its CMC value (130 mM),152 while the concentrations employed were significantly 
higher than the CMCs of C12TAB (CMC ~15 mM145) and C16TAB (CMC ~1 mM145). In 
the case of C8TAB, there is an absence of these “nanoreactors”, which may explain lack of 
nanoparticle formation under these conditions. The self-assembly of C12TAB and C16TAB 
lipid surfactants to nanoscale micelles above their respective CMCs is therefore key for the 
functioning of the plasmonic nanosensor.  
 
Key features of gold nanoparticle absorbance spectra include the shape of the surface 
plasmon resonance band and the position of the maximal (peak) absorption wavelength. 
While C16TAB-templated nanoparticles showed a single maximal absorption peak (at ca. 
520 nm), C12TAB-templated nanoparticles showed two peaks: one at ca. 520 nm (visual 
region) and another at ca. 700 nm (near infrared or NIR region; Figure 3.5 B), particularly 
at higher doses of ionizing radiation. The width of the spectral profiles at lower doses 
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signifies a somewhat polydisperse population of the nanoparticles (Figures 3.5 A, B and 
11)153. The absorbance peaks are red-shifted with decreasing radiation doses, suggesting 
an increase in particle size under these conditions compared to those obtained at higher 
doses.  
 
Nanoparticles formed in presence and absence of ionizing radiation were further 
characterized for their hydrodynamic diameters and morphology using dynamic light 
scattering (Figure 3.13) and transmission electron microscopy (TEM; Figure 3.14, 3.15 
and 3.16), respectively. TEM images indicated that a mixture of spherical and rod-shaped 
nanoparticles was observed at the higher radiation doses (47 Gy) in case of C12TAB as the 
templating surfactant (Figure 3.14 D). This can explain the absorption spectral profile with 
peaks in both, the visual and near infrared range of the spectrum in case of nanoparticles 
templated using 20 mM C12TAB (Figure 3.5 B). A significant decrease in the near infrared 
absorption peak is observed at lower X-ray doses. Although the spectral profile indicates 
formation of gold nanospheres, we observed an ensemble of unique anisotropic (dendritic 
and nanowire) structures (Figure 3.15). Such structures were not observed at similar X-
ray doses when 20 mM C16TAB was used as the templating surfactant. A strong interaction 
energy (U) between C12TAB and Au (111) has been previously described154. This strong 
affinity for the Au (111) crystal plane is thought to favor slower desorption of the surfactant 
along Au (111) leading to growth along other available crystal planes. This can allow for 
the formation of rod-shaped and other anisotropic nanostructures. Although C16TAB has 
been used to synthesize nanowires and nanorods previously, these methods typically 
involve the use of additional chemicals including NaOH or AgNO3 .102,155 In the current 
74 
 
case, it is likely that the gold nanoparticles aggregate more rapidly in situ due to the strong 
hydrophobic nature of the long of C16TAB chains, leading to the formation of quasi-
spherical nanoparticles and not anisotropic nanostructures.154     
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Figure 3.13 (A) Nanoparticle hydrodynamic diameter vs. radiation dose evaluated using 
dynamic light scattering. An increase in average particle diameter is observed with a 
decrease in radiation dose for both 20 mM C16TAB (red circles) and 20 mM C12TAB (blue 
triangles). (B) Hydrodynamic diameter vs. radiation dose for different concentrations of 
C16TAB (plotted on a log10 scale on the X-axis). An increase in average particle diameter 
is observed with a decrease in radiation dose for all four different concentration of C16TAB 
employed. Blue circles: 2mM; green diamonds: 4mM; orange circles: 10mM and yellow 
circles: 20mM C16TAB.  
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C A 
B D 
Figure 3.14 Transmission Electron Microscopy (TEM) images of nanoparticles after 
exposure to ionizing (X-ray) radiation using two different lipid surfactants, 20 mM C16TAB 
(left) and 20 mM C12TAB (right). (A) 1 Gy, (B) 47 Gy, (C) 5 Gy and (D) 47 Gy. 
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A B 
C D 
Figure 3.15 Transmission electron microscopy (TEM) images of anisotropic 
nanostructures (A) dendritic and (C) nanowire-like structures formed in case of C12TAB at 
5 Gy X-ray radiation dose. Images on the right show magnified images of the highlighted 
regions inside red box from Figures (A) and (C).   
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TEM images indicated a reduction in the size of the metal nanoparticles with increasing 
radiation dose. Dynamic light scattering (DLS) studies on irradiated samples (Figure 3.13 
and Table 3.1) also indicated a decrease in nanoparticle hydrodynamic diameters with 
increases in X-ray dose, which is in good agreement with information from TEM images. 
High radiation doses generate a larger number of free radicals in comparison to lower 
radiation doses, which can lead to the reaction with and therefore, consumption of a higher 
number of metal ions. This leads to the formation of a higher concentration of zerovalent 
gold species in comparison to samples irradiated at lower doses. These unstable Au(0) 
seeds grow and can be capped by the cationic lipid surfactant resulting in smaller sized 
nanoparticles.99 In contrast, at lower doses of ionizing radiation, the ratio of concentration 
of Au(0) to Au(I) is likely smaller. It is possible that unreacted metal ions coalesce with 
the smaller population of gold seeds and in turn lead to the formation of nanoparticles with 
larger diameters.99  
G 
Figure 3.16 Transmission Electron Microscopy (TEM) images of gold nanoparticles 
formed after exposure to ionizing (X-ray) radiation using the following conditions of 
C16TAB. (A) 10 mM and 5 Gy, (B) 10 mM and 47 Gy, (C) 4 mM and 5 Gy, (D) 4 mM and 
15 Gy, (E) 2 mM and 0.5 Gy, (F) Magnified image of highlighted area of E showing smaller 
particles, and (G) 2 mM and 2.5 Gy. 
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Surfactant Dose 
Average 
Diameter 
(nm) 
Standard 
Deviation 
Diameter (nm) 
Average Polydispersity 
Index(PDI) 
C16 20mM 1 Gy 138.4 5.3 0.2 
  3 Gy 122.8 1.9 0.2 
  5 Gy 121.1 20.7 0.3 
  10 Gy 102.3 13.2 0.2 
  16 Gy 88.5 12.1 0.2 
  26 Gy 72.6 4.7 0.2 
  37 Gy 57.3 4.0 0.3 
  47 Gy 45.5 3.4 0.3 
C16 2mM 0.5 Gy 81.9 8.9 0.3 
  1 Gy 60.2 6.1 0.3 
  1.5 Gy 48.2 7.3 0.4 
  2 Gy 42.9 3.8 0.4 
  2.5 Gy 39.8 3.6 0.4 
C16 4mM 1 Gy 133.4 10.4 0.2 
  3 Gy 124.2 5.2 0.2 
  5 Gy 105.3 6.3 0.2 
  7.5 Gy 88.6 8.1 0.3 
  10 Gy 92.6 8.6 0.3 
  12.5 Gy 81.3 6.9 0.3 
  15 Gy 74.2 5.5 0.3 
  26 Gy 57.4 2.4 0.3 
  37 Gy 32.0 0.4 0.5 
  47 Gy 22.1 1.3 0.6 
C16 10mM 1 Gy 126.4 1.5 0.2 
  3 Gy 127.1 1.6 0.2 
  5 Gy 124.8 2.1 0.2 
  10 Gy 124.9 5.0 0.2 
  16 Gy 106.2 5.4 0.2 
  26 Gy 72.2 7.1 0.2 
  37 Gy 59.4 3.3 0.3 
  47 Gy 50.9 2.3 0.2 
C12 20mM 1 Gy 141.6 32.2 0.5 
  3 Gy 112.2 5.3 0.2 
  5 Gy 75.2 5.0 0.3 
  10 Gy 40.4 1.0 0.5 
  16 Gy 23.9 1.1 0.6 
  26 Gy 15.7 0.8 0.6 
  37 Gy 17.9 0.7 0.6 
  47 Gy 21.6 2.7 0.6 
Table 3.1 Average hydrodynamic diameters of gold nanoparticles formed after irradiation 
along with their corresponding polydispersity indices.  
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We next investigated the translational potential of our plasmonic nanosensor for detecting 
X-ray radiation under conditions that simulate those employed in human prostate 
radiotherapy in the clinic. While radiotherapy is common in the treatment of prostate 
cancer patients, exposure of normal tissues (e.g. underlying rectal wall) to radiation is a 
cause for concern. Information on the dose delivered during a particular stage of a 
fractionated radiotherapy regimen can help plan the subsequent stage in order to achieve 
better patient outcomes. However, to our knowledge, there is no available method for 
determining the actual dose received by the rectal wall during prostate radiotherapy. 
Endorectal balloons are typically used for holding the prostate in place and for protecting 
the rectal wall during radiotherapy treatments in humans.156 We therefore used the 
endorectal balloon as means to administer the plasmonic nanosensor, and used this set-up 
to determine the dose received at different points along the rectal wall. In all cases, the 
efficacy of the plasmonic nanosensor was evaluated in endorectal balloons ex vivo; no 
studies on human patients were carried out. 
 
We first incorporated 1.5 ml of the precursor solution (20 mM C16TAB  + AA + HAuCl4) 
into endorectal balloons as shown in Figure 3.17A in order to investigate the efficacy of 
the plasmonic sensor using this potential method of delivery. The nanosensor precursor 
solution was subjected to two relatively high, but clinically relevant doses of 7.9 and 10.5 
Gy (n=3). These relatively high doses were used in order to establish proof-of-concept 
efficacy of the nanosensor in the endorectal balloon. The absorbance of the plasmonic 
nanosensor, which changes color inside the balloon itself (light pink color seen in Figure 
3.17B for a balloon subjected to a radiation dose of 10.5 Gy), was employed to determine 
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the radiation dose delivered to the balloon. A calibration curve between 5 and 37 Gy from 
the plot between maximum absorbance and radiation dose after 7 hours was employed to 
determine the radiation dose delivered. Doses of ~8.5 ± 1.7 Gy and ~7.9 ± 2.0 Gy were 
calculated from the calibration curve for delivered doses of 10.5 Gy and 7.9 Gy, 
respectively (Table 3.2). Due to the nonlinearity of the curve below 5.3 Gy, the control (0 
Gy) showed a value ~4.4 ± 0.41 Gy (n = 3) when the calibration equation was employed, 
indicating that the operating region of the plasmonic nanosensor, with a CTAB 
concentration of 20 mM, is between 5 Gy and 37 Gy and is not reliable for lower doses of 
radiation for CTAB concentrations of 20 mM.  
 
Figure 3.17 (A) An endorectal balloon with precursor solution not subjected to irradiation 
with X-rays (B) Endorectal balloon post irradiation with 10.5 Gy X-rays. The dashed 
rectangle shows a light pink colored dispersion following exposure to X-ray radiation.  
 
 
 
 
 
Delivered Dose 
(Gy) 
Measured 
Absorbance 
(A.U) 
Calculated Dose 
from the calibration 
curve  
Average Radiation 
Dose Delivered ± 
S.D 
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(Gy) (Gy) 
0 0.003, 0.002, 0.009 4.19, 4.09, 4.85 4.38 ± 0.41 
7.9 0.05, 0.015, 0.045 9.30, 5.50, 8.76 7.85 ± 2.05 
10.5 0.061, 0.035, 0.032 10.50, 7.67, 7.35 8.51 ± 1.73 
 
Table 3.2 Absorbance values measured 7 hours following exposure of endorectal balloons 
with the plasmonic nanosensor (20 mM C16TAB concentration) following exposure to 
different doses of ionizing radiation. The calibration equation used was Absorbance = 
0.0092*Dose - 0.0356. The 0 Gy data point is outside the linear range (5 – 37 Gy) of the 
plasmonic nanosensor. 
Based on the above findings, we next investigated the detection efficacy of the plasmonic 
nanosensor in an anthropomorphic phantom that is employed to simulate prostate 
radiotherapy treatments in the clinic. In these studies, 200 µL of the precursor solution 
(C16TAB (2mM) + AA + HAuCl4) was filled in microcentrifuge tubes, which were then 
taped to the outside surface of an endorectal balloon such that they were aligned along the 
stem (Figure 3.18A). We used a lower concentration of C16TAB (2 mM) in these studies, 
since this concentration can detect doses between 0.5 – 2 Gy, which are directly relevant 
to conventional radiotherapy. The phantom, with the endorectal balloon placed under the 
simulated prostate tissue, was irradiated based on a treatment plan described in the 
Experimental section and shown in Figures 3.18B. The treatment plan was designed such 
that the prostate and the rectal wall were irradiated with 1 Gy (dark blue line in Figure 
3.18B), while the dose fall-off at the end was 0.5 Gy (yellow line in Figure 3.18B). Thus, 
two microcentrifuge tubes (capsules 1 and 2) placed on the stem of the balloon just below 
the prostate were subjected to 1 Gy, while the third one (capsule 3) outside the balloon was 
subjected to 0.5 Gy (Figure 3.7B). This set up was employed in order to obtain spatial 
information on the delivered dose along the rectal wall in the tissue phantom. 
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Figure 3.18 (A) Digital image showing the nanoscale precursor solution (200 µL) in 
microcentrifuge tubes placed along the stem outside of an endorectal balloon. (B). X-Ray 
contrast image of the phantom which shows the dose treatment plan, prostate tissue, the 
endorectal balloon, and the microcentrifuge tube / nanosensor location below the prostate 
tissue and on the endorectal balloon. (C). Digital image of the plasmonic nanosensor 2 h 
following treatment with X-rays in the prostate phantom. 
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Capsule No. 
(Actual Dose 
Delivered in 
Gy) 
Measured 
Absorbance 
(A.U) 
Calculated Dose 
from the calibration 
curve  
(Gy) 
Average Radiation 
Dose Delivered ± 
S.D 
(Gy) 
1 (1) 0.12, 0.138, 0.154 1.09, 1.20, 1.30 1.20 ±0.11 
2 (1) 0.105, 0.154, 0.137 1.00, 1.30, 1.20 1.17± 0.16  
   3 (0.5) 0.016, 0.03, 0.025 0.44, 0.53, 0.50 0.49 ± 0.04 
 
 
Table 3.3 X-ray Radiation dose determined using the plasmonic nanosensor placed on an 
endorectal balloon in a prostate phantom as shown in Figure 3.18. The absorbance was 
determined 2 h after radiation exposure using the equation Absorbance = 0.1597*Dose – 
0.0542. The linear range for this condition ranged from 0.5 Gy to 1.5 Gy. A C16TAB 
concentration of 2mM was used in these studies.  
 
Optical images (Figure 3.18C) clearly indicate the formation of blue-violet colored 
dispersions for capsules 1 and 2, while a dispersion of lighter intensity can be seen in 
capsule 3. The absorbance of the dispersions were measured 2 h following exposure to 
radiation, and a calibration curve was employed to estimate the radiation dose as indicated 
by the radiation sensor. Table 3.3 shows a comparison of the actual dose delivered and the 
dose estimated from the calibration of the plasmonic nanosensor.  Data from the plasmonic 
nanosensor indicates that capsules 1 and 2 received doses of ~1.2 ± 0.1 Gy (actual dose = 
1 Gy) and ~1.2 ± 0.2 Gy (actual dose = 1 Gy), respectively, while capsule 3 received a dose 
of ~0.5 ± 0.04 Gy (actual dose = 0.5 Gy) (Table 3.3). These are excellent estimates of the 
actual doses received by the capsules in the tissue phantom, and more importantly, can be 
employed to obtain spatial information on the radiation dose delivered to the rectal wall 
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below the prostate. Taken together, our results indicate the utility of the plasmonic 
nanosensor as a simple detection system in simulated clinical settings. These results 
demonstrate a potential clinical application of the plasmonic nanosensor in prostate cancer 
radiotherapy. It is very likely that different formulation methods and / or fabricated devices 
will be necessary in translating this technology to different clinical applications. 
3.4 Conclusions  
 
We have demonstrated a simple, versatile and powerful nanosensor platform for dosimetry 
of therapeutically relevant doses of ionizing radiation for potential use in cancer 
radiotherapy. This is a unique method since it (1) is easy to formulate and visualize due to 
the colorimetric response, and (2) does not need expensive equipment for detection. While 
a ‘yes / no’ determination may be made simply by observation using the naked eye, only 
an absorbance spectrophotometer is required for quantifying the radiation dose. A visible 
color change also ensures the ease of detecting the radiation dose with the naked eye. It 
was found that both, C12TAB and C16TAB were able to function as templating molecules 
in the plasmonic nanosensor at concentrations above their critical micelle concentration 
(CMC), while spontaneous nanoparticle formation was observed at lipid surfactant 
concentrations below the CMC. The toxicity of C16TAB can be a limitation, although 
appropriate formulation and administration methods (e.g. endorectal balloons) may obviate 
these concerns to some extent.157 We were able to enhance the sensitivity of the nanosensor 
to lower radiation doses by modifying the concentration of C16TAB, thus making this a 
highly versatile platform for a variety of applications. Furthermore, these observations 
suggest that interplay between surfactant chemistry and aggregation state determine the 
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extent of nanoparticle formation by lipid-based surfactant molecules. Nanoparticles formed 
during the radiation sensing operation were characterized by UV-Vis spectroscopy, 
dynamic light scattering and transmission electron microscopy in order to obtain detailed 
information on particle size and morphology. Different nanostructures, including spheres, 
rods, and dendrites were obtained depending on the cationic surfactant employed. Finally, 
we demonstrated the utility of the current technology in translational applications; the 
plasmonic nanosensor was able to detect the delivered radiation dose with satisfactory 
accuracy when placed in an endorectal balloon ex vivo. The plasmonic nanosensor was able 
to detect doses as low as 0.5 Gy, and was able to report on the spatial distribution of 
radiation dose delivered in the vicinity of the rectal wall when investigated using an 
endorectal balloon placed in the prostate phantom. The translational application of such a 
dosimeter can help therapists with treatment planning and potentially enhance selectivity 
and efficacy of treatment leading to improved patient outcomes. Future work will involve 
investigations into engineering new generations of templating molecules that improve the 
sensitivity of detection with lower potential toxicities, formulation methods for improving 
the versatility of this technology, and appropriate pre-clinical models in order to facilitate 
translation of this technology in clinical radiotherapy applications.  
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Chapter 4 DETECTION OF THERAPEUTIC LEVELS OF IONIZING 
RADIATION USING PLASMONIC NANOSENSOR GELS 
4.1 Introduction 
Radiotherapy and chemotherapy are among the most widely administered treatment 
modalities in cancer158. Radiotherapy is typically administered in fractions of 2 Gy dose / 
day leading to a cumulative dose of 20-70 Gy over the course of the treatment; 1 Gy is 1 
joule of energy absorbed by a mass of 1 kg. Clinical radiotherapy utilizes advanced 
methods including image-guided delivery, intensity-modulated radiation therapy (IMRT), 
stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT)159. Treatment 
planning in these approaches involves numerous processes and individuals, which can 
increase the probability of error127. The ability to determine the actual dose delivered to 
target disease sites and / or adjoining healthy tissue can lead to significant reduction in 
error and may show correlations with response and morbidity leading to more effective 
treatment planning.   
  
Current dosimeters include semiconductor diodes and thermoluminescent dosimeters 
(TLDs)160. TLD operation is time consuming and requires a specialist operator, and 
semiconductor diodes are energy and dose rate dependent. Currently available dosimeters 
cannot be molded into different shapes that can conform to tissues during clinical 
radiotherapy. Polymer gel dosimeters were developed in order to overcome these 
limitations, and have been explored in IMRT and SRS treatments. However, a key 
limitation in using polymer gel based dosimeters is the use of magnetic resonance imaging 
(MRI) for determining the delivered dose, which makes their routine use very challenging. 
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Taking these factors into consideration, there is a strong requirement for the development 
of a simple gel-based dosimeter which can detect therapeutic doses of ionizing radiation. 
In particular, advances in molecular and nanoscale systems can lead to simple and effective 
approaches for detecting therapeutic doses of ionizing radiation161.  
 
Gold nanoparticles have attracted great interest in biomedical diagnostics and chemical 
sensing owing to unique optical properties associated with the size and shape of these 
nanoparticles66, 67.  We recently developed a liquid-phase sensor that is based on the 
formation of gold nanoparticles from a colorless metal salt solution upon exposure to 
therapeutic levels of ionizing radiation162. Although this is a powerful and simple approach 
for detecting ionizing radiation, a liquid-phase system has limitations in cases where 
detecting doses over a two-dimensional surface area may be necessary. In the current study, 
we report a simple colorimetric gel-based plasmonic nanosensor that can detect ionizing 
radiation in the dose range that is conventionally employed in fractionated clinical 
radiotherapy (i.e. 0.5 - 10 Gy). In this system, gold nanoparticles are generated in 
translucent gels upon irradiation with ionizing (X-ray) radiation levels employed in 
fractionated radiotherapy. Formation of gold nanoparticles renders color to the originally 
colorless and translucent gel, which facilitates visual detection as well as quantitative 
colorimetric dose determination. To our knowledge, these colorimetric gel-based 
plasmonic nanosensors are first of their kind, and can potentially be translated to clinical 
use in radiotherapy.  
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4.2 Materials and Methods 
Materials. Gold(III) chloride trihydrate (HAuCl4.3H2O), dodecyltrimethylammonium 
bromide (C12TAB) (≥98%) and L-ascorbic acid (AA) were purchased from Sigma-Aldrich. 
Cetyltrimethylammonium bromide (C16TAB) was purchased from MP chemicals. All 
chemicals were used as received from the manufacturer without additional purification. 
MilliQ water, at a resistivity of 18.2 MΩ.cm, was used as solvent for all experiments.    
 
Hydrogel Preparation for Irradiation. Cx=12,16TAB (600 µL of 50 mM solution in MilliQ 
water) was mixed with 30 µL of 10 mM HAuCl4 in MilliQ water. Different amounts of 
agarose were dissolved in DI water and heated until a clear solution of 5%, 7.5% or 10% 
w/v agarose were formed. Liquid agarose (500 µL) was then mixed with the gold-surfactant 
mixture. This liquid mixture (650 µL) was allowed to set in prefabricated molds, which 
results in agarose discs of ~1.5 cm diameter. Ascorbic acid (650 µL of 10 mM in MilliQ 
water) was allowed to diffuse into the gel for 10 minutes leading to the formation of the 
hydrogel nanosensor precursor. These translucent hydrogel discs were used subsequently 
for irradiation studies.  
 
X-Ray Irradiation. A Varian Truebeam linear accelerator radiation therapy system at the 
Banner-M.D. Anderson Cancer Center in Gilbert, AZ (one-way travel time of 
approximately 20 min from ASU) delivering a 6 MV photon beam was used to irradiate 
the translucent hydrogel at a dose rate of 15.6 Gy/min. The samples are irradiated at doses 
of 0, 1, 2, 3, 5, 7.5 and 10 Gy. 
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Nanosensor Gel Dosimetry in an Anthropomorphic Thorax Phantom. All phantom 
experiments were carried out at the Banner-M.D. Anderson Cancer Center in Gilbert, AZ 
(one-way travel time of approximately 20 min from ASU). A CIRS tissue equivalent thorax 
phantom was aligned on a Philips RT CT table with CT room aligning lasers. A total of 
150 CT scan images were acquired with a 1 mm image thickness and 1 mm image spacing 
which were then exported to a Philips Pinnacle treatment planning system. The thorax 
phantom was then contoured and a treatment plan was generated for a 6 MV radiation 
beam. Pinnacle’s Collapsed Cone Convolution Superposition (CCCS) algorithm was used 
to calculate the dose in the thorax phantom. A 3 Gy dose was delivered to the skin of the 
phantom while a 2 Gy dose was delivered to the second mediastinum (6 cm from the top) 
of the thorax phantom. Post irradiation analyses (e.g. absorbance) were performed at 
Arizona State University in Tempe, AZ. A calibration curve was developed for doses 
ranging from 0-3 Gy by irradiating the gel nanosensor samples at 100 cm source-to-surface 
distance or SSD with a standard uniform beam.  
 
Absorbance Spectroscopy. A BioTek Synergy 2 plate reader was used to determine the 
absorbance profiles of the irradiated and control samples. Absorbance values of gel 
samples in a 24 well plate were measured from 300 to 990 nm with a step size of 10 nm. 
Nanopure water was used as blank for the study. The characteristic plasmonic absorption 
peak between 500-600 nm was used as an indicator of gold nanoparticle formation. This 
absorbance value was offset by subtracting absorbance value at 990 nm (A990) from the 
peak (maximum) value. A curve was plotted with the maximum values obtained against 
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their corresponding doses for C12TAB and C16TAB for nanosensor gel samples. To 
maintain consistency a different calibration curve was generated for the phantom studies 
since the source to surface distance (SSD) was different for this set up compared to gels 
not used in the phantom. The calibration equations obtained were subsequently used to 
calculate the dose delivered in the phantom.  
 
Scanning Electron Microscopy. Following X-ray irradiation, the gel nanosensor samples 
were dried by exposing them to air at room temperature. The gel was sputter-coated with 
a thin film of gold-palladium prior to microscopy. SEM analyses were carried out in an XL 
30 Environmental instrument in order to visualize the presence of gold nanoparticles in the 
agarose hydrogel.  
 
Image Processing. All images were acquired using a Canon EOS 1100D camera under 
suitable lighting. The images were cropped to the desired size in the Fotor Photo Editor 
application. No further editing was carried out on the pictures reported in this article.  
 
Statistical Analyses. All irradiation experiments were carried out a minimum of three 
times independently unless otherwise stated. The results are expressed as mean ± one 
standard deviation. These calculations were carried out using Microsoft Excel. 
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4.3 Results and Discussion  
The working principle of the agarose gel-based nanosensor is based on the reduction of 
gold ions to gold nanoparticles following exposure to ionizing radiation (Figure 4.1). 
Agarose gels containing gold ions are colorless and translucent, and the gel changes color 
to maroon due to the formation of gold nanoparticles upon exposure to therapeutic levels 
of ionizing (X-ray) radiation. Zerovalent gold ions Au(0) generated in this process 
ultimately lead to nanoparticle nucleation and growth163. Originally existing in a trivalent 
state Au(III) in metal salts, the gold salt was first reduced to its monovalent Au(I) form 
using ascorbic acid. This was carried out in order to increase the thermodynamic 
favorability towards the formation of Au(0) species, because the reduction potential of 
Au(I) is higher than that of Au(III); only one electron is required to reduce Au(I) to 
Au(0)137, 138. Irradiation with ionizing radiation (X-rays) engenders splitting of water 
molecules in the gel, which, in turn, leads to the formation of ionizing radicals. Radiation-
induced free radicals, e- and H., are reducing in nature, and OH. is an oxidizing agent. These 
OH. radicals impede nanoparticle formation but can be removed by ascorbic acid, which 
acts as an antioxidant134.  
A 
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In addition to the gel and gold ions, we employed Cx (x=12,16)TAB surfactants in this study 
in order to facilitate the formation of gold nanoparticles139. The agarose polysaccharide 
contains functional moieties which can simultaneously assist in reduction of gold salt and 
templating of gold nanoparticles164. Altogether, a colorless metal salt precursor solution 
comprising of a mixture of auric chloride (HAuCl4), L-ascorbic acid (AA) and cetyl (C16) 
or dodecyl (C12) trimethylammonium bromide (Cx; x=16, 12TAB) surfactant molecules and 
agarose140, 141, form the key constituents of the novel gel based plasmonic nanosensor for 
detecting therapeutic levels of ionizing radiation. Key factors which influenced our current 
selection of the agarose hydrogel include (1) low toxicity / biocompatibility, (2) water 
solubility of the gel constituent material, (3) ease of generation, and (4) ease of mechanical 
property modulation. Agarose-based hydrogels have been investigated as scaffolds for 
Figure 4.1 (A) Schematic of the hydrogel nanosensors for the detection of therapeutic 
levels of ionizing radiation (e.g. X-rays). A mixture of 10 mM HAuCl4 and 50 mM CxTAB 
(x=12, 16) is mixed with liquid agarose and allowed to set in a circular mold to form a disc 
(16 mm in diameter and 3 mm in thickness). Ascorbic acid (10 mM) is allowed to diffuse 
into the gel from the top for 10 minutes immediately prior to subjecting the disc to different 
doses of ionizing radiation. Irradiation of this colorless hydrogel with ionizing radiation 
(X-rays) results in the formation of gold nanoparticles in the hydrogel, which results in a 
visible change in color of the gel from colorless to maroon. (B) Chemical reactions 
involved in the current hydrogel-based nanosensor. HAuCl4 solution, which is yellow in 
color, changes to orange upon addition of the surfactant (CxTAB). Subsequent addition of 
ascorbic acid (C6H8O6) led to reduction of Au(III) to Au(I), which renders the gel colorless 
and translucent. Irradiation with ionizing radiation (X-rays) results in the formation of gold 
nanoparticles (AuNPs), which render a burgundy color to the gel due to the plasmonic 
properties of these nanoparticles. 
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regenerating damaged tissues or as platforms for controlled drug release owing to their low 
toxicities165, 166.  
  
We first carried out several control experiments in order to investigate the suitability of the 
current agarose-based plasmonic nanosensor system. Wang et.al demonstrated that mixing 
HAuCl4 with heated agarose164 induced the spontaneous formation of gold nanoparticles. 
However, in absence of ionizing radiation, we did not observe the formation of a red / 
maroon-colored hydrogel (Figure 4.2A); a concomitant absorbance peak between 500-600 
nm, which is indicative of gold nanoparticles, was also not seen (Figure 4.3A). Formation 
of an intense yellow-colored liquid was seen when a mixture of HAuCl4 and CxTAB (x = 
12 or 16) was mixed with heated agarose, likely due to the replacement of chloride ions by 
bromide ions from CxTAB (Figure 4.2B and C)138, 167. This ligand transfer leads to a new 
absorbance peak at ~370 nm (Figures 4.3B and C), and subsequent cooling led to the 
formation of pale yellow-colored gels. Addition of ascorbic acid to this gel formulation 
reduces the gold salt from Au(III) to Au(I)168 rendering the gel colorless (Figures 4.2D 
and E), which is consistent with previous observations138, 162; the loss in color is also 
indicated by the loss or absence of peaks in the UV-vis spectrum (Figure 4.3D and E). 
This colorless formulation is used as the plasmonic nanosensor gel in all subsequent 
radiation detection studies. In the absence of ionizing radiation, this precursor gel (i.e. 
agarose containing ascorbic acid, HAuCl4 and CxTAB) remained colorless due to minimal, 
if any, formation of gold nanoparticles; no absorbance peak was seen at ca. 520 nm. In the 
absence of CxTAB surfactant molecules, direct addition of ascorbic acid to agarose gels 
containing HAuCl4 resulted in the spontaneous formation of gold nanoparticles169. In the 
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absence of ascorbic acid, irradiation of agarose gels containing CxTAB and HAuCl4 with 
X-rays did not induce a change in the yellow color of the gels (Figure 4.4), although a 
small peak at 520 nm was observed in case of 10% agarose (Figure 4.5 A). Taken together, 
these results indicate that all components i.e. agarose, HAuCl4, CxTAB, and ascorbic acid 
(AA) are necessary to form the colorless precursor gel formulation of the plasmonic 
radiation nanosensor. 
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Figure 4.2 Images of the precursor nanosensor agarose gels not subjected to X-rays. 
Images were acquired 1 hr following formulation. (A) Agarose gels containing only 10mM 
HAuCl4, (B) Agarose gel formulated with 10 mM HAuCl4 and 50 mM C12TAB (no 
ascorbic acid), (C) Agarose gel formulated with 10 mM HAuCl4 and 50 mM C16TAB (no 
ascorbic acid) (D) Agarose gel formulated with 10 mM HAuCl4, 50 mM C12TAB and 10 
mM ascorbic acid, (E) Agarose gel formulated with 10 mM HAuCl4, 50 mM C16TAB and 
10 mM Ascorbic Acid. Columns (I), (II) and (III) correspond to 5%, 7.5% and 10% (w/v) 
agarose respectively.  
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Figure 4.3 Absorbance spectra of agarose gels containing (A) 10 mM Au3+ (i.e. HAuCl4), 
(B) 10 mM Au3+ + 50 mM C16TAB, (C) 10 mM Au3+ + 50 mM C12TAB, (D) 10 mM Au 
+ C16TAB + 10 mM ascorbic acid (AA), and (E) 10 mM Au3+ + 50 mM C12TAB + 10 mM 
AA. These spectra were acquired 1h following preparation of the individual gel 
formulations. 
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Figure 4.4 Images of control agarose gels acquired after 1hr and 2 Gy radiation; ascorbic 
acid was not used in these formulations (A) agarose gels consisting of only 10 mM HAuCl4, 
(B) agarose gel formulated with 10 mM HAuCl4 and 50 mM C12TAB, (C) agarose gel 
formulated with 10 mM HAuCl4 and 50 mM C16TAB. Columns (I), (II) and (III) 
correspond to 5%, 7.5% and 10% (w/v) agarose respectively. 
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Figure 4.5 Absorbance spectra of different control formulations irradiated with 2 Gy X-
ray dose dose (A) 10 mM Au3+ (i.e. HAuCl4) (B) 10 mM Au3+ + 50 mM C16TAB (C) 10 
mM Au3+ + 50 mM C12TAB. The spectra were acquired 1hr following irradiation. Note: 
ascorbic acid was not used in these control gel formulations. 
 
Irradiation of the precursor gel formulation with different doses of ionizing radiation 
resulted in the formation of gold nanoparticles, which rendered a maroon color to the gel 
(Figure 4.6). Exposure of hydrogel to ionizing radiation results in the formation of e-aq and 
H. radicals upon water splitting, which facilitates the reduction of monovalent gold Au(I) 
ions to its zerovalent Au(0) state170. Further nucleation and coalescence of the Au(0) 
species (seeds) leads to the formation of gold nanoparticles171; the gold nanoparticles are 
likely stabilized by the CxTAB surfactant molecules present in the gel172. The intensity of 
the maroon color depends on the concentration of gold nanoparticles in the gel, which, in 
turn, is dependent on the radiation dose delivered to the gel. This increase in color intensity 
is eventually a direct result of the increase in the number of free radicals generated at higher 
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radiation doses173, which can reach a saturation level at a particular dose beyond which the 
colorimetric response stays invariant.  
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Figure 4.6 Images of 5% (w/v) agarose gel containing (A) 50 mM C12TAB and (B) 50 mM 
C16TAB surfactants following exposure to different doses of ionizing (X-ray) radiation.
Formation of gold nanoparticles renders a maroon color to the gel. Images were acquired 
1 h after subjecting the gels to X-ray irradiation. All samples contain 10 mM HAuCl4 and 
10 mM ascorbic acid.  
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The color change of gels, from colorless to maroon, was visible to the naked eye as early 
as 10 minutes following exposure X-rays (Figures 4.6, 4.7 and 4.8), although lower doses 
(0.5 and 1 Gy) required 15-20 mins for a visible change in color. The change in color was 
quantified using UV-vis absorbance spectroscopy 1 h following irradiation, since this was 
the earliest when we could determine absorbance due to travel time between the radiation 
center and ASU (absorbance analysis). A characteristic spectral peak in the range of 500-
600 nm (Figure 4.9 and 4.10) was indicative of gold nanoparticle formation in the gel. No 
significant difference in the absorbance intensity was observed over a period of four hours 
once the color was formed (Figure 4.11).  Longer durations were not investigated, but we 
do not anticipate fading or bleaching since the colorimetric response is based on formation 
of nanoparticles, which are more stable than dyes. Formation of nanoparticles in the gel 
was further verified using field-emission scanning electron microscopy (Figure 4.12). 
Image analysis indicated that the average size of gold nanoparticles formed in the gel was 
~ 35 nm. 
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Figure 4.7 Images of 7.5% (w/v) agarose nanosensor gel with (A) C16TAB and (B) 
C12TAB following irradiation with different radiation doses. Images were acquired 1 h 
after irradiation. 
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Figure 4.8 Images of 10% (w/v) agarose nanosensor gel containing (A) C16TAB and (B) 
C12TAB following irradiation with different radiation doses. Images were acquired 1 h 
after irradiation. 
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Figure 4.9 Absorbance spectra of 5% (w/v) agarose nanosensor gels containing (A) 
C12TAB and (B) C16TAB irradiated with different X-ray doses. Characteristic absorbance 
peaks between 500 – 600 nm wavelength are indicative of gold nanoparticle formation. 
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Figure 4.10 Absorbance spectra of (A) 10 mM HAuCl4 + 50 mM C16TAB + 7.5% (w/v) 
agarose + 10 mM ascorbic acid (B) 10 mM HAuCl4 + 50 mM C12TAB + 7.5% (w/v) 
agarose + 10 mM ascorbic acid (C) 10 mM HAuCl4 + 50 mM C16TAB + 10% (w/v) agarose 
+ 10 mM ascorbic acid (D) 10 mM HAuCl4 + 50 mM C12TAB + 10% (w/v) agarose + 10 
mM ascorbic acid, subjected to various doses of X-ray radiation.  
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Figure 4.11 Kinetics of gold nanoparticle formation in 5% (w/v) agarose nanosensor gels 
with (A) C12TAB and (B) C16TAB following irradiation with different doses of X-rays. 
Absorbance spectra of the gels were acquired from 300 – 900 nm and the peak value of the 
absorbance (typically ca. 530 nm) at every time point was used to generate this plot. 
Earliest determination of the absorbance values was at 1 h due to travel time between the 
Banner-M.D. Anderson Cancer Center (radiation treatment) and ASU (absorbance 
analyses). 
 
Figure 4.12 SEM image showing gold nanoparticles formed in a 5% (w/v) agarose 
nanosensor with C12TAB as surfactant post 2 Gy irradiation. Note the location of the SEM 
in the gel inset is approximate. 
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Both C12TAB and C16TAB surfactant species were successful in facilitating the formation 
of gold nanoparticles in the therapeutic radiotherapy dose range, although C12TAB 
demonstrated a higher efficacy for the formation of nanoparticles at lower doses (e.g. 0.5 
Gy). Following reduction of gold ions to zerovalent gold, nanoparticle growth occurs due 
to collisions among Au(0) seeds or between Au(0) seeds and unreacted Au3+ ions; 
surfactant molecules eventually cap the nanoparticles formed. We hypothesize that 
C12TAB possesses a higher diffusion coefficient compared to C16TAB due to its smaller 
size. This, in turn, is likely responsible for its effective transport through the gel network, 
which facilitates nanoparticle formation at lower doses. Increasing the agarose content (w/v 
ratio) can limit the diffusion of molecules and nanoparticles through the gel matrix. Indeed, 
a decrease in the intensity of the maroon color formed was seen following 1 Gy irradiation 
when 10% agarose was used as compared to 5% agarose (Figures 4.6B and 4.8B). The 
absorbance value decreased from 0.1066 to 0.04, indicating that increasing the agarose 
concentration decreased nanoparticle yields likely as a result of diffusion limited growth. 
We also observed that the size of the nanosensor gel did not significantly influence the 
qualitative colorimetric response; gels formulated in 96 well plates (~7 mm in diameter 
and ~3 mm in thickness) also demonstrated a characteristic linear response to those 
formulated above (i.e. gels generated in 24 well plates, ~1.5 cm in diameter and ~3 mm in 
thickness) despite their smaller diameters (Figures 4.13A and 4.13B). 
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(A) 
 
(B) 
 
Figure 4.13 Efficacy of nanosensor gels formulated in 96 well plates, which led to gels 
with smaller dimensions. (A) Absorbance spectra of 5% (w/v) agarose nanosensor gels 
containing C12TAB. (B) Calibration of maximum absorbance vs. radiation dose 1hr post 
radiation. 
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Following irradiation, nanosensor gels were investigated using UV-spectroscopy in order 
to obtain a quantitative correlation between nanoparticle formation and the delivered 
radiation dose. The maximum absorbance value was plotted as a function of X-ray 
radiation dose ranging from 0.5-10 Gy (Figures 4.14, 4.15 and 4.16), which is used for 
conventional and hypo fractionated radiotherapy in the clinic. As seen in Figure 4.14, the 
C12TAB surfactant was more effective at templating the formation of gold nanoparticles 
compared to C16TAB; a more intense maroon color of the nanosensor gels was seen in the 
case of C12TAB compared to that obtained using C16TAB. A linear range of gel absorbance 
was obtained between X-ray doses of 0 – 3 Gy using C12TAB as the templating surfactant 
and a calibration curve was generated (Figures 4.17A). This is very much within the dose 
range used in conventional fractionated radiotherapy in the clinic. Higher radiation doses 
did not enhance gold nanoparticle formation as seen by the invariant absorbance at doses 
≥ 5 Gy. The efficacy of the nanosensor gel was determined by delivering an actual dose 
of 1.5 Gy (not used for generating the calibration curve). The color change at 1h was 
quantified using absorbance analysis, and use of the calibration curve resulted in a dose 
estimation of 1.61 ± 0.16 Gy for the actually delivered dose of 1.5 Gy, which indicates the 
utility of this approach for dosimetry in fractionated radiotherapy. Clinically available 
NanoDots OSLDs™ resulted in a final dose of 1.63 ± 0.007 Gy (n=3). Clinical error 
percentages for dosimeters are approximately 3.9% for MOSFETs and 5.1% for TLDs174, 
respectively. Our colormetric gel nanosensor has an error of 7%, which is comparable to 
that observed with NanoDots OSLDs™ and are in the range of those reported for 
MOSFETs and TLDs, which can be more cumbersome to use.  
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Figure 4.14 Absorbance response of the plasmonic nanosensor gel following irradiation 
with X-rays; maximum absorbance vs. radiation dose 1h post X-ray irradiation is shown in 
the plot. Circles indicate the nanosensor response for C12TAB, and triangles indicate the 
response for C16TAB formulated with 10 mM HAuCl4 in a 5% (w/v) agarose gel. 
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Figure 4.15 Absorbance response of the plasmonic nanosensor gel following irradiation 
with X-rays. Maximum absorbance vs. radiation dose 1h post irradiation is shown in the 
plot. Solid line indicates response with C12TAB and dashed line indicates the response with 
C16TAB for 7.5% (w/v) agarose gel. 
 
 
Figure 4.16 Absorbance response of the plasmonic nanosensor gel following irradiation 
with X-rays. Maximum absorbance vs. radiation dose 1h post irradiation is shown in the 
plot. Solid line indicates response with C12TAB and dashed line indicates the response with 
C16TAB for 10% (w/v) agarose gel. 
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Figure 4.17 (A) Calibration curve of gel absorbance vs. radiation dose (0 – 3 Gy). This 
curve used for nanosensor gel-based dosimetry of fractionated radiotherapy doses in 
absence of an anthropomorphic thorax phantom. (B) Calibration curve of gel absorbance 
vs. radiation dose (0 – 3 Gy). This curve used for nanosensor gel-based dosimetry of 
fractionated radiotherapy doses at the isocenter (100 cm SSD) delivered to the 
anthropomorphic thorax phantom.  
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Radiation dosimeters for in vivo / ex vivo applications should exhibit energy independence, 
dose rate independence, and minimal attenuation of the incoming ionizing radiation 
energy175. The nanosensor gel showed no significant differences in the optical response 
(i.e. color change / absorbance) when different dose rates and energies were employed 
(Figure 4.18A). This can be expected since the minimum energy required to ionize water 
is ≈11 eV176, which is substantially lower than the energy delivered in these systems. 
Sources that deliver energy above the required minimum photon energy can ionize water 
molecules leading to formation of free radicals that can reduce metal ions to nanoparticles. 
Decreasing the dose rate to 1 Gy/min from 6 Gy/min also did not significantly affect the 
final absorbance of the nanosensor gel, likely because they both generate approximately 
the same number of free radicals. Radiolysis products are a function of radiation type (α , 
β  and γ radiation) and independent of dose rate since the energy deposited remains constant 
irrespective of the rate at which the dose is being generated173. The reduction of metal ions 
by the hydrated electron is completed in a short time (order of 10-7 – 10-6 s) compared to 
the longer time scales of nucleation and crystal growth of the nanoparticles (order of 
minutes)148. We hypothesize that since the metal ions reduced by the hydrated electrons 
are similar in both cases, the final concentration of nanoparticles is independent of dose 
rate. The relatively low concentration of heavy metal ions (Au3+) in the agarose hydrogel 
does not alter the incident radiation dose of 1 Gy (Figure 4.18B), which is another key 
requirement of an effective dosimeter. Our results demonstrate that the response of the 
nanosensor gel is independent of the dose rate delivered and does not attenuate the dose 
delivered (i.e. no absorption of the incoming energy), all of which are desirable 
characteristics for in vivo / ex vivo dosimetry.        
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(A) 
 
(B) 
 
Figure 4.18 (A). Maximum absorbance of the agarose nanosensor gels irradiated with 2 
Gy at different dose rates and energy (6 MV and 15 MV). No significant differences in 
absorbance were observed under these conditions employed indicating dose rate and 
energy independence of the nanosensor gel system (DS indicates the dose rate in Monitor 
Units/min) (B). Ion chamber dosimeter is placed below the agarose hydrogel (A) molded 
to the shape of a 4 inch petri dish (PD) to measure heavy metal (Au) induced radiation 
attenuation. Even in the presence of heavy metal (Au) and ascorbic acid (AA) there is no 
significant dose attenuation observed.  
 
We further investigated the translational capabilities of the nanosensor gel using an 
anthropomorphic thorax phantom (Figure 4.19A) which allows the determination of 
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radiation dose at the skin and mediastinum. The lower half of the mediastinum was 
subjected to a dose of 2 Gy while the skin was irradiated with 3 Gy as shown by the 
treatment plan in Figure 4.19B. Hydrogel discs containing C12TAB as surfactant were 
formulated into similar shapes and sizes as those used for calibration (carried out outside 
the phantom), and placed at the site in the phantom in order to monitor the radiation dose 
delivered. A linear curve between 0 Gy and 3 Gy was used to quantify the radiation dose 
delivered to the phantom. Based on the calibration (Figure 4.17 B), a dose of 2.15 ± 0.18 
Gy was estimated for a delivered dose of 2 Gy, and a dose of 3.27 ± 0.35 Gy was estimated 
for the 3 Gy delivered to the skin. The distinct visual color change, coupled with a simple 
quantitative measurement (UV-Vis absorbance), indicates the potential of this approach 
for detecting clinically relevant radiotherapy doses.  
(A) 
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(B) 
 
 
 
 
 
 
 
3 Gy 
2 Gy 
Figure 4.19 (A) Image of the anthropomorphic thorax phantom used in the current 
radiation dosimetry studies (B) An X-ray computed tomography (CT) scan image of the 
thorax phantom used in the experiments, showing the radiation dose treatment plan. The 
inside of the phantom is irradiated with a 2 Gy dose while the skin was irradiated with 3 
Gy dose. 
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Delivered  Dose  
(Gy) 
Average radiation Dose 
Delivered ± one S.D. (Gy) 
 Gel Nanosensor  
(n=3) 
3 3.27 ± 0.35 
2 2.15 ± 0.18 
 
Table 4.1 The table indicates the dose delivered according to the treatment plan and the 
radiation dose estimated by the gel based plasmonic nanosensor. 
  
 
4.4 Conclusions  
 
To our knowledge, this is the first demonstration of a colorimetric gel dosimeter for 
detecting therapeutically relevant doses of ionizing radiation currently employed in 
individual fractions in fractionated radiotherapy. The nanosensor gel was able to detect 
doses as low as 0.5 Gy, demonstrated a linear response in the range of 0 – 3 Gy, and was 
effective when placed in an anthropomorphic thorax phantom, all of which indicate the 
suitability of this approach in detecting radiation doses delivered during an individual 
fraction (typically 2 Gy) in fractionated radiotherapy. Use of hydrogels can facilitate 
adaptation to different anatomical shapes (e.g. skin, breast, etc.), and the ease of detection 
and quantification of this approach can facilitate easy translation to clinical use. Although 
agarose was used as a model for biocompatible hydrogels, several gel systems, including 
poly(lactic-co-glycolic acid) or PLGA, could also be investigated for this application. 
Ascorbic acid is an FDA-approved GRAS (generally recognized as safe) compound. One 
potential concern of the current gel nanosensor system is the toxicity of C16TAB and 
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C12TAB as templating surfactants, especially at higher concentrations. However, this can 
be mitigated by the use of lower concentrations and more effective formulation methods 
(e.g. secondary containment in a device)177. However, further biocompatibility studies 
using animal (e.g. mouse) models will be necessary to determine this. In addition, 
identification of biocompatible templating molecules can further obviate potential toxicity 
concerns. We anticipate that these new developments will accelerate the translation of 
nanosensor gels for detecting radiation doses in the clinic. 
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Chapter 5 HYDROGEL NANOSENSORS FOR COLORIMETRIC DETECTION 
AND DOSIMETRY IN PROTON BEAM THERAPY 
5.1 Introduction 
 
Radiation therapy is one of the primary treatment modalities employed for the ablation of 
various tumors in a clinical setting178. Ideally, one can enhance therapeutic outcomes of 
ionizing radiation by maximizing the sparing of the volume of healthy tissues that 
otherwise get exposed to XRT. At present, most external beam radiotherapy (EBRT) is 
administered using high-energy photons (e.g. X-rays), which characteristically deliver exit 
doses. This results in the delivery of significant amounts of radiation to normal tissues lying 
either adjacent or towards the distal end of the target (e.g. tumor). This can lead to side 
effects, including radiation-induced toxicity, in healthy tissues.  
 
Proton beam therapy is an alternate form of radiation therapy in which particles (protons), 
instead of high-energy photons, are delivered to the tumor, potentially leading to greater 
control and precision over dose deposition at the disease site179. This can lead to decreased 
damage to the surrounding tissue and cause fewer side effects post radiation treatment. This 
is primarily due to the unique dose deposition characteristics of protons known as the Bragg 
peak180. As the protons enter a patient’s body they lose their kinetic energy following 
collisions with electrons in tissues. As the protons slow down, their interaction cross 
section with electrons increases steadily until it reaches a sharp maximum shortly before 
the protons come to rest. This sharp maximum gives rise to the dosimetric Bragg peak181 
of maximal dose at the target site.  
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Radiation doses are typically delivered in fractions of 2 Gy dose/day (conventional 
fractionated radiotherapy) leading to a cumulative dose in the range of 20 - 70 Gy for the 
entire treatment course (1 Gy = 1 Joule energy absorbed by 1 kg mass). Typically, patients 
are treated daily once a day, 5 days per week, and over a period of 8-9 weeks. Following 
the development of sophisticated imaging techniques and beam delivery modalities, 
hypofractionated proton beam therapy in which, higher doses are delivered per treatment 
fraction (e.g. 4 Gy dose/day), has also found increased application in the treatment of 
cancer. This modality of treatment has been employed for aggressive tumor sites including 
in the liver, prostate and lung where high radiation doses are required in order to allow for 
a high rate of local control with minimal toxicity to the surrounding tissue182-184.  
 
The complexity of precisely delivering radiation doses to tumor sites has increased 
dramatically over the last decade. The rapid development of these advances has led to some 
imbalance in the development of verification technologies (dosimeters) for detecting 
potential sources of error during treatment. Clearly, detection of excess or deficient 
radiation levels delivered to patients will lead to improved safety and efficacy of the 
treatment185. Solid-state dosimeters, including p-type semiconductor diodes and diamond 
detectors, are among those employed in the clinic186. These detectors require specialized 
equipment for reading output (i.e. radiation dose), exhibit energy dependence, can require 
expensive fabrication processes, and do not conform to human anatomical features. These 
difficulties partially motivated the use of radiochromic films in clinical settings. The 
response of these films to radiation is typically measured at up to 24 hours post irradiation 
until relative stability of response is achieved187. A faster response is required to determine 
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the delivered radiation dose in order to administer any modifications to the treatment plan 
in order to ensure the safety of the patient. Polymer gel dosimeters require the use of 
sophisticated and expensive visualization modalities including magnetic resonance 
imaging (MRI)161, 186, which limits their practical use in the clinic. There is a need for a 
novel dosimeter that can overcome these limitations, demonstrate a rapid and robust 
performance (e.g. response time less than 24 hours), result in safe and effective monitoring 
radiation doses in proton therapy, potentially leading to improved patient outcomes. 
 
Gold nanoparticles have been used in a wide range of applications including catalysis, 
imaging, diagnostics and molecular delivery66, 67, 188. Of particular relevance, colorimetric 
assays using gold nanoparticles have been employed as sensors for the detection of analytes 
including toxic metal ions and biological enzymes189, 190. Gold nanoparticles are easy to 
synthesize, inert, functionalizable, and demonstrate tunable size and shape dependent 
properties (including colorimetric responses)191, all of which make them attractive for 
sensor development.  
 
Advances in molecular and nanoscale systems offer new options for effective radiation 
dosimetry192. Ionizing radiation causes formation of free radicals in water following 
hydrolysis. We employed this phenomenon in concert with effective templating molecules 
(e.g. aliphatic surfactants) in order to engender the formation of plasmonic (gold and gold-
silver) nanoparticles from their respective metal ion formulations93, 162, 193-195. The 
formation of plasmonic nanoparticles in liquid or gel formulations is accompanied by a 
visible color change which is distinct from the original metal ion formulation, which is 
125 
 
colorless. Here, we report, for the first time, a colorimetric approach for the rapid detection 
of therapeutic levels (0-3 GyRBE) of proton irradiation (Relative Biological Effectiveness 
or RBE is defined as the ratio of doses required to reach the same level of biological 
effectiveness when comparing two ionizing radiation treatment modalities)196. The extent 
of the color intensity depends on the dose of protons delivered to the gel and can be used 
for quantitative dose determination. To our knowledge, this is the first colorimetric 
nanosensor for detecting and predicting proton doses and has high potential for translation 
to clinical proton beam radiotherapy. 
5.2 Materials and Methods 
 
Materials. Gold(III) chloride trihydrate (HAuCl4.3H2O), decyltrimethylammonium 
bromide (C10TAB) (≥98.0%; non-aqueous titration grade), dodoceyltrimethylammonium 
bromide (C12TAB) (≥98%), myristyltrimethylammonium bromide (C14TAB) (≥99%), L-
ascorbic acid  and agarose were purchased from Sigma-Aldrich. Cetyltrimethylammonium 
bromide (C16TAB) was procured from MP Chemicals. The chemicals received from the 
vendors were not purified further. MilliQ water (18.2 MΩ.cm) was used as solvent for all 
experiments.  
 
Preparation of the Precursor Hydrogel. HAuCl4 (30 µL of 10 mM solution) was mixed 
with 600 µL of 50 mM solution of Cx=10,12,14,16TAB aliphatic surfactants, and 100 µL of 
the above mixture were discarded. Heated aqueous agarose (500 µL of 5% v (ml) /w (mg)) 
was added to the gold-surfactant solution. 24 well plates (diameter ~16 mm) were used to 
set the liquid mixture (200µL, 400µL and 650 µL) and form gels with a thickness of ~1, 2 
and 3 mm respectively. 10mM ascorbic acid (200µL for a 1mm gel, 400µL for a 2mm gel 
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and 650 µL for a 3mm gel) was allowed to diffuse into the gel for 10 minutes, resulting in 
the formation of translucent gel discs. These discs were used for irradiation studies as 
precursor hydrogels. 
 
Proton Beam Irradiation. All CT simulations of the phantom based setup and proton 
beam irradiations were conducted at the Proton Beam Therapy Center at Mayo Clinic 
Hospital, Phoenix, AZ. CT simulations were performed using the SOMATOM Definition 
AS (Siemens Healthcare, Erlangen, Germany), and spot-scanning based proton treatment 
plans were created using the Eclipse (Varian Medical Systems, Palo Alto, CA) treatment 
planning system (version PCS 13.7) (TPS). Proton irradiations were delivered using the 
PROBEAT-V Proton Beam Therapy System (Hitachi, Ltd., Tokyo, Japan). Proton beam 
therapy doses are customarily prescribed and reported in relative biological effectiveness 
(RBE) - weighted absorbed dose (DRBE). In this work, in order to obtain physical dose 
D_RBE values may simply be divided by a constant factor of 1.1.  
 
Gel samples were placed in the inner wells of a 24-well plate, which was placed on the 
table with 5 cm-thick acrylic blocks placed above and below it. A CT simulation of the 
phantom was performed with slice thicknesses of 2 mm. A single Field Uniform Dose 
based treatment plan was designed in order to deliver 0.5 GyRBE uniformly across the 
central wells. The treatment was optimized such that the 99% of the dose reporting 
reference volume received 100% of the dose. In order to deliver larger doses to these gel 
samples, sequential treatment plans were generated by simply scaling the doses to higher 
DRBE levels: 0.5, 1.0, 1.5, 2.0, 3.0, 4.0 and 5.0 GyRBE. These doses delivered to our samples 
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were validated with another reference film dosimeter. A piece of Gafchromic EBT3 film 
(Ashland, Bridgewater, NJ) was placed directly below the well plate during irradiation of 
the gel with 2.0 GyRBE.  Reference dosimetry using these calibrated gafchromic films 
matched the TPS calculated doses to within +/- 2.5%. While the irradiation times ranged 
between 41 seconds for the 0.5 GyRBE dose and 86 seconds for the 5.0 GyRBE dose, dose 
rate dependence of these dosimeters has not been investigated in this particular study. 
 
Plasmonic Gel Dosimetry on an Anthropomorphic Child Phantom. A CT simulation, 
using a slice thickness of 1 mm and a pitch of 1.0, was performed on an ATOM 704 
anthropomorphic phantom (CIRS Inc., Norfolk, VA), which models a 1-year-old infant. 
Three radio-opaque markers were placed at isocenter, and two more were placed at the 
head and foot to ensure a reproducible setup. A plan was created whereby a posterior-
anterior field was used to deliver a prescription DRBE of 1.8 GyRBE to a target encompassing 
the spine. The phantom was irradiated with gel samples placed on the table at various points 
beneath it, providing a measurement of the skin dose to the phantom.  
 
Absorbance Spectroscopy. Following irradiation with different proton doses, the 
absorbance spectra of the gel samples were measured for wavelengths ranging from 300 to 
990 nm with a step size of 10 nm using a BioTek Synergy 2 plate reader. All absorbance 
measurements were carried out at 2 hours following irradiation, because the travel time 
from the Mayo Clinic to ASU can vary. However, the color change was seen as early as 15 
minutes post irradiation in most cases. The absorbance values obtained were offset by 
subtracting the wavelength at 990 nm. The peak between 500-600 nm was used as an 
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indicator for the formation of gold nanoparticles. A maximum absorbance value between 
500-600 nm vs. proton dose was plotted for all surfactants.  
 
Compression Testing. Force under compression for failure was recorded using a TA.XT 
Plus Texture Analyzer (Texture Technologies Corp., Hamilton, MA) equipped with 
Exponent (Stable Microsystems) software. The hydrogels were placed between the 
stationary plate and the moving accessory (TA-8; 1/4" spherical ball). The accessory 
movement speed used was 2mm/sec and a trigger force of 0.049N was set. The maximum 
compressive force force required was measured through the force vs distance curve 
generated.  
 
Image Processing. A Canon EOS 1100D camera was used to acquire all gel images. The 
Fotor Photo Editor application was used to crop the images to the desired size, but no 
further editing was carried out. All pictures reported in this article were acquired for 
visualization alone and not used for quantification of the dose response, which was carried 
out using absorbance analysis.  
 
Transmission Electron Microscopy. The irradiated sample was kept at room temperature 
overnight for air drying. The dried sample was soaked in epoxy resin. Thin slices of the 
cured epoxy-containing sample were sectioned using an ultramicrotome. These thin 
samples were imaged using a Philips CM 12 Transmission electron microscope.  
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Statistical Analyses. All experiments were carried out in triplicate unless otherwise stated. 
Statistical analysis calculations were carried out using Microsoft Excel and data are 
expressed as the mean of these independent experiments ± one standard deviation. 
 
5.3 Results and Discussion 
 
The ability to detect proton doses administered to tissues can have significant implications 
for improving treatment outcomes in cancer radiotherapy. To this end, a robust nanosensor 
that can reliably detect doses at the intended target and / or at nearby tissues can enhance 
the efficacy of radiotherapy, which can lead to improved patient outcomes. Here, we report 
our studies on a gel-based colorimetric nanosensor that can detect doses employed for 
fractionated proton radiotherapy in the clinic. The nanosensor works on the principle that 
exposure of a precursor hydrogel to high-energy radiation (e.g. photons) or particles (e.g. 
protons) results in the formation of free radicals upon hydrolysis (water splitting), which, 
in turn, reduce the encapsulated gold ions to gold nanoparticles within the gel matrix 
(Figure 5.1)162, 193. The plasmonic properties of these gold nanoparticles renders a color 
(typically maroon) to the gel. The intensity of the color is governed by amount 
nanoparticles formed, which, in turn, is dependent on the dose of protons absorbed.  
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Initially, gold exists as trivalent Au(III) ions along with the cationic surfactant molecules 
within the heated agarose solution. These Au(III) metal ions are first reduced to 
monovalent Au(I) ions using ascorbic acid as the reducing agent194. The reduction potential 
of Au(I) is higher than that of Au(III), which increases the thermodynamic favorability of 
zerovalent gold ion or Au(0) formation138, 197. These Au(0) ions are thought to nucleate and 
grow to form gold nanoparticles; the cationic surfactant used in the formulation (CxTAB; 
x=10, 12, 14, or 16) likely stabilizes the gold nanoparticles formed and may also play a 
role in templating the nanoparticles.  
 
Agarose 
gel 
Nanosensor 
precursor 
Gel dosimeter 
post irradiation 
10 min 
incubation  
Ascorbic 
Acid 
During 
Irradiation 
Proton 
Gantry 
Figure 5.1 Schematic of nanosensor gel dosimeters for proton beam therapy. Cylindrical 
hydrogel discs, 16 mm diameter and 3 mm height, are formulated with 10 mM HAuCl4, 
50 mM CxTAB (x=10, 12, 14 or 16) and 5% (w/v) agarose. Just prior to irradiation, 10 
mM ascorbic acid is added from the top and allowed to diffuse into the gel for 10 minutes. 
A characteristic maroon color is seen post irradiation due to formation of gold 
nanoparticles within the gel matrix.  
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Irradiation of Au(I)-containing agarose gels with high-energy proton particles can facilitate 
splitting of water molecules in the hydrogel, which, in turn, can result in the formation of 
e-, H. and OH. free radicals198. Of these, e- and H. are reducing in nature and help reduce 
Au(I) ions to zerovalent Au(0) ions. Ascorbic acid, an antioxidant, is thought to help 
quench the oxidizing OH. radicals formed in the process199, which can further enhance the 
efficacy of nanoparticle formation. The agarose hydrogels are initially translucent and 
colorless prior to irradiation, but change color to maroon once exposed to protons due to 
formation of gold nanoparticles within the matrix, resulting in a visible indicator of proton 
therapy doses. Surfactants of different chain lengths (Cx, where x=10, 12, 14, or 16TAB) were 
employed to facilitate the formation of gold nanoparticles. Water solubility, 
biocompatibility and ease in formulation of hydrogels were the key factors influencing the 
selection of agarose as the gel matrix in these studies.  
 
We fabricated agarose gels with thicknesses of 1, 2 or 3 mm loaded with C12TAB and 
C14TAB surfactants and investigated them for a colorimetric response following irradiation 
with protons (2 Gy). An increase in the absorbance was observed with an increase in the 
gel thickness following irradiation (Figure 5.2). It was observed that the 1mm and 2mm 
thick gels formed a higher meniscus curvature making the gels non-homogenous. This led 
to the formation of a non homogenous distribution of gold nanoparticles in the gel, which 
could even be visually observed (Figures 5.3A, 5.3B, 5.4A and 5.4B).  However, the 
distribution of gold nanoparticles was visually homogeneous in gels that were ~3 mm in 
thickness (Figures 5.6A and 5.6B). Absorbance values, used to quantify gold nanoparticle 
formation, were similar at different points along the diameter, which further indicated a 
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uniform distribution of nanoparticles formed in the 3 mm thick agarose matrix (Figure 
5.5).  This uniform distribution of nanoparticles and the ease of handling of the 3 mm 
hydrogels made this formulation an excellent choice for further radiation experiments. 
 
 
 
Figure 5.2 Absorbance spectra of the hydrogel nanosensor following irradiation with 
proton beam therapy. A plot depicting maximum absorbance vs radiation dose 2 hours post 
irradiation is shown. Gels containing 50 mM C12TAB surfactant irradiated with 0 GyRBE 
(depicted by blue diamonds) and 2 GyRBE (depicted by grey triangles), and 50 mM C14TAB 
surfactant irradiated with 0 GyRBE (depicted by orange squares) and 2 GyRBE (depicted by 
yellow circles) with varying thickness are shown in the plot.  In the figure, GyRBE is denoted 
as only as Gy. 
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Figure 5.3 Images of nanosensor gel of thickness 1 mm containing C12TAB or C14TAB 
surfactants. (A) Control gels irradiated with 0 GyRBE (B) nanosensor gels irradiated with 2 
GyRBE radiation dose using proton beams. All gels contain 10 mM HAuCl4 and 10 mM 
ascorbic acid. All images were taken 2 hours after irradiation of gels with protons. 
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Figure 5.4 Images of nanosensor gel of thickness 2mm containing C12TAB or C14TAB 
surfactants. (A) Control gels irradiated with with 0 GyRBE and (B) nanosensor gels 
irradiatied with 2 GyRBE radiation dose using proton beams. All gels contain 10 mM 
HAuCl4 and 10 mM ascorbic acid. All images were taken 2 hours after irradiation of gels 
with protons. 
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Figure 5.5 Absorbance values of 3mm Agarose gels at different locations on the hydrogel 
measured 2 hours post irradiation. Gels containing (A) C12TAB and (B) C14TAB 
surfactants were irradiated with 2 GyRBE radiation dose using proton beams. All gels 
contain 10 mM HAuCl4 and 10 mM ascorbic acid.  
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A number of control experiments were carried out in order to investigate the performance 
of the gel nanosensor system. An intense yellow color of the hydrogel was observed 
0 GyRBE 0.5 GyRBE 1 GyRBE 
2 GyRBE 3 GyRBE 4 GyRBE 5 GyRBE 
0 GyRBE 0.5 GyRBE 1 GyRBE 
2 GyRBE 3 GyRBE 4 GyRBE 5 GyRBE 
Figure 5.6 Images of nanosensor gels containing (A) 50 mM C12TAB and (B) 50 mM 
C14TAB surfactants, irradiated with different doses of proton beams as indicated. All gels 
contain 10 mM HAuCl4 and 10 mM ascorbic acid. All images were taken 2 hours after 
irradiation of gels with protons.  
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following the mixture of HAuCl4 and CxTAB (x=10,12,14 or 16) with heated agarose. The 
observed color is caused by the ligand exchange of Cl- in AuCl4- to Br- present in CxTAB138. 
It is likely that AuBr4- exists as stable CTA-AuBr4- metallomicelles within the agarose 
matrix138. Ascorbic acid reduces AuBr4- to AuBr2-, which indicates conversion of gold ions 
from the trivalent Au(III) state to the monovalent Au(I) state200. Ascorbic acid is a weak 
reducing agent and thus, only partial reduction of the gold (from Au(III) to Au(I)) is likely 
possible in the presence of a high concentration of the surfactant. This is because the 
oxidation potential of the ascorbic acid reduces in micellar environments201. The yellow-
colored hydrogels turn colorless once ascorbic acid is added to the hydrogel, which is the 
precursor hydrogel used in all proton irradiation studies. We suggest that the presence of 
micelles in our hydrogel system leads to enhanced shielding between Au+ ions and ascorbic 
acid, which retards spontaneous nanoparticle formation.  
 
Irradiation of ~3 mm agarose hydrogels containing HAuCl4 and CxTAB with protons but 
in the absence of ascorbic acid did not induce any color change to the hydrogel (Figure 
5.7). Similarly, irradiation of gels containing a mixture of HAuCl4 and agarose alone (no 
ascorbic acid or CxTAB) did not result in a change in color (Figure 5.7). These results 
indicate that all components - HAuCl4, CxTAB, ascorbic acid  and agarose - play a key role 
in the formulation of the plasmonic hydrogel based nanosensor for detecting proton doses. 
Interestingly, we observed that C10TAB shows a slight development of color, which 
indicates spontaneous nanoparticle formation even in absence of radiation. C10TAB (CMC 
~65mM) does not form micelles at concentrations employed (~25mM) in the current 
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system202. This likely leads to low steric hindrance and allows for spontaneous nanoparticle 
formation, which can be visually observed (Figure 5.8).   
(A) 
 
 
 
  
 
 
(B) 
 
 
 
Figure 5.7 Images of controls of agarose gels acquired 2 hours post a 2 GyRBE radiation 
dose containing (A) 10 mM HAuCl4 and 50 mM Cx=10,12,14&16TAB surfactant (From left to 
right), but no ascorbic acid (B) only 10 mM HAuCl4, and no Cx=10,12,14&16TAB or ascorbic 
acid. No change in color was observed post irradiation.  
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0 GyRBE 0.5 GyRBE 1 GyRBE 
2 GyRBE 3 GyRBE 4 GyRBE 5 GyRBE 
0 GyRBE 0.5 GyRBE 1 GyRBE 
2 GyRBE 3 GyRBE 4 GyRBE 5 GyRBE 
Figure 5.8 Images of nanosensor gel samples composed of (A) 50 mM C10TAB and (B) 
50 mM C16TAB surfactants. All gels contain 10 mM HAuCl4 and 10 mM ascorbic acid.
All images were taken 2 hours after irradiation of samples with protons.  
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All surfactants employed were able to facilitate and template the formation of gold 
nanoparticles when exposed to the therapeutic doses of proton irradiation (0-5 GyRBE). A 
characteristic maroon color of gold nanoparticles was visible post irradiation in the 
hydrogels (Figures 5.6A, 5.6B, 5.8A and 5.8B). The time necessary for the development 
of the color development was dependent on the nature of surfactant used. C12TAB-loaded 
agarose demonstrated the color change as early as ~5 min, but C14TAB-loaded hydrogel 
demonstrated a color change in ~10 minutes following irradiation with a 2 GyRBE dose, 
which is conventionally employed in fractionated radiotherapy (Figures 5.9). Low doses 
(0.5 GyRBE or 1 GyRBE) irradiation required longer times (~15 minutes) for the development 
of the maroon color. Formation of gold nanoparticles was further visualized using 
transmission electron microscopy (TEM; Figure 5.10); non-homogenous particle 
distribution was observed with particles ranging from 20-100 nm in diameter / longest 
dimension. 
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Figure 5.9 Images of nanosensor gels formulated with 50 mM C12TAB and C14TAB 
surfactants. Gels were irradiated with a 2 GyRBE dose of proton beams, and images were 
taken at (A) t = 0 mins, (B) t = 5 mins, (C) t = 10 mins and (D) t = 15 mins post irradiation.
All gels contain 10 mM HAuCl4 and 10 mM ascorbic acid. Images are representative from 
n= 3 experiment. 
 
Figure 5.10 Transmission Electron Microscopy (TEM) micrographs of gold nanoparticles 
generated within the nanosensor gel formulated with C12TAB as surfactant and irradiated 
with 2GyRBE proton radiation dose. (A) Low-magnification image depicting presence of 
gold nanoparticles in the dried hydrogel. Scale bar = 0.5µm (B) High-magnification image 
of the highlighted region in Figure A. Scale bar = 0.1µm 
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The increase in color intensity of the nanosensor gel is directly dependent on the formation 
of gold nanoparticles upon irradiation, which depends on the generation of free radicals. 
Increases in proton dose results in an increase in the formation of free radicals. Thus, 
absorbance of the hydrogel is an indicator of the dose delivered to the gel. Consequently, 
absorbance of the hydrogels was quantified using UV-vis spectroscopy 2 hours post 
irradiation with protons (Figure 5.11) in order to quantify the colorimetric response of the 
nanosensor gels. A characteristic spectral peak corresponding to the presence of gold 
nanoparticles was observed at ~520nm. Once the change in gel changed color occurred, no 
further change in color was observed for up to 4 hours, indicating stability of the generated 
nanoparticles over time (Figure 5.12). We monitored visual and spectroscopic changes in 
the control hydrogel (0 GyRBE) and the hydrogel irradiated with 2 GyRBE for a longer 
duration (Figure 5.13 and 5.14). It was observed that no significant changes in the 
absorbance signal was noticeable even after one week. Gold nanoparticles are known to be 
stable and we do not anticipate change in the color of the gel over longer durations, 
although it is unlikely that the nanosensor gels will be used for longer studies because the 
turnaround between two fractionated radiotherapy sessions is ~24 h. We also determined 
the mechanical integrity (hardness) of pristine agarose hydrogel and compared it to the 
nanosensor hydrogels pre and post proton irradiation (2 GyRBE) (Figure 5.15). The 
hardness of the different gels was studied by measuring the maximum force required to 
indent the hydrogel which was quantified from the force vs distance plot obtained. All 
samples were compared to pure agarose using unpaired two-tailed t-test. The p-values 
obtained were greater than 0.05 indicating no significant changes in the hardness of the 
nanosensor gels compared to that of agarose. These results indicate that proton treatment 
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and concomitant nanoparticle formation do not have a significant effect on the mechanical 
integrity of the gels. 
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Figure 5.11 Absorbance spectra of nanosensor gels containing (A) C10TAB, (B) C12TAB, 
(C) C14TAB and (D) C16TAB as surfactants post irradiation with proton beams at different 
doses. Gold nanoparticle formation is indicated by a characteristic peak between 500 – 600 
nm. In the figure, GyRBE is denoted as Gy. 
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Figure 5.12 Absorbance of gold nanoparticles formed in agarose hydrogels formulated 
with (A) C10TAB, (B) C12TAB, (C) C14TAB and (D) C16TAB following irradiation with 
different proton doses. Absorbance spectra were measured 2 hours post irradiation with the 
maximum absorbance (typically at a wavelength between 500 – 600 nm) plotted against 
time to generate the plot. In the figure, GyRBE is denoted as Gy. 
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Figure 5.13 The stability of the colorimetric response of the hydrogel nanosensor was 
studied for up to one-week (1 w) post irradiation of the gel samples with protons. 
Absorbance spectra of C12TAB- or C14TAB-loaded nanosensor gels irradiated with 0 
GyRBE and 2 GyRBE were acquired at the indicated time points. Unpaired T-test was 
performed using the function T.TEST in MS Excel for each time point and the absorbance 
value was compared to the absorbance value at 2 h. The p-values were found to be greater 
than 0.05 and hence the change in the absorbance was considered to be insignificant, 
indicating stability of the colorimetric response of the nanosensor gels. N = 3 independent 
experiments. 
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Figure 5.14 Images of nanosensor gels containing irradiated with (i) 0 GyRBE (control) and 
(ii) 2 GyRBE. In each image, C12TAB-loaded gels are on the left and C14TAB-loaded gels 
are on the right. Images were obtained after (A) 2 hours (B) 1 day and (C) 1 week post 
irradiation with protons (or not in case of the control or GyRBE images). Representative 
images from n=3 independent experiments. 
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Figure 5.15 Material hardness of the nanosensor gels was measured using a TA.XT 
Texture Analyzer. The above plot shows the maximum force required by each gel sample 
to completely indent the nanosensor. All the samples were compared to pure agarose using 
unpaired 2-tailed t-test, indicating no significant changes in the hardness of the gel. 
 
A correlation between the administered proton radiation dose and maximum absorbance at 
2 h was plotted between 0 - 5 GyRBE (Figure 5.16 and 5.17), which is a range commonly 
used in conventional fractionated proton beam therapy. It is desirable to have a sensor that 
functions in the conventional therapeutic range (1-2 Gy). However, recent developments 
in radiotherapy require a sensor that can also be adapted with ease to detect higher radiation 
doses typically used in hypofractionated regimes (i.e. > 2Gy / fraction). The range of the 
gel nanosensor can be tuned by simply modifying the concentration of the surfactant 
C12TAB (Figure 5.18A, 5.18B, 5.19A and 5.19B). Such ease in modulating the sensitivity 
of the nanosensor offers a significant advantage over existing conventional dosimeters.  
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Figure 5.16 Absorbance spectra of the nanosensor gel following irradiation with proton 
beams. A plot depicting maximum absorbance vs radiation dose 2 hours post irradiation is 
shown. (A) yellow squares represent C10TAB surfactant-loaded gels and while (B) grey 
diamonds representing C16TAB with 10 mM HAuCl4 and 10 mM ascorbic acid with 5% 
agarose is shown in the plot. 
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Figure 5.17 Absorbance spectra of the nanosensor gel following irradiation with proton 
beams. A plot depicting maximum absorbance vs radiation dose 2 hours post irradiation is 
shown. (A) blue circles represent C12TAB surfactant-loaded nanosensor gels and (B) 
orange triangles represent C14TAB-loaded nanosensor gels. Agarose gels (5%) were 
formulated with 10 mM HAuCl4 and 10 mM ascorbic acid in all cases. 
 
Figure 5.18 Absorbance spectra of the nanosensor gel following irradiation with proton 
beam therapy. A plot depicting maximum absorbance vs radiation dose 2 hours post 
irradiation is shown. C12TAB gels formulated with concentrations (A) 100 mM depicted 
with blue diamonds (B) 150 mM depicted with orange squares with 10 mM HAuCl4 and 
10 mM ascorbic acid with 5% agarose is shown in the plot. 
0
0.05
0.1
0.15
0.2
0.25
0.3
0 1 2 3 4 5
M
ax
im
um
 A
bs
or
ba
nc
e 
(A
.U
.)
Proton Dose (GyRBE)
C12
C14
0
0.05
0.1
0.15
0.2
0.25
0 2 4 6 8 10
M
ax
im
um
 A
bs
or
ba
nc
e 
(A
.U
.)
Dose (Gy)
100 mM
150 mM
153 
 
(A) 
 
                     
 
 
 
                    
 
 
 
(B) 
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6 GyRBE 8 GyRBE 10 GyRBE 
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6 GyRBE 8 GyRBE 10 GyRBE 
Figure 5.19 Images of nanosensor gels containing (A) 100 mM and (B) 150 mM C12TAB 
surfactant irradiated with different doses of proton beams as indicated. All gels contain 10 
mM HAuCl4 and 10 mM ascorbic acid. All images were taken 2 hours after irradiation of 
gels with protons. 
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Reaction volumes on the nanoscale can enhance reaction rates of e-aq generated upon 
radiolysis with [AuBr2]- ions attached to the head group of the micelle. It has been 
previously reported that the efficiency of charge transfer was enhanced in presence of 
cationic micelles (hexadecyltrimethylammonium bromide or CTAB micelles and a mixture 
of CTAB and cetylpyridinium or CP micelles) compared to anionic micelles203. It was 
hypothesized that hydrated electrons were more easily transported in the solvent, possibly 
due to the favorable attractive force between this negatively charged species and cationic 
micelles204. This attractive force can lead to an increased probability of capture of hydrated 
electrons by the micelle and reaction with [AuBr2]-. When these electrons interact with an 
empty site (i.e. no Au+ is present), an electron hopping / migration mechanism can facilitate 
intermicellar reaction between Au+ ions and hydrated electrons leading to the formation of 
Au0 atoms205.  
 
Compared to C10TAB and C16TAB, C12TAB and C14TAB showed higher efficacies of 
nanoparticle formation, as indicated by the maximum absorbance determined for a given 
radiation dose. In our current formulation, C10TAB does not form micelles based on the 
concentration used. In the absence of micelles, hydrated electrons are not influenced by the 
positive field and hence recombine and participate in secondary chemical reactions before 
reacting with Au+ ions. This leads to a reduced yield of Au0 atoms which, in turn, results 
in low yields of gold nanoparticles in case of C10TAB compared to CxTAB (x=12, 14). The 
other three surfactant CxTAB (x=12, 14, 16) do form micelles under the formulation 
conditions employed in the current study. There are three possible outcomes for the decay 
of radiation-generated hydrated electrons as shown schematically in Figures 5.20A-C. The 
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electron is attracted towards the micelle but reacts with other generated free radicals (H. 
and OH.) to form secondary products like hydrogen before reaching the micelle / gold 
ions206. The second possibility is that the electron reaches an empty site of the micelle and 
undergoes migration/hopping to reduce the gold ion present in the nearby Au1+ occupied 
site. The third and final decay mechanism involves direct interaction of the electron with a 
gold ion in the micelle resulting in the conversion of Au1+ to Au0. We hypothesize that the 
maximum reduction occurs when a micelle of sufficient charge is present with the optimal 
aggregation number of the surfactants leading to micelle formation. 
(A) 
 
(B) 
 
(C) 
 
Figure 5.20 Three possible scenarios of the decay of generated hydrated electron post 
irradiation with protons. (A) Formation of peroxides and other secondary products, (B) 
Electron hopping from an empty micellar site of the generated hydrated electron to reduce 
a nearby Au(I) ion, and (C) Direct reduction by the generated electron of Au(I) ion to 
Au(0). 
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C16TAB has a stronger positive electrostatic field compared to the other surfactants 
employed in the study due to the higher aggregation number of monomers required to form 
a self-assembled micelle207. Due to the high aggregation number of C16TAB (90)208, the 
probability of a hydrated electron directly reducing an [AuBr2]- ion is lower when 
compared to that with C12TAB and C14TAB. The availability of hydrated electron 
migration/hopping for reducing Au+ ions is also significantly reduced under the influence 
of a strong electrostatic field203. This can result in lower yields of zerovalent Au0 ions, 
which, in turn, is responsible for lower yields of gold nanoparticles. Experimentally, this 
is indicated by the lower absorbance values seen in case of C16TAB compared to C12TAB 
or C14TAB under similar irradiation conditions. We suggest that C12TAB and C14TAB with 
aggregation numbers 55 and 75 respectively208, form micellar nanostructures with surface 
charge characteristics that are optimal for facilitating the formation of gold nanoparticles 
in gels in a dose-dependent manner following proton irradiation.   
 
We next evaluated the predictive ability of our nanosensor with C12TAB or C14TAB 
formulated in the agarose gel, leading to their functions as potential dosimeters. A linear 
correlation between gold nanoparticle absorbance and radiation dose was found in the 
range of 0 – 3 GyRBE for both C12TAB and C14TAB (Figure 5.21). The calibration curve 
with C12TAB had a correlation of y=0.069x, while that with C14TAB was y=0.074x, where 
y is the absorbance and x is the dose in GyRBE. A test dose of 1.5 GyRBE was delivered to 
the gel to investigate the predictive ability of the nanosensor gels. The color change of this 
test gel was quantified 2 hours post irradiation using the respective calibrations, which 
157 
 
indicated a dose of 1.8 ± 0.44 GyRBE for the C12TAB gels and 2.1 ± 0.1 GyRBE for the 
C14TAB surfactant gels, indicating better predictive ability of the C12TAB gels. 
 
 
Figure 5.21 Calibration curve for C12TAB (blue dotted line) and C14TAB (orange dotted 
line) using maximum absorbance vs proton dose from 0 - 3 GyRBE, 2 h post irradiation. 
 
A simple homogenous phantom, e.g. a cube or cylinder, is not adequate for verifying the 
accuracy of the delivered radiation dose.209 A system that mimics human anatomy as 
closely as possible is therefore necessary for more accurately predicting the efficacy of 
radiotherapy in the clinic. We used an anthropomorphic child phantom for investigating 
the translational potential of the plasmonic nanosensor hydrogel for proton irradiation 
(Figure 5.22A). Gels formulated with C12TAB or C14TAB surfactants were employed in 
the phantom studies, because of the better calibration curves obtained with these surfactants 
compared to the other surfactants. The gels were placed within the defined field under the 
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spine of the phantom (Figure 5.22B) and subjected to a dose of 1.8 GyRBE; the respective 
calibration curves from 0-3 GyRBE were used for estimation of the dose delivered. A 
prediction of 1.6 ± 0.2 GyRBE was made using the calibration curve for C12TAB, and a 
prediction of 1.4 ± 0.4 GyRBE was made using the calibration curve for C14TAB calibration 
curve, respectively. Our nanosensor hydrogel with C12TAB surfactant shows an 11% error 
to the true value of the dose delivered (i.e. 1.8 GyRBE). Clinically used MOSFETs have an 
error percentage of ± 5% which is comparable to our current system210. The performance 
of the sensor can further be improved by fine tuning several key processes during 
fabrication including like preserving uniformity of gel pore size. Pore sizes and 
distributions in hydrogels have been previously shown to control the in situ growth of gold 
nanoparticles211. A control over pore size can be employed to exert better control over 
nanoparticle reduction and growth kinetics which can lead to consistent nanoparticle sizes 
following radiation. The clearly visible color change, simple detection technique using 
absorbance spectroscopy, and the ability to quantitatively predict doses demonstrates the 
potential of the hydrogel nanosensor for dosimetry in fractionated proton beam 
radiotherapy in the clinic. 
 
(A) 
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(B) 
 
Figure 5.22 (A) Evaluation of the predictive ability of hydrogel nanosensors using an 
anthropomorphic child phantom placed on the irradiation table and subjected to proton 
therapy. (B) an X-ray computed tomography (CT) scan image of the phantom used in the 
experiments. The spinal cord of the phantom is irradiated with 1.8 GyRBE. 
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Surfactant 
 
Actual Dose 
Delivered (GyRBE) 
Average Dose 
Delivered ±  
one S.D. (GyRBE) 
 
C12TAB 
 
1.8 
 
1.6 ± 0.2 
 
C14TAB 
 
1.8 
 
1.4 ± 0.4 
Table 5.1 The table indicates the dose delivered to each of the surfactants employed in the 
experiments and the average dose calculated using the C12TAB and C14TAB-based 
hydrogel nanosensors. 
 
5.4 Conclusions 
 
To our knowledge, we have developed the first gel-based colorimetric nanosensor for 
detecting and predicting radiation dose delivered in proton beam therapy. The hydrogel 
nanosensor was able to detect doses as low as 0.5 GyRBE and showed a robust linear 
calibration between a dose range of 0-3 GyRBE. The gel nanosensor was able to predict the 
dose delivered to an anthropomorphic child phantom with significant accuracy, indicating 
promise for translation to the clinic. In addition to the simple, visible, stable and 
quantifiable nature of the readout, the hydrogel system can be contoured for patient 
personalized treatments. Agarose and ascorbic acid are generally regarded as safe, and 
C16TAB is used in antibacterial formulations used on skin212. Although the surfactants used 
in the formulation of the gels can be toxic at elevated concentrations, use of secondary 
containment devices or eventual replacement of the surfactant with biocompatible 
templating molecules will alleviate these concerns. The development of a new generation 
of cationic surfactants that allow for precise control of nanoparticle size and yields can lead 
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to sensors with improved prediction abilities. We believe that this one-of-a-kind 
nanosensor holds high promise for translation to clinical proton beam therapy. 
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Chapter 6 ELECTRON BEAM DOSIMETRY USING PLASMONIC HYDROGEL 
NANOSENSOR 
6.1 Introduction 
 
Radiotherapy is a frequently employed technique for the treatment of cancer.213, 214 
Significant advancements in the control over the gantry rotation and the introduction of 
multileaf collimators have facilitated the improvements in treatment efficacy.215 This 
progress has given rise to development of novel radiation delivery techniques like intensity 
modulated radiotherapy (IMRT), image guided radiotherapy (IGRT), stereotactic 
radiotherapy and radiosurgery (SRS) and conformal radiotherapy. Currently, high energy 
photons are the primary source of radiation in clinical settings. But when administered to 
a tumor site there exists a large exit dose outside the target volume resulting in radiation-
induced toxicity.216, 217 To overcome this, high energy charged particles (electrons) are 
employed in clinical radiotherapy218. Electron beams have an inherent property of 
depositing their maximum dose at the required depth beyond which there is a sharp  
radiation dose fall off219. The high dose gradients result in radiation dose sparing of the 
healthy tissue from undesirable radiation damage. This mandates the use of electron beam 
radiotherapy over high energy photons for skin malignancies. Characteristics such as 
uniform dose deposition, altering dose depth by mere change in beam energy and ease in 
treatment planning make it a viable option for treatment of cancerous lesions.  
 
Precise measurements of the delivered dose are critical for patient safety and treatment 
efficacy. Although there have been rapid advancements in the techniques involved in 
163 
 
electron beam treatment, there is a lack in the development in dosimeters to keep up with 
improved techniques. Conventionally used dosimeters include thermoluminescent 
dosimeters (TLDs), radiochromic films and semiconductor diodes have significant 
drawbacks. Measurements using TLDs are very time consuming and labor intensive 
making its routine operation very cumbersome220. Semiconductor diodes with their 
accurate readout are limited due to its dose rate dependence which limits their periodic 
operation.221 Radiochromic films lack the ability to conform and adapt onto patient specific 
anatomy making them prone to positional instability and causing dose inconsistency with 
the delivered and predicted dose.222, 223 There is still a need for a dosimeter that can detect 
doses in the therapeutic window while addressing all the above challenges.  
 
Recent advancements in molecular and nanoscale systems could play a key role in the 
development of a dosimeter for the detection of therapeutic levels of ionizing radiation.224 
Gold nanoparticles with their unique optical and physiochemical properties have found 
application in diagnostics, imaging and drug delivery.224-228 Taking advantage of the 
inherent property of gold nanoparticles, we recently designed a liquid based colorimetric 
sensor dependent on the formation of gold nanoparticles from its colorless precursor salt 
solution upon irradiation162. We further formulated the next generation colorimetric sensor 
by developing a hydrogel-based sensor to facilitate easy handling and minimize application 
concerns229, 230. In this study, we extend the applicability of the hydrogel nanosensor to the 
detection of high energy electrons employed clinically. The system consists of a cationic 
surfactant stabilized gold nanoparticles generated upon exposure to high energy electrons 
rendering a change in color to pink/maroon to the hydrogel. The intensity of color increases 
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with increasing irradiation and is used as a measure to quantify the delivered radiation dose. 
Finally, the ability of the hydrogel nanosensor to capture topographical dose profiles using 
a fixing agent post irradiation is reported. To the best of our knowledge, this colorimetric 
nanosensor for electron beam dosimetry is the first of its kind which could have potential 
translational applications in clinical settings. 
 
6.2 Materials and Methods  
 
Materials. Molecular biology grade agarose, L-ascorbic acid (AA), 
dodoceyltrimethylammonium bromide (C12TAB) (≥98%), L-glutathione reduced (≥98%), 
gold(III) chloride trihydrate (HAuCl4.3H2O) and myristyltrimethylammonium 
bromide(C14TAB)(≥99%) were acquired from Sigma-Aldrich. Cetyltrimethylammonium 
bromide(C16TAB) was obtained from MP Chemicals. Sodium dodecylsulfate was obtained 
from Bio-Rad Laboratories while Tween 20 was purchased from Fisher Scientific. The 
chemicals were employed in the study with no further processing or purification. The 
solvent employed in the study was MilliQ water (18.2 MΩ.cm).  
 
Hydrogel Nanosensor Preparation. To fabricate a hydrogel with a diameter of ~1.5 cm 
and thickness of 3 mm, a 24 well plate is used as a mold. Briefly, 600 µL of a 50 mM  stock 
solution of CxTAB (x = 12,14,16) was prepared and mixed with 30 µL of 10 mM HAuCl4 
in a 1.7 mL microcentrifuge tubes. From this mixture, 100 µL was removed prior to the 
addition of heated 2% liquid agarose (500 µL). From this mixture, 650 µL was removed 
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and poured into the molds of the well plate and allowed to set as gels prior to irradiation 
experiments. The gels were then incubated in 10 mM Ascorbic Acid (650µL) for 10 minute 
resulting in translucent hydrogels.  
 
To fabricate a hydrogel with a diameter of ~3.5 cm and thickness of 3 mm, a 6 well plate 
is used as a mold. Briefly, 1.63mL of a 75 mM stock solution of C14TAB was prepared and 
mixed with 81.6 µL of 10 mM HAuCl4 in a 15 mL microcentrifuge tubes. From this 
mixture, 272 µL was removed prior to the addition of heated 2% liquid agarose (1.44 ml). 
This mixture (2.88mL) was poured into the molds of the well plate and allowed to set as 
gels prior to irradiation experiments. The gels were then incubated in 10 mM Ascorbic 
Acid (2.88 ml) for 10 minutes resulting in translucent hydrogels. 
 
X-ray irradiation. All experiments were conducted at the Banner-MD Anderson Cancer 
Center in Gilbert. The energy and dose rate of the beam were set at 6 MeV and 600 MU/min 
unless otherwise mentioned. A standard field size of 10 cm x 10 cm was maintained 
throughout the study. For spatial dose deposition, only half the gel was placed in the 
irradiation field. Post irradiation, further analysis was carried out at Arizona State 
University in Tempe, AZ (approximate travel time of 30 minutes).  
 
Post-processing of Hydrogel Nanosensor. Glutathione was used as a post processing 
agent to quench nanoparticle formation. Glutathione was added from the top of the gel, 30 
minutes post irradiation and incubated for 10 minutes. The volumes used for incubation 
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were 650 µL for a hydrogel nanosensor with a diameter of 1.5cm and 2.88 mL for a 
hydrogel nanosensor with a diameter of 3.5cm. The residual glutathione from the surface 
of the hydrogel nanosensor was discarded and used for further quantification. 
 
Absorbance Spectroscopy. The absorbance spectra for all samples was obtained using a 
BioTek Synergy™ 2 plate reader. Absorbance values were measured from 300 nm to 990 
nm with a step size of 10 nm. MilliQ water was used as blank for all experiments. Although 
the change in color is observable 15 minutes post irradiation, due to the travel time between 
Banner M.D Anderson Cancer Center, Gilbert and Arizona State University, Tempe 
measurements were quantified 2 hours post irradiation. To normalize the absorbance 
spectra for further analysis, the absorbance at 990nm was subtracted from the absorbance 
of all wavelengths. Absorbance at 540 nm wavelength was plotted as a function of radiation 
dose to generate the calibration curve which is used to determine unknown radiation doses. 
 
Topographical Mapping of Hydrogel Nanosensor. A 1536 well plate set up in a BioTek 
Synergy™ 2 plate reader having a grid size of ≈2mm x 2mm was used. Absorbance values 
at 540 nm and 990 nm were measured along the entire gel surface, leading to a dose map 
of the gel surface. The final absorbance was calculated by subtracting the absorbance 
values of water and 990 nm wavelength from the absorbance value at 540 nm wavelength. 
The calibration curve was used to predict the delivered dose to each cell of the grid 
corresponding to its topographical dose map over the gel surface. 
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Transmission Electron Microscopy (TEM). The gels were dissolved in 1,2-propane diol 
(a chaotropic agent) by gently heating at 80 °C for 15 mins. The resultant liquefied hot 
mixture was centrifuged at 4000 rpm for 10 mins and supernatant agarose-propane diol 
mixture was discarded carefully to isolate the gold nanoparticles pellet. The pellet was 
further dispersed in deionized water. The samples were prepared for imaging by casting a 
drop of this mixture onto a carbon film onto a TEM grid. The samples were dried overnight 
in air. A CM200-FEG instrument operating at 200 kV in the LeRoy Eyring Center for Solid 
State Sciences at ASU was used for imaging of gold nanoparticles in the irradiated gels. 
 
Hydrogel Nanosensor Dosimetry in Anthropomorphic Thorax Phantom. The 
anthropomorphic phantom was positioned on the radiotherapy table and aligned using 
guiding lasers. The hydrogel nanosensor was positioned in the middle of a 10cm x 10cm 
radiation field. A 1.3 cm tissue-equivalent bolus was placed on top of the hydrogel 
nanosensor. Each hydrogel nanosensor received a radiation dose of 2.5 Gy. 
 
Image Acquisition. All images were acquired using a HPLaserJet 3390. Furthermore, 
images were cropped to the required size and no further editing or post processing of the 
images was carried out.  
 
Statistical Analysis. All experiments were performed in quintuples unless otherwise 
specified. Data analysis for all independent experiments was performed using Microsoft 
Excel. Data reported in the manuscript are represented as mean ± one standard deviation. 
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6.3 Results and Discussion 
 
Electron beam therapy is frequently used for the treatment of superficial layers (epidermis 
and dermis) of malignant skin lesions231. Fractionated electron beam therapy involves 
delivering a cumulative dose of 20-70 Gy in fractions of 1-2 Gy per session over a course 
of several weeks232. There is a need to ensure precise and accurate delivery of radiation to 
patients. Current dosimetry devices are complex to fabricate and cumbersome to operate 
thereby limiting its routine use. There is still a critical need for the development of facile 
dosimeters that are robust, easy to fabricate and operate to ensure patient safety during 
radiotherapy.  
 
The principle behind the hydrogel nanosensor is the reduction of gold salt to gold 
nanoparticles following exposure to high energy electrons. Gold (HAuCl4), present 
natively in its trivalent state Au(III) is thermodynamically unfavorable to reduce as 
compared to Au(I)137. To carry out the conversion of Au(III) to Au(I) and retain it in its 
monovalent state without undergoing further reduction, a room temperature reaction using 
ascorbic acid (Vitamin C) was carried out in the presence of three distinctly charged 
(cationic, anionic and non-ionic) surfactants. In the presence of sodium dodecylsulfate 
(anionic) and Tween-20 (non-ionic surfactant), the addition of ascorbic acid results in the 
development of a pink/purple color and a characteristic peak between 500 and 600nm in 
the UV-Visible spectra suggesting spontaneous formation of gold nanoparticles (Figure 
6.1). Interestingly, in the presence of the cationic surfactant, no spontaneous nanoparticle 
formation is observed with lack of color developed (transparent) and the absence of the 
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characteristic peak in the UV-Visible spectra (Figure 6.1). The presence of a transparent 
solution has been attributed to the formation of Au(I) ions138. We hypothesize the favorable 
electrostatic interaction between the negatively charged tetrachloroaurate ions and 
positively charged cationic surfactant leads to enhanced shielding of Au(III) to ascorbic 
acid thereby inhibiting spontaneous gold nanoparticle formation. Based on this rationale, 
we employed cationic surfactants for our studies.  
 
High energy electrons employed in the study for irradiation could be involved in both direct 
and indirect mechanisms of reduction of Au(I) to Au(0). Exposure to ionizing radiation 
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Figure 6.1 UV-Visible spectra and digital images illustrating the presence and absence of 
spontaneous gold nanoparticle formation with three distinctly charged surfactants. Both 
anionic and non-ionic surfactants display spontaneous nanoparticle formation (<2mins) 
with the presence of a spectral peak between 500-600nm while in the presence of cationic 
surfactants no such spectral peaks are observed. The inset displays the presence of a pink 
and purple colored dispersion which are characteristic of gold nanoparticles when anionic 
and non-ionic surfactant are employed while a colorless solution is seen when cationic 
surfactant is employed indicating no spontaneous nanoparticle formation. The surfactants 
used are C16TAB (cationic), SDS (Anionic) and Tween 20 (Non-ionic) at a concentration 
of 20mM. The final gold and ascorbic acid concentrations were 0.2mM and 4mM 
respectively.  
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involves generation of reactive free radicals including hydrated electrons (e-aq), hydrogen 
free radicals (H.) and hydroxyl free radicals (OH.) through the splitting of water233. The 
generation of reducing species including e-aq and H. play a vital role in the reduction of 
Au(I) to Au(0). Although OH. is an oxidizing agent and can impede nanoparticle formation 
through dissolution of Au(0), the presence of ascorbic acid (anti-oxidant) could potentially 
minimize these unfavorable side reactions234. High energy electrons irradiation could also 
be potentially involved in direct reduction of Au(I) to Au(0). To facilitate easy handling 
and concerns during application, we have further incorporated the gold salt, cationic 
surfactant and ascorbic acid in an agarose hydrogel. Agarose based hydrogels have 
acquired lot of attention as controlled drug release platforms and as scaffolds for 
regenerative tissues due to their low toxicity235. The selection criteria for agarose as the 
hydrogel base for our nanosensor was based on the following parameters: its 
biocompatibility, ease in modulation of mechanical properties by mere change in 
concentration and ease in generation of the gel235.  
 
Hydrogel nanosensors with a diameter of ≈ 1.5cm and ≈ 3mm thickness were fabricated 
with three different cationic surfactants (CxTAB) with varying chain lengths (x = 12, 14 
and 16) and their response to therapeutic levels of high energy electrons irradiation (0-5Gy) 
were determined. In all cases exposure to high energy electrons rendered a maroon color 
to the hydrogel due to the formation of gold nanoparticles while the non-irradiated control 
remained colorless (Figure 6.2). For any given cationic surfactant, increasing levels of 
exposed high energy electrons resulted in a deepening of the maroon color developed in 
the hydrogel nanosensor. Exposure of hydrogel nanosensor to increasing levels of high 
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energy electrons resulted in a direct increase in the number of reducing species, which, in 
turn, led to a higher probability of reduction of Au(I) to Au(0). Further nucleation and 
growth of Au(0) results in the formation of gold nanoparticles imparting the characteristic 
color (maroon) to the hydrogel.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The change in color from colorless to maroon for C12TAB loaded hydrogels were observed 
≈5 minutes post irradiation, while the color change for C14TAB and C16TAB surfactant 
employed hydrogels were seen ~10 minutes and ~15 minutes post irradiation respectively. 
Interestingly, we observe that the varying the chain length of the surfactant affects the 
sensitivity of the hydrogel nanosensor to high energy electrons. Specifically, for a fixed 
radiation dose of 1 Gy decreasing the chain length of the cationic surfactant resulted in an 
increase in the developed color in the hydrogel nanosenosor. At the surfactant 
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Figure 6.2 Image of hydrogel nanosensor contain (top) 50 mM C16TAB, (middle) 50 mM 
C14TAB and (bottom) 50 mM C12TAB surfactants, irradiated with different doses of 
electron beam as indicated. All gels contain 10 mM HAuCl4, ascorbic acid. All images 
were taken 2 hours post irradiation with electrons. No L-glutathione was added to 
hydrogels post irradiation. 
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concentrations employed in the study (final concentration ≈20mM), the cationic surfactants 
in the study form micelles.145 Gold nanoparticle growth is governed by the frequency of 
collisions between cationic micelles containing AuBr2- and with the radiation generated 
zerovalent Au(0) atoms before they are stabilized by the cationic surfactant in the hydrogel 
nanosensor.236 We hypothesize that decreasing chain length results in increasing diffusion 
coefficients of the micelles.237 This increased mobility could potentially result in an 
increased frequency of collision involving cationic surfactant loaded AuBr2- and radiation 
generated Au(0) resulting in higher yields of gold nanoparticles with decreasing order of 
cationic chain length.  
 
The hydrogel nanosensors were further quantified using UV-Visible spectroscopy 2-hour 
post irradiation (Figure 6.3). A characteristic spectral peak between 500 and 600nm 
indicative of gold nanoparticles is observed.238 On further analysis, a clear increase in 
absorbance at 540nm is observed with increasing levels of high energy electrons (Figure 
6.4). This trend corroborates the increase in intensity of pink/maroon that is seen with the 
naked eye. To further visualize the presence of gold nanoparticles, the irradiated hydrogel 
nanosensor was characterized using transmission electron microscopy (Figure 6.5). A non-
homogenous particle distribution was observed with an average particle size ≈ 54 ± 17nm. 
Although both C12TAB and C14TAB surfactant containing hydrogels were capable of 
nanoparticle formation, C14TAB was employed for all further experiments. 
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Figure 6.3 Absorbance spectra of hydrogel nanosensor containing 50 mM (A) C12TAB, 
(B) C14TAB and (C) C16TAB as surfactant post irradiation as a function of radiation dose. 
Appearance of the characteristic peak between 500-600nm is indicative of gold 
nanoparticle formation. Absorbance of the hydrogel nanosensor was measured 2 hours post 
irradiation. 
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Figure 6.4 Absorbance at 540nm as a function of radiation dose. The formulation of the 
hydrogel nanosensor with 50mM C12TAB (Blue Circle), 50mM C14TAB (Orange 
Diamond) and 50mM C16TAB (Green Squares). Absorbance at 540nm was measured 2 
hours post irradiation. 
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Clinical radiotherapy involves radiation field sizes larger than 1cm2.239 In order to adapt to 
larger field sizes, hydrogel nanosensors of ≈ 3.5 cm diameter and ≈ 3 mm thickness were 
fabricated with a final concentration of 30mM C14TAB surfactant. These hydrogel 
nanosensors were further investigated to determine their ability to preserve topographical 
radiation information by irradiating one-half of the hydrogel nanosensor with a dose of 
3Gy. We observe a change in color to pink/maroon in one half of the hydrogel nanosensor. 
However, observation of these hydrogel nanosensors over longer durations displayed a 
“bleed-over” of the color to the non-irradiated regions (Figure 6.6). We attribute this 
phenomenon to additional growth of nanoparticles in the non-irradiated regions due to 
collisions between unreacted AuBr2- ions in the non-irradiated region with radiation 
Figure 6.5 Transmission Electron Microscopy (TEM) micrographs of gold nanoparticles 
with C14TAB as surfactant irradiated with a 4 Gy electron beam dose. (Left) Low 
magnification image depicting the presence of gold nanoparticles in the dried hydrogel. 
(Right) High magnification image of the highlighted region (Dashed Red Box).  
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generated gold nanoparticles in the irradiated region. To inhibit this “bleed-over” 
phenomena, we hypothesized that the addition of a quenching agent to complex/react with 
the unreacted AuBr2- will be required to prevent further nucleation and growth in the non-
irradiated regions. Gold-thiol bond has been demonstrated to be similar to the gold-gold 
bond, and in light of this we reasoned the addition of glutathione (thiol containing 
tripeptide) would complex/react with unreacted AuBr2- ions.240 Indeed, incubation with 
glutathione for 10 minutes (30 minutes post radiation) led to the complete arrest of the 
“bleed-over” phenomena. Based on this observation, , further studies were conducted with 
the post addition of glutathione. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Glutathione    + Glutathione 
30 minutes 
 
 
 
60 minutes 
 
 
 
90 minutes 
Figure 6.6 Images of the hydrogel nanosensor incubated with no glutathione (Left) and 
with 25mM glutathione for 10 minutes (30 minutes post-irradiation). Topographical dose 
profile is maintained upon incubation with glutathione.  
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Prior to quantifying the topographical dose profile delivered to the hydrogel nanosensor, 
the hydrogel nanosensors were exposed to various levels of therapeutically relevant high 
energy electrons (Figure 6.7). The absorbance value at 540 nm wavelength is plotted 
against its corresponding administered dose to generate the calibration curve which will be 
used to determine unknown radiation doses (Figure 6.8). While the response saturated 
beyond 5 Gy, a linear trend with an equation y=0.03x (y is the absorbance at 540nm and x 
is the dose in Gy) is observed between 0 – 5 Gy. Three unknown pilot doses were employed 
to verify the efficacy of the hydrogel nanosensor(Table 6.1). These results demonstrate the 
ability of the hydrogel nanosensor to predict the delivered radiation dose. The spatial dose 
distribution capability of the nanosensor was tested by irradiating half of the hydrogel 
nanosensor with a 3 Gy radiation dose (Figure 6.9). Upon completion of the irradiation, a 
visual appearance of maroon/pink is observed in the irradiated region while the non-
irradiated regions remains transparent. Glutathione is added 30 minutes post-irradiation to 
preserve the topographical dose profile. The absorbance at 540nm is measured in finite 
grids of ≈2mm x 2mm along the diameter of the hydrogel nanosensor and is used to predict 
the delivered radiation dose. The line profile predicted along the diameter of the hydrogel 
nanosensor is in agreement with delivered radiation dose fall-off profile. These results 
taken together indicate the potential of the hydrogel nanosensor to qualitatively and 
quantitatively determine topographical dose profiles.   
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Figure 6.7 Images of hydrogel nanosensor irradiated with different doses of electron beam 
irradiation. The hydrogel nanosensor contains 10 mM HAuCl4, 75 mM C14TAB, 2% (w/v) 
agarose and incubation with 10 mM ascorbic acid for 10 minutes. Hydrogel nanosensor 
was further incubated with glutathione (25mM) for 10 minutes 30 minutes post irradiation. 
All images were taken 2 hours post irradiation. 
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Delivered 
Radiation  
Gy 
Predicted 
Radiation  
Gy 
Error % 
1.5 1.23 ± 0.21  18 
2.8 2.85 ± 0.29  1.8 
4.5 4.0 ± 0.24 11 
Table 6.1 Table indicating the efficacy of the hydrogel nanosensor in predicting the dose 
delivered. Error percentages range between 2 to 20%.  
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Figure 6.8 (A) Absorbance at 540nm as a function of radiation dose. The linear range in 
the therapeutic window of the hydrogel nanosensor (0-5 Gy) is indicated. (B) Calibration 
curve for C14TAB using absorbance at 540nm as a function of radiation dose between 0 
and 5 Gy. The hydrogel nanosensor contained C14TAB at a concentration of 75mM. 
Absorbance of the hydrogel nanosensor was measured 2 hours post irradiation. 
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Radiotherapy involves the use of a wide range of dose rates for the effective treatment of 
tumors241. To ensure dose rate independence of the hydrogel nanosensor, they were 
exposed to three different dose rates with a final culminating dose of 3Gy (Figure 6.10). 
No significant differences in the absorbance response was observed emphasizing the dose 
rate independence of the hydrogel nanosensor. This is not surprising as the number of free 
radicals generated for the reduction of Au(I) to Au(0) is independent of dose rate and only 
dependent on the final dose delivered. We further investigate the efficacy of the hydrogel 
nanosensor in predicting the delivered dose to an anthropomorphic thorax phantom (Figure 
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Figure 6.9 (A)Image depicting the colorimetric response of the hydrogel nanosensor 
irradiated on half with a 3 Gy dose. The appearance of a pink/maroon color illustrates the 
capability of the hydrogel nanosensor to qualitatively distinguish the irradiated and the 
non-irradiated regions. (B) Dose fall off-profiles comparing the simulated dose (Blue 
Triangles) with the predicted dose (Orange Circles) indicating the efficacy of the hydrogel 
nanosensor to quantitatively determine the topographical dose profiles.  
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6.11). The hydrogel discs were kept on top of the skin in the center of the radiation field 
on the skin of the phantom while being administered a dose of 2.5 Gy. Based on the 
calibration curve acquired from absorbance spectroscopy, the delivered was calculated to 
be 2.55 ± 0.02 Gy. The percentage error calculated was 2% which is similar to existing 
dosimeters which have an uncertainty less than 10%.230 The distinct visual color change, 
coupled with a simple quantitative measurement (UV–Visible absorbance) indicates the 
translational potential of this approach for detecting clinically relevant radiotherapy doses. 
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Figure 6.10 Absorbance at 540nm as a function of dose rate. Three different dose rates 
(100,600 and 1000 MU/minute) were employed in the study. No significant differences 
were observed indicating dose rate independence. One-way ANOVA with α = 0.05 was 
performed and no significance between all three groups was established.  
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Figure 6.11 Setup depicting the anthropomorphic thorax phantom and (Right) Image of 
the hydrogel nanosensor after exposure to 2.5 Gy. The hydrogel nanosensor predicts a 
radiation dose of 2.55 ± 0.02Gy. 
 
184 
 
6.4 Conclusions 
To our knowledge, this is the first colorimetric plasmonic hydrogel nanosensor for the 
detection and prediction of radiation dose delivered in electron beam radiotherapy. The 
hydrogel nanosensor displayed a robust linear calibration between therapeutically relevant 
radiation dose range (0 – 5) using a simple UV-Visible spectrophotometer. The hydrogel 
nanosensor was able to predict the radiation dose administered to the anthropomorphic 
thorax phantom. Finally, we demonstrated the capability of the hydrogel nanosensor to 
qualitatively and quantitatively distinguish regions exposed to radiation and not exposed 
to radiation. To further improve the prediction efficacy of the current hydrogel nanosensor, 
development of novel cationic surfactants and other templating agents is essential. This 
would allow for the realization of superior control in size and yields of nanoparticles which 
directly contributes to the hydrogel nanosensor accuracy. In addition, the use of a hydrogel 
can facilitate adaptations that allows for patient specific dosimetry depending on the patient 
anatomy. Owing to its facile fabrication and ease in quantification, we anticipate that the 
hydrogel nanosensor can potentially be translated to clinical electron beam therapy. 
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Chapter 7 DETERMINATION OF TOPOGRAPHICAL RADIATION DOSE 
PROFILES USING GEL NANOSENSORS 
7.1 Introduction 
 
Rapid development of new technologies has contributed to significant advances in cancer 
radiotherapy. For example, multileaf collimation and sophisticated planning software 
permit the delivery of a higher conformal radiation dose to patients, which has led to 
improved outcomes and quality of life post treatment242. These processes involve 
delivering a high radiation dose to the target tumor while minimizing dose to the 
surrounding healthy tissue243. However, rapid implementation of these new technologies, 
which were intended to reduce the risks of underdosing or overexposing the patient to 
radiation, might counterintuitively induce new sources of error244. For instance, software 
errors in linear accelerators could lead to significant radiation overdosing leading to patient 
morbidity245.  Independent verification of the radiation dose delivered at and / or near the 
target tissue can further advance patient safety246.  
 
Most clinically used sensors including thermoluminescent dosimeters (TLDs), ion 
chambers and silicon diodes are capable of point dose measurements but are unable to 
capture topographical radiation dose profiles247. Radiographic films were developed to 
overcome these limitations and have been explored to provide topographical information 
during radiotherapy. However, their performance is impacted by operating conditions (e.g. 
humidity) that cause post-irradiation artifacts248. The major disadvantage of these 
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radiographic films is the post-irradiation wait time (>24 hours) required prior to 
scanning249, which, in turn, obviates their routine clinical use.  There is a critical need for 
a sensor that can effectively report topographical dose distribution at or near tissues with 
minimal post-irradiation wait times for applications in treatment planning and verification.  
 
Molecular and nanoscale sensors can overcome limitations with conventional systems and 
are practical alternatives as facile radiation sensors161. Quantum dots and metal organic 
frameworks (MOFs) demonstrate an intense scintillating response but provide only point 
dose information limiting their application in the clinic250, 251. Polymer gel dosimeters rely 
on sophisticated readout techniques (e.g. MRI) for post-irradiation analysis, which makes 
their clinical application cumbersome and expensive252. Radiation-triggered conversion of 
a non-fluorescent monomer to a fluorescence-emitting polymer has been investigated for 
dose detection18, but the response was susceptible to decay over time potentially giving 
rise to challenges in measurement. In light of these limitations, there is a need to develop 
robust and facile sensors to qualitatively and quantitatively determine topographical 
(spatial) dose profiles in clinical radiotherapy.  
 
Gold nanoparticles possess unique physical and chemical characteristics that make them 
an excellent platform for the development of sensors66, 253-255. We recently developed a 
colorimetric  sensor in which, ionizing radiation triggers the formation of gold 
nanoparticles from its corresponding colorless salt precursors162. Formulation of a gel-
based nanosensor facilitates easier handling and application in clinical radiotherapy229, 256. 
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Here, we demonstrate the application of a gel nanosensor formulation for the colorimetric 
detection of complex distribution profiles leading to topographical mapping of radiation 
doses along tissues. This approach combines the ease of colorimetric detection and 
quantification with a fast and robust response. To our knowledge, we demonstrate, for the 
first time, the use of a molecular and nanoscale technology for determining topographical 
dose distribution in live canine patients. Taken together, our results demonstrate the 
potential for clinical translation of this technology for treatment planning and dose 
verification in cancer radiotherapy.  
     
7.2 Materials and Methods 
 
Materials. Hydrogen tetrachloroaurate trihydrate (HAuCl4.3H2O), 
myristyltrimethylammonium bromide (C14TAB) (99%), L-ascorbic Acid (AA), Sodium 
Sulfide nonahydrate (Na2S.9H2O), sodium chloride, sodium bromide, sodium bromide and 
molecular biology grade agarose were acquired from Sigma-Aldrich. No further 
purification of the chemicals was carried out. MilliQ water (18.2 MΩ.cm) was used as 
solvent for all experiments conducted. 
  
Preparation of the Precursor Gel Nanosensor. Tetrachloroauric acid (30 µL of 10 mM 
in MilliQ water) was mixed with C14TAB surfactant (600 µL of 75 mM in MilliQ water). 
From the resulting mixture, 100 µL was discarded prior to further use. Agarose was 
dissolved in MilliQ water to obtain a final concentration of 2% w/v and heated until a clear 
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transparent solution was obtained. This heated agarose (500µL) was added to the 
tetrachloroauric and cationic surfactant mixture. The above liquid (650 µL) was poured 
into a 24 well tissue culture well plate to form the gel nanosensor with a thickness of ~3 
mm and a diameter of ~1.5 cm. Ascorbic acid (650 µL of 10 mM in MilliQ water) was 
allowed to diffuse from top of the gel for 10 minutes and excess AA was discarded. The 
gel was washed using MilliQ water to further remove any excess ascorbic acid on the 
surface. Gel nanosensors were also prepared in 6-well tissue culture plates (~3.6 cm 
diameter) using similar procedures in order to investigate larger dimensions. 
 
X-Ray Irradiation. All irradiation experiments were carried out at the Banner-MD 
Anderson Cancer Center in Gilbert, AZ. A Varian TrueBeam Linear Accelerator was used 
to irradiate the samples with X-rays an energy of 6MV at a dose rate of 600MU/min. For 
complete exposure of the samples to irradiation, the gel nanosensors were placed within a 
10 cm x 10 cm irradiation field. For demonstrating spatial dose distribution, only half the 
gel nanosensor was placed within the 10 cm x 10 cm irradiation field while the other half 
was outside the field of irradiation. After irradiation, the samples were analyzed further at 
Arizona State University in Tempe, AZ. (Travel time of approximately 30 minutes)  
 
Post-processing of irradiated Gel Nanosensors. Various quenching agents, Na2S and 
NaX, where X=Cl, Br, or I (650 µL of 5mM), were investigated in order to quench the 
nanoparticle formation reaction. The quenching agents were added on top of the gel 
nanosensor at various times post irradiation (5, 9, 15 and 30 minutes) and incubated for 10 
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minutes. The liquid on the surface was discarded after incubation and the gel nanosensors 
were used for further quantification.  
 
Absorbance Spectroscopy.  A BioTek Synergy 2 plate reader was used to quantify 
absorbance spectra of all the samples for wavelengths ranging from 300 to 990 nm with a 
step size of 10 nm. Absorbance measurements for all samples were obtained 2 hours post 
irradiation although the color formation was seen as early as 5 minutes. The absorbance 
value of MilliQ water at all wavelengths was used as the blank in all corresponding 
measurements. These values were then normalized by subtracting the absorbance value at 
990 nm wavelength for each gel nanosensor  sample. The absorbance value at 540nm was 
measured for all irradiated and non-irradiated gels and was offset by their corresponding 
absorbance value at 990nm. These values were further corrected by subtracting the A540nm-
A990nm value obtained for MilliQ water. To ensure that the absorbance corresponding to the 
non-irradiated gel nanosensor  (0 Gy) is 0, the absorbance of the non-irradiated gel 
nanosensor (0 Gy) is subtracted from itself and the absorbance of the irradiated gel 
nanosensor. These values were plotted as a function of the radiation dose (in Grays or Gy, 
where 1 Gy = 1 Joule energy absorbed / kg) in order to generate a calibration curve.  
 
Transmission Electron Microscopy (TEM). Irradiated gels were dissolved in 1,2-
propane diol (chaotropic agent) in order to facilitate drop casting onto TEM grids and 
heated to 80°C for 15 minutes. This mixture was centrifuged at 4000 rpm for 10 mins. The 
supernatant was removed and was further dispersed in MilliQ water. This solution was 
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further cast onto TEM grids. The samples were dried in air overnight and visualized using 
a CM200-FEG instrument operating at 200 kV in the LeRoy Eyring Center for Solid State 
Sciences at ASU. Elemental analysis was carried out in order to determine the composition 
of the nanoparticles formed. 
 
Topographical Dose Determination in an Anthropomorphic Head and Neck 
Phantom. An anthropomorphic head and neck phantom was used to determine the efficacy 
of topographical dose determination of the gel nanosensor in a clinical setting. CT images 
(1mm) were acquired throughout the head region and transferred to a Philips Pinnacle 
treatment planning system. In order to simulate an actual clinical treatment, an irregularly 
shaped GTV (gross target volume) was generated using several CT images.  The GTV was 
defined superficially above the left maxillary sinus and a single 6MV highly conformal 
photon (X-ray) beam was aimed at a discrete angle at the target in order to avoid nearby 
critical structures such as the left orbit.  A multi leaf collimator (MLC) was used to shape 
and conform the radiation dose to a target field of 2.5 cm x 1.9 cm. Within this target 
region, a crescent shaped beam was delivered using the MLC. A 1.5 cm tissue-equivalent 
bolus material was placed over the target area in order to provide an adequate dose buildup 
and coverage at the skin surface. A 2 Gy single dose was calculated to dmax (1.5cm depth).  
 
Topographical Dose Determination in Canine Cancer Patients Undergoing 
Radiotherapy. Prior to the canine study, the experimental protocol described below was 
documented and approved by ASU’s Institutional Animal Care and Use Committee 
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(IACUC). The pet owner signed a consent form approved by ASU’s IACUC prior to any 
study.  
 
Irradiation set up for Canine patients. Prior to irradiation, both canine patients, called A 
and B here, were anaesthetized to assist immobilization during treatment. Patient A’s skin 
received a radiation dose of 2 Gy within a field size of 4 cm x 4 cm and patient B’s skin 
received a radiation dose of 3 Gy within a field size of 6 cm x 14 cm. To achieve maximum 
dose deposition and to enable a dose buildup to the skin, a 1.5 cm bolus was wrapped 
around the leg of patient B. The gel nanosensor (≈3.5 cm diameter) and a Gafchromic 
EBT3™ film (≈3.5 cm diameter) were wrapped in a plastic bag in order to prevent direct 
contact with the skin of the patient. One half of the gel nanosensor and the Gafchromic 
EBT3™ film were placed on the region which was exposed to radiation while the other 
half of each was placed outside the field of irradiation. For patient A, the gel nanosensor 
and the Gafchromic EBT3™ film were placed on the skin while for patient B they were 
placed on top of the bolus. In addition, in the case of patient B, a separate gel nanosensor 
and Gafchromic EBT3™ film were placed entirely within the radiation field underneath 
the bolus to validate the delivery of the 3 Gy dose. Following radiation treatment, the gel 
nanosensor and Gafchromic EBT3™ films were removed and analyzed as described in the 
following sections. 
  
Topgraphical Mapping of Gafchromic EBT3™ films. Following irradiation with X-
rays, an EPSON Expression 10000XL Graphic Arts Scanner was used to scan films prior 
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to analysis, consistent with clinical practice257. After scanning, the RIT dosimetry software 
(RIT113 Classic V6.0) was used to analyze digitized image of the films. Pixel values at 
discrete points with a 2 mm spacing between each point were measured along the digitized 
films. Each pixel value is correlated to the predicted dose using clinical standard calibration 
curve and a corresponding topographical dose map is acquired. The regions receiving a 
high radiation dose are depicted in red and those receiving a low irradiation dose are 
depicted in blue.  
 
Topographical Mapping of Gel Nanosensors. Absorbance values at 540 nm and 990 nm 
were determined along the surface of the entire gel (diameter of ~1.5 cm) using a 1536 well 
plate setup in a BioTek Synergy 2 plate reader. Each grid has a finite size of ≈2 mm x 2 
mm, which results in approximately 110 grids along the entire gel for which the absorbance 
values are obtained, leading to a dose map on the gel surface. The final absorbance value 
at a given grid was calculated based on the method described for generating the calibration 
curve. The calibration curve was used to predict the radiation dose delivered to each point 
on the grid and a corresponding topographical dose map over the entire gel surface is 
obtained. The regions that received high doses of radiation are depicted in red and those 
receiving low radiation doses are depicted in blue.  
 
Image Acquisition. All images were acquired using an iPhone 7 camera under ambient 
lighting and automatic settings which were maintained throughout the course of the study. 
The images were cropped to the desired size for representation. No further editing or post-
193 
 
processing was carried out. These images were not used for quantification of the dose but 
only for visualization of the gels. 
 
Statistical Analyses. All irradiation experiments were carried out a minimum of three 
times independently unless otherwise mentioned. The results are expressed as mean ± one 
standard deviation. All calculations were carried out using Microsoft Excel 2016. 
 
7.3 Results and Discussion  
In conventional fractionated cancer radiotherapy, a patient is administered doses in 
fractions ranging from 1-5 Gy every day leading to a cumulative dose of 20-90 Gy258. 
However, there are no in-built dosimeters in radiotherapy systems and existing dosimeters 
lack the ability to report topographical dose distribution along tissues. Facile radiation 
sensors that are predictive, easy to operate, robust, and cost-effective can lead to the 
development of wearable detectors and enable clinicians to effectively deliver radiation to 
target tissues, leading to increased safety and improved patient outcomes.  
 
Here, we demonstrate the efficacious detection of topographical dose distribution of 
ionizing radiation (e.g. X-rays) using a novel gel-based colorimetric nanosensor. In its 
original form, gold ion exists in a trivalent (+3) state which is reduced to a metastable +1 
valence state via a room temperature reaction with ascorbic acid (vitamin C)138. Irradiation 
of these gels leads to splitting of water molecules (radiolysis) into highly reactive free 
radicals including hydrated electrons (e-aq), hydrogen free radicals (H.) and hydroxyl free 
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radicals(OH.)259. The generated hydrated electrons reduce the monovalent gold to its 
zerovalent state leading to the formation of gold atoms. These atoms nucleate and mature 
into gold nanoparticles, which engender a change in color from colorless to red/maroon 
color in the gel. The increase in color intensity of the gel nanosensor with increasing 
radiation dose is directly proportional to the formation of gold nanoparticles upon 
irradiation, and is used for calibrating the response of the gel nanosensor. A quenching 
agent (Na2S) is further supplemented in order to preserve dose distribution profiles and 
generate topographical dose maps. 
 
We first determined the response of the fully irradiated gel in order to establish a calibration 
of absorbance with dose. The time required for the development of color in the gels (Figure 
7.1) was dependent on the concentration of the surfactant used and the radiation dose 
delivered. For a fixed radiation dose (10 Gy), the time required for the development of 
color increases with an increase in concentration of the surfactant; for concentrations from 
50 to 100 mM, the maximum time required for change in color increased from 5 to 15 
minutes. However, at the highest surfactant concentration (150 mM) employed in the study, 
no visible color change was observed even after 30 minutes. We also observed an increase 
in intensity of color in the gel nanosensor  with decreasing surfactant concentration for a 
fixed radiation dose. We summarize these phenomena using illustrations for low and high 
concentrations of surfactant as shown in Figure 7.2. At all concentrations of C14TAB 
employed in the study (50-150 mM), the surfactant exists in the form of micelles (CMC ≈ 
5mM)260. We reason that at any given time there are three distinct species, (1) free gold 
ions, (2) C14TAB micelles and (3) gold ions bound to C14TAB micelles and that there exists 
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an equilibrium between them261. At low surfactant concentrations, some Au1+ are free in 
solution and others are electrostatically bound to the micelles142. With increasing surfactant 
concentration, there is an increase in the number of C14TAB micelles in the system which 
drives the formation of more gold ion-bound C14TAB micelles261. Consequently, the 
number of free Au1+ decreases with a simultaneous increase in the gold micelle complex. 
We hypothesize that radiolysis leads to reduction of only free Au1+ ions. We reason that 
this likely leads to a higher yield of nanoparticles with an increased rate of formation at 
low surfactant concentrations due to the reduction of a higher number of free Au1+ ions to 
Au0 when compared to the system at high surfactant concentration. These Au0 atoms 
mature into gold nanoparticles through surface-assisted reduction of unreacted free Au1+ 
ions262.  
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Following irradiation, a quantitative correlation between the intensity of the color formed 
in the gels and the delivered dose was determined using absorbance spectroscopy (Figure 
7.3). Radiation resulted in the formation quasi-spherical gold nanoparticles that exhibited 
a characteristic light absorption spectral peak between 500 and 600 nm253. A decrease in 
the width of the spectral profile is observed with increasing radiation dose indicating a 
Figure 7.1 Images of gel nanosensors containing various concentrations of C14TAB (50-
150mM) following exposure to various doses of ionizing radiation (0-10 Gy). A visible 
increase in intensity in the maroon color is observed with increasing dose of ionizing 
radiation for all C14TAB concentrations employed.  
 
Figure 7.2 Schematic illustration of the proposed mechanism. At low surfactant 
concentrations, most gold ions are likely free in solution (unbound to micelles). With 
increasing surfactant concentration, the equilibrium shifts to the right with a decrease in 
free gold ions. Upon irradiation, the number of Au0 atoms formed due to reduction at low 
surfactant concentration is higher due to the presence of a higher number of free gold ions 
when compared to the system at high surfactant concentration. The higher number of free 
gold atoms lead to increased yield of gold nanoparticles due to surface assisted reduction 
with unreacted gold ions. 
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decrease in polydispersity of the nanoparticles formed. A blue-shift in the absorbance peaks 
with increasing radiation dose suggests a decrease in particle size compared to those 
obtained at lower radiation doses162. The peak absorbance intensity increases with 
increasing radiation dose corroborating the observed increase in color intensity. A decrease 
in the peak absorbance at 540 nm with increase in concentration of the cationic surfactant 
is observed likely due to micellar inhibition of the reduction of Au(I) to Au(0)142. We 
previously observed similar trends in spectral width changes, blue shifts and peak 
absorbance changes with different levels of ionizing radiation162, 229, 256. The maximum 
peak absorbance at 540 nm was plotted as a function of the delivered radiation dose in 
order to quantify the gel nanosensor response (Figure 7.4). A linear response was observed 
with increasing radiation dose for all concentrations of the surfactant.  
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Figure 7.  From Top to Bottom; Absorbance spectra of gel nanosensor containing (A) 
50mM, (B) 62.5mM, (C) 75mM, (D)100mM, (E)150mM. The gels were irradiated with 0, 
2, 4, 6, 8 and10 Gy. Characteristic absorbance peaks between 500 and 600nm are 
indicative of gold nanoparticles. The corresponding radiation dose are mentioned in the 
legend with increasing radiation dose (top to bottom).  
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Figure 7.4 Peak absorbance spectra at 540nm plotted versus radiation dose post irradiation. 
(A) The plot indicates the gel nanosensor response as a function of concentration of 
C14TAB with a fixed Na2S addition time of 5 minutes. (B) The plot indicates the gel 
nanosensor response as a function of time of addition of Na2S with a fixed C14TAB of 
50mM. These results indicate the adaptability of the sensor to measure various radiation 
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dose range through simple fine tuning of C14TAB concentration or/and time of addition of 
sodium sulfide.   
 
We next determined the ability of the gel nanosensor to detect topographical distribution 
of radiation dose by irradiating one-half of the gel nanosensor with a 4 Gy dose. The near 
immediate (~2 min) visual appearance of maroon color only in the irradiated region 
indicates the presence of gold nanoparticles following radiation (Figure 7.5). However, 
the color was observed to “bleed over” to the non-irradiated region 1 h post irradiation 
(Figure 7.5A), which indicated a loss of topographical information in the gel over time. 
Increasing the weight percent of agarose from 3% to 4%, in order to decrease the pore 
size263, did not help preserve topographical integrity of dose distribution (Figure 7.5B). 
 
As an approach for maintaining topographical information of the delivered dose, we 
hypothesized that radiolytically generated gold nanoparticles act as seeds for unreacted 
gold ions on the non-irradiated region leading to the formation of additional gold 
nanoparticles143. These additional gold nanoparticles, in turn, impart color to non-irradiated 
regions and drive the bleed over phenomena, which leads to loss of topographical dose 
information. Incubation for 10 minutes (5 minutes post irradiation) with sodium sulfide 
(Na2S) led to complete suppression of the bleed over of color (Figure 7.5C); sodium 
halides (NaX, X = Cl, Br, I), however, were ineffective for this purpose.  In the absence of 
sodium sulfide, growth of gold nanoparticles is a result of two distinct steps262. The first 
step involves the reduction of Au1+ to Au0 atoms, which nucleate and develop into small 
nanoclusters. The second step determines the overall size and the number of particles 
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formed. This step involves the growth and maturation of nanoparticles induced due to 
attachment and reduction of free gold ions on existing nanoclusters. We reason that 
quenching of the unreacted gold ions in the non-irradiated region is a critical step in 
preserving topographical dose information. Therefore addition of sodium sulfide, which 
reduces the unreacted free gold ions to gold sulfide nanoparticles264 inhibits the bleed over 
phenomena and retains the topographical dose information required for modern 
dosimetry(Figure 7.6).  
A 
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Figure 7.6 Schematic illustration of the proposed mechanism used for detecting spatial 
dose distribution. Early addition of Na2S leads to the reduction of unreacted gold ions to 
NaCl NaBr NaI Na2S Control 
Figure 7.5 (A) Image of agarose gel (left) prior to irradiation, (middle) Top half irradiated 
with 4 Gy and image acquired 2 minutes post irradiation, and (right) Image acquired 1 hour 
post irradiation. A visible increase in intensity of color in the non-irradiated region leads 
to loss of topographical information. (B) i. Image of 3 w/v % agarose gel (left) 2 minutes 
post irradiation and (right) 1 hour post irradiation; ii. Image of 4 w/v % agarose gel (left) 
2 minutes post irradiation and (right) 1 hour post irradiation indicates that increase in 
agarose weight percentage does not preserve topographical dose information (C) Images 
of gel nanosensor incubated with 5 mM sodium sulfide and various sodium halides for 10 
minutes and imaged after 1 hour. No loss of topographical information observed upon 
incubation with sodium sulfide.  
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gold sulfide particles, which obviate further reaction and color bleed over. These ions 
wound have otherwise likely contributed to the growth of radiolytically generated gold 
nanoparticle resulting in bleed over of the color to non-irradiated regions. Upon delayed 
addition of Na2S, most of the radiation-generated gold nanoparticles have matured and 
further addition of the quenching agent does not affect the final yield of gold nanoparticles 
in the gel nanosensor. This results in an increase in absorbance in the gel nanosensor as a 
function of time of addition of Na2S post-irradiation. 
 
Increasing the wait time post irradiation before incubation with sodium sulfide led to an 
increase in absorbance for a fixed radiation dose (Figure 7.4 B). Specifically, for a fixed 
radiation dose of 6 Gy, the average absorbance increased from 0.07 to 0.17 with increasing 
the wait time prior to addition of sodium sulfide post irradiation from 2 to 9 minutes. 
Addition of Na2S immediately (i.e. 2 min post irradiation) likely leads to the reduction of 
unreacted gold ions to gold sulfide particles. This can reduce the growth of radiolytically 
generated gold nanoparticles, which in turn, can result in lower absorbance values observed 
for the shorter wait times (Figure 7.6). With a delayed addition of Na2S (i.e. 9 min post 
irradiation), we hypothesize that most of the radiation-generated gold nanoparticles have 
matured and further addition of the quenching agent does not affect the final yield of gold 
nanoparticles. This results in an increase in absorbance as a function of wait time post 
irradiation before the addition of Na2S for a given radiation dose (Figure 7.4 B). Although 
it is important that the gel nanosensor detects doses used in conventional fractionated 
radiotherapy (i.e. 1-2 Gy per fraction), the sensor can be adopted for a wider dose range 
(2-8 Gy) used in modern radiotherapy by simply fine tuning the concentration of the 
cationic surfactant and/or modulating the time of addition of sodium sulfide.  This level of 
flexibility is not available in existing dose detection systems, which typically have a fixed 
linear response.  
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Upon addition of sodium sulfide, both the irradiated and non-irradiated regions of the same 
gel were independently visualized using transmission electron microscopy (TEM; please 
see Experimental Section). Elemental analysis using energy-dispersive X-ray (EDX) 
spectroscopy indicated two overlapping peaks in the non-irradiated region, (1) M-shell 
peak at 2.12 keV corresponding to gold and (2) K-shell peak at 2.3 keV likely due to the 
presence of sulfur (Figure 7.7 A)265. The irradiated region contains a higher yield of gold 
nanoparticles and displays a sharp peak corresponding to only the M-shell of gold (Figure 
7.7 B). Comparison of both spectra indicates the formation of gold sulfide nanoparticles in 
the presence of Na2S in the non-irradiated region. The mean diameter of nanoparticles in 
the non-irradiated region was between 5.6 ± 1.7nm (Figure 7.8 A). The irradiated region 
consists of nanoparticles with a size range of 52.7 ± 23.4nm (Figure 7.8 B). The presence 
of a higher number of nanoparticles with a diameter greater than 2 nm lead to the 
development of the characteristic color of gold nanoparticles (maroon/pink) observed in 
the irradiated regions266.   
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Figure 7.7 Elemental analysis of nanoparticles after incubation with Na2S in the (A) 
irradiated region and the (B) non-irradiated region. The presence of a broadened peak in A 
indicates the presence of gold sulfide nanoparticles. The peak attributions are done based 
on those in the literature265.  
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Figure 7.8 TEM image showing presence of nanoparticles (A) after incubation with 
sodium sulfide (nanoparticle dimensions: 5.6 ± 1.7 nm) and (B) without incubation with 
sodium sulfide (nanoparticle dimensions: 52.7 ± 23.4 nm). Corresponding magnified 
images of the highlighted region are shown on the right. A total of 15 particles were used 
for quantification of nanoparticle dimensions.  
 
We further investigated the capability of the gel nanosensor for visualizing diverse 
topographical radiation dose patterns (Figure 7.9). The gel nanosensor was irradiated with 
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a square field (1 cm x1 cm) with a 1 cm non-irradiated spacing between each field. Each 
sequential square was irradiated with incremental doses resulting in multiple squares within 
the gel nanosensor. The increase in intensity of the color is indicative of the increasing 
dose, while preserving the topographical integrity. Regions that are not irradiated do not 
demonstrate a change in color (Figure 7.9A). We also demonstrated the capability of the 
gel nanosensor for detecting complex radiation patterns as shown by the model dose that 
read “ASU” (Figure 7.9B). In these studies, the radiation dose was delivered sequentially 
which results in delayed appearance of the last two letters, viz. “S” and “U” compared to 
appearance of “A”. 
 
 
 
 
 
 
 
 
 
t = 0 min t = 1 min 
t = 3 min t = 2 min 
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Clinical radiotherapy for skin and breast cancer lesions commonly employs radiation field 
sizes that are larger than 3 cm x 3 cm in area267-269. In order to accommodate larger radiation 
fields, we fabricated a gel nanosensor with the same thickness (~3 mm) but a larger 
diameter (~3.5 cm). The gel nanosensors were loaded with a surfactant concentration of 75 
mM, irradiated over the whole area with doses ranging from 0-4 Gy and treated with 5 mM 
Na2S 30 minutes post-irradiation (Figure 7.10 A). Following irradiation, peak absorbances 
at 540 nm of the irradiated and the non-irradiated gel nanosensors were plotted as a function 
of radiation dose in order to obtain a linear calibration curve between 0-4 Gy (Figures 7.10 
B, C). The predictive efficacy of the sensor was determined using a dose of 1.5 Gy, which 
was not used for generating the calibration curve. The change in color was quantified using 
the previously generated calibration curve and the dose was estimated to be 1.28 ± 0.1 Gy 
which is comparable to the delivered dose indicating the predictive ability of the gel 
nanosensor. In order to investigate the ability to detect topographical dose distribution, one-
half of the gel was irradiated with 2 Gy by positioning it at the edge of the radiation field 
and the other half was not irradiated. The absorbance at 540 nm was recorded in finite grids 
(≈2x2 mm) along the diameter of the gel nanosensor and the radiation dose was predicted 
using the previously established calibration curve. The topographical radiation dose profile 
predicted by the gel nanosensor is in excellent agreement with the delivered dose profile 
Figure 7.9 (A) Representative image of a petridish containing the gel nanosensor (3mm 
thick and ≈10cm diameter) irradiated by a 1cm x 1cm square field of X-ray radiation. From 
left each square indicates increasing radiation dose from 0.5 Gy (Red Box), 1 Gy, 1.5 Gy, 
2 Gy, 2.5 Gy, 3 Gy, 3.5 Gy, 4 Gy, 4.5 Gy and 5 Gy; the black box in the middle image 
shows 0 Gy. (B) Representative image of a complex topographical dose pattern (ASU 
letters) generated using a 2Gy X-ray dose. The petridish has a diameter of 10cm. All gel 
nanosensors  contain 50mM C14TAB and Na2S was added 30 minutes post irradiation.   
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(Figure 7.11). These results indicate the potential of the gel nanosenor for qualitatively 
and quantitatively detecting regions irradiated with ionizing radiation and distinguishing 
them from those that are not irradiated.   
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Accidental exposure to radiation can cause significant tissue injury and skin is the first 
organ exposed to radiation damage; radiation-induced skin injuries range from erythema 
to necrosis270. We investigated the translational capability of the gel nanosensor for 
predicting radiation doses delivered to a head and neck phantom (Figures 7.12 A and 7.12 
Figure 7.10 (A) Images and (B) absorbance spectra of gels containing 75 mM C14TAB 
following exposure to different doses of ionizing radiation. Characteristic peaks between 
500 and 600 nm are indicative of gold nanoparticle formation. (C) Absorbance at 540nm 
as a function of radiation dose is used as a calibration curve to determine unknown doses. 
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Figure 7.11 (Left) Colorimetric response of the gel nanosenor irradiated on one half with 
a 2 Gy dose. A visible appearance of maroon color in the irradiated region illustrates the 
ability of the gel nanosensor to predict topographical dose profiles. (Right) Dose fall-off 
profile for half a gel nanosensor irradiated by 2 Gy. The delivered radiation dose and the 
predicted are comparable indicating the efficacy of the gel nanosensor in determining 
topographical information. In all cases, Na2S was added 30 min post irradiation. 
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B). An irregular crescent-shaped radiation dose field was delivered to the phantom in order 
to mimic clinically administered radiotherapy (Figures 7.12 C and 7.12 D). The distinct 
visual change in color is a qualitative indicator of the radiation delivered to the gel 
nanosensor (Figure 7.12 E). The previously generated calibration curve was employed to 
predict the dose based on the intensity of the color developed (please see the Experimental 
section). The predicted absorbance dose is highest in the middle (bright red) of the pattern 
and decreases in intensity towards the edge (light red) of the field. Specifically, the core of 
the pattern receives an average dose of 2.3 Gy as determined by the treatment planning 
system and the gel nanosensor predictions were in excellent agreement with the planned 
dose profile (Figures 7.12 F and 7.12 G). These results suggest the ability of the gel 
nanosensor for detecting and predicting complex radiation patterns employed during actual 
clinical human radiotherapy.  
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C D E 
F G 
A B 
0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4
0.3 0.0 0.0 0.4 0.0 0.4 0.1 0.1 0.0 0.0 0.1
0.0 0.4 1.6 1.7 2.0 2.1 1.9 1.8 0.7 0.1 0.0
0.2 1.1 1.9 2.2 2.3 2.4 2.4 2.3 2.1 1.6 1.3
2.0 2.3 2.4 2.3 2.3 2.3 2.4 2.5 2.3 2.2 1.8
1.9 2.3 2.1 2.3 1.6 1.3 1.7 1.8 1.9 2.1 1.9
1.2 0.9 0.9 0.3 0.1 0.1 0.2 0.3 0.4 0.5 0.3
0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2
0.5 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.4
0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.0 0.0
0.1 0.1 0.3 0.7 0.8 0.9 0.7 0.5 0.2 0.1 0.0
0.2 0.6 1.1 1.6 1.9 1.9 1.8 1.4 0.8 0.4 0.1
0.4 1.2 2.0 2.2 2.3 2.3 2.3 2.2 1.7 1.0 0.3
0.7 1.4 1.9 2.0 2.0 2.0 2.1 2.2 2.1 1.6 0.7
0.3 0.8 0.9 1.0 0.9 0.8 1.1 1.4 1.5 1.4 0.6
0.1 0.2 0.2 0.2 0.2 0.2 0.3 0.4 0.5 0.4 0.2
0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
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Although mice and rats are widely employed and inexpensive, their small anatomy relative 
to that of humans can lead to significant differences in dosimetry271 and can limit  the 
extrapolation of these findings to human patients. Canine patients circumvent these 
challenges because of their larger size, and similarity in contours and treatment methods to 
that of human patients. We investigated the gel nanosensors as independent radiation 
dosimeters for verifying the dose delivered to two canine patients undergoing radiotherapy; 
the patients are henceforth referred to as “Patient A” and “Patient B”. The efficacy of the 
gel nanosensor was also compared with conventional radiochromic films used in the clinic. 
To our knowledge, this is first time a nanoscale based dosimeter has been employed in the 
detection of radiation dose delivered to live canine patients undergoing clinical treatments.  
 
The surface of patient A was administered a dose of 2 Gy to the skin (Figures 7.13). The 
gel nanosensor was positioned at the edge of the radiation field and the ability to measure 
Figure 7.12 (A) Image of an anthropomorphic head and neck phantom treated with an 
irregularly shaped radiation field below the left eye. (B) Image of the gel nanosensor 
positioned on the anthropomorphic phantom in the radiation field mimicking a 
conventional radiotherapy session. (C and D) Treatment planning images representing an 
irregularly shaped radiation field used to deliver a complex radiation pattern under the eye 
of the phantom. (E) Visual image of the irradiated pattern on the gel nanosensor. Only the 
irradiated region develops a maroon color while the non-irradiated region remains 
colorless. (F) Topographical dose profile of the delivered radiation to the anthropomorphic 
phantom. The profile is generated from the treatment plan used during the actual irradiation 
of the head and neck phantom. (G) Absorbance along the irradiated gel nanosensor in 
≈2mm x 2mm grids was quantified using a calibration curve to quantify a topographical 
dose profile. The core dose received by the crescent-shaped profile (2.3 Gy) is comparable 
to the predicted dose profile from the gel nanosensor (2.3 Gy). This suggests the capability 
of the gel nanosensor to qualitatively and quantitatively predict the complex topographical 
dose profiles. Colors indicate the intensity of color with red being the highest dose and 
blue indicating a lower radiation dose. The experiments were performed 3 times 
independently.   
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topographical dose information was evaluated (Figures 7.13). Upon completion of the 
treatment, a maroon color on one-half of the gel was clearly seen while the non-irradiated 
region remained colorless (Figure 7.13 E). The previously generated calibration curve was 
used to predict the delivered dose. Unsurprisingly, the dose delivered is highest in the 
irradiated region (denoted by red squares). As expected the intensity decreases from left to 
right (dark red to light red to blue) indicating a decrease in the intensity of the delivered 
radiation dose. Specifically, the predictions made by the gel nanosensor of ≈2Gy in the 
irradiated region were in excellent agreement with the treatment planning system and the 
radiochromic film. The gel nanosensor also predicts minimal radiation dose (≈0.1Gy) 
outside the irradiation region illustrating its capability it predicting topographical dose 
profiles. The gel nanosensor predicts the irradiated and the non-irradiated region 
effectively and the performance is comparable to the predictions of a conventional 
radiochromic film (Figures 7.13 E and 7.13 F).  
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2.0 2.0 2.0 2.0 1.6 0.9 0.3 0.1 0.1
2.0 2.0 2.0 2.0 1.6 0.9 0.3 0.1 0.1
2.0 2.0 2.0 2.0 1.6 0.9 0.3 0.1 0.1
2.0 2.0 2.0 2.0 1.6 0.9 0.3 0.1 0.1
2.0 2.0 2.0 2.0 1.6 0.9 0.3 0.1 0.1
2.0 2.0 2.0 2.0 1.6 0.9 0.3 0.1 0.1
2.0 2.0 2.0 2.0 1.6 0.9 0.3 0.1 0.1
2.0 2.0 2.0 2.0 1.6 0.9 0.3 0.1 0.1
2.0 2.0 2.0 2.0 1.6 0.9 0.3 0.1 0.1
C D 
A B 
2.4 2.2 2.2 1.9 1.1 0.1 0.0 0.1 0.1 
2.2 2.1 2.0 1.7 0.6 0.0 0.0 0.1 0.1 
2.1 2.0 2.0 1.8 1.0 0.2 0.0 0.0 0.1 
2.1 2.0 2.0 1.7 0.7 0.2 0.1 0.0 0.1 
2.2 2.0 2.0 1.9 1.1 0.1 0.0 0.1 0.1 
2.0 2.0 2.0 1.9 0.8 0.0 0.0 0.1 0.1 
2.1 2.0 2.0 1.9 1.3 0.1 0.1 0.1 0.2 
2.3 2.1 2.1 2.0 1.0 0.1 0.1 0.1 0.1 
2.4 2.4 2.4 2.1 1.2 0.4 0.2 0.1 0.3 
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Patient B received a fractionated dose of 3 Gy at the target tumor site on the surface of skin 
(Figures 7.14) and 1.5 Gy on the surface above the bolus.  A visible change in color was 
observed over the entire gel, which was placed underneath the bolus (Figure 7.14 F). The 
gel nanosensor estimates a core uniform dose of ≈2.8 Gy, which closely matches the 
estimate made by the radiochromic film (≈3.2Gy). It is important to note that the time 
required for color development and evaluation of the radiochromic film was >24hours, 
which contrasts to that for the gel nanosensor which was only ~1 hour. In addition, it is 
possible to generate tissue-conformal formulations with the gel nanosensor, which is 
difficult with the more rigid radiographic films. To capture the topographical profile of the 
administered dose, half the gel nanosensor was placed on top of the bolus and exposed to 
radiation. As expected, the irradiated region turned maroon while the non-irradiated area 
remained colorless (Figure 7.14 H). The core of the irradiated region was estimated to 
receive a dose of ≈1.7 Gy as is closely predicted by the radiochromic film (≈1.4Gy). The 
regions outside the irradiated region received minimal dose (≈0 Gy) as predicted by the gel 
nanosensor, which closely matches the predictions of the radiochromic film. Using the gel 
Figure 7.13 Representative image of (A) half the gel nanosensor and (B) half the 
radiographic film positioned in the radiation field on patient A. (C) Treatment planning 
software depicting the delivery of a 2 Gy dose delivered to the surface of patient A. (D)
The expected dose fall-off profile of 2 Gy inside the radiation field and a minimal radiation 
(0.1 Gy) outside the field. A color change is visible clearly in both the (E) gel nansensor 
whose color changes to maroon and (F) radiographic film whose color changes to dark 
green post-irradiation. The dose map of the predicted dose for both the gel nanosensor and 
radiographic film is depicted below each corresponding sensor (please see the 
Experimental section). The dose profiles are similar indicating the efficacy of the gel 
nanosensor for clinical dosimetry. The time for readout of the gel nanosensor was 1 hour 
while the radiochromic film required >24 hours prior to readout. The experiments were 
performed 3 times independently for the gel nanosensor and the radiographic film. 
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nanosensor, we were able to independently corroborate the efficacy of the treatment plan 
used to treat Patient B. All these results taken together, along with the simplicity in 
fabrication with minimal equipment requirement, operation, readout and cost effectiveness 
(≈5 cents per gel; only material cost considered) demonstrates the translational potential of 
the colorimetric gel nanosensor for detecting and predicting topographical radiation doses 
in clinical radiotherapy.  
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Figure 7.14 (A) Representative image of the final setup of Patient B. Half the gel 
nanosensor and the Gafchromic EBT3™ film is placed on the radiation field on top of the 
bolus which was delivered a radiation dose of 1.5Gy (Image does not contain the gel 
nanosensor and the Gafchromic EBT3™). (B) Representative image of the gel nanosensor 
placed on the treated region which was delivered a radiation dose of 3Gy. (C) Treatment 
planning software depicting the delivery of a 3Gy dose delivered to the skin of patient B. 
(D) The expected dose delivered to the skin of the patient and (E) surface dose (1.5cm 
above the bolus). A color change is visible clearly in both the (F) gel nansensor to 
pink/maroon (G) radiographic film to dark green post-irradiation. The heat map of the 
predicted dose for both the gel nanosensor and radiographic film is depicted below each 
corresponding sensor(See experimental section). The dose profiles are similar in all cases 
indicating the efficacy of the gel nansensor to clinical dosimetry. The time for readout of 
the gel nanosensor was 1 hour while the radiochromic film required >24 hours prior to 
readout. The experiments were performed 3 times independently for the gel nanosensor 
and the radiographic film. 
 
H I 
F G 
3.2 3.2 3.2 3.2 3.3 3.2 3.2 3.2
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2.5 3.0 3.2 3.3 3.2 3.3 3.4 3.2
0.1 0.2 0.3 0.8 1.2 1.3 1.3 1.4
0.1 0.1 0.2 0.3 0.8 1.3 1.3 1.3 1.3 1.3
0.1 0.1 0.2 0.3 0.8 1.3 1.3 1.3 1.3 1.3
0.1 0.1 0.2 0.3 0.8 1.3 1.3 1.3 1.3 1.3
0.1 0.2 0.2 0.4 0.9 1.3 1.4 1.4 1.4 1.4
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0.1 0.2 0.2 0.4 0.9 1.3 1.3 1.3 1.4 1.4
0.1 0.2 0.2 0.4 0.9 1.3 1.3 1.4 1.4 1.4
0.2 0.2 0.2 0.4 0.9 1.3 1.3 1.4 1.4 1.4
0.3 0.2 0.4 0.9 1.3 1.4 1.4 1.4
3.3 3.0 3.0 2.9 2.9 3.3 3.0 3.2
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2.6 2.5 2.6 2.8 2.8 2.8 2.8 2.8 2.7 2.6
2.4 2.4 2.6 2.7 2.7 2.8 2.6 2.8 2.7 2.8
2.5 2.4 2.9 2.8 2.8 2.9 2.8 2.8 2.8 2.8
2.7 2.6 2.9 2.8 2.7 2.8 2.8 2.8 2.7 2.9
3.1 2.7 2.8 2.9 2.9 2.8 2.9 2.8 2.9 2.9
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0.1 0.0 0.0 -0.1 0.5 1.4 1.6 1.8
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7.4 Conclusions  
To our knowledge, this is the first demonstration of a colorimetric gel nanosensor for 
detecting and distinguishing regions exposed to irradiation. The addition of a chemical 
quenching agent, sodium sulfide, reveals topographical dose distribution obtained during 
clinical radiotherapy. We also demonstrated the ability of the gel nanosensor to respond to 
varying levels of ionizing radiation by tuning the concentration of the surfactant used and 
time of addition of the quenching agent. Various simple and complex motifs were patterned 
on the gel nanosensor illustrating the ability of the sensor to capture dose profiles obtained 
in fractionated clinical radiotherapy. The effectiveness of the sensor was evaluated for 
predicting complex topographical dose profiles delivered to an anthropomorphic head and 
neck phantom. The efficacy of the colorimetric gel nanosensor was demonstrated for 
visualizing and quantifying topographical dose distribution in live canine patients. The 
effectiveness of the gel nanosensor was comparable to Gafchromic EBT3™ films, which 
required more than 24 hours before readout, indicating significant advantages of the 
former. The ease of fabrication, simple operation procedures that require only a 
spectrophotometer without any sophisticated training, rapid and stable readout, possibility 
of formulating tissue-conformal geometries and relatively low cost (≈$0.50 per gel 
nanosensor only material cost considered) indicate the high disruptive and translational 
potential of the gel nanosensor technology for determining complex topographical dose 
distribution profiles in clinical radiotherapy. It is anticipated that clinical adoption of the 
gel nanosensor technology for determining topographical dose distributions in tissues will 
lead to improved patient safety and outcomes.  
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Chapter 8 MOLECULAR ENGINEERING OF AN AMINO ACID DOSIMETER 
FOR CLINICAL RADIOTHERAPY 
8.1 Introduction  
Approximately three new cases and one mortality are reported due to cancer every minute 
in the US272. Despite promising advances in therapeutic interventions, radiotherapy 
remains a mainstay of clinical intervention for several cancers. Nearly two-thirds of 
patients receive some form of radiation as treatment273. The primary intention of curative 
radiotherapy is twofold: to deliver a high and uniform dose to the target lesion to achieve 
local tumor control while simultaneously minimizing the dose to normal tissue to avoid 
long term complications to the patient243. To manage safe and accurate dose delivery to the 
patient, radiotherapy relies on dosimetry for optimization of prescribed dose during 
treatment. Human error, equipment failures and faulty operating procedures could 
potentially lead to inaccurate dosing leading to morbidity in patients. Dynamically 
changing radiation fields and smaller beam sizes, have introduced new challenges for 
routine dosimetry and quality assurance274. A change in paradigm in accurate dosimetry is 
necessary not only for treatment optimization but also for radiation protection of the 
patient.  
 
The available dosimeters are not sufficient for many clinical applications especially to 
provide accurate radiation dose information with minimal post processing. 
Thermoluminescent dosimeters have attracted attention but their routine use is challenging 
due to its labor intensive operation and extensive training required prior to their 
operation220. Silicon diode detectors response are subject to design and the operating 
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environment making them unreliable for periodic operation275. In addition, current 
dosimeters are not compliant to conform to the human anatomy routinely encountered 
during radiotherapy. Polymer gel dosimeters have a much better tissue conformity, but 
toxic components involved in fabricating the sensor and the requirement of sophisticated 
readout techniques like MRI have prevented their clinical translation252. Due to the 
limitations of existing sensors, there is an unmet need to develop a new and effective 
dosimeter that ensures accurate predictions of prescribed dose along with ease of operation. 
 
Molecular and nanoscale systems offer unrealized potential for the development of 
dosimeters that could lead to simple yet effective approaches for detecting therapeutic 
levels of ionizing radiation161. Quantum dots have demonstrated a strong scintillation 
response upon exposure to ionizing radiation but current synthesis techniques result in 
batch-to-batch variations making them unreliable as a dosimetry standard276. Investigation 
of carbon nanotubes as active transducers for the detection of gamma-ray radiation lack the 
sensitivity towards therapeutic levels of ionizing radiation restricting their applicability in 
the clinic277. Metal organic framework as scintillators have limited applicability due to the 
toxicity of metal ions used during development and fabrication278. In light of these 
disadvantages, there is still a need to develop a robust yet simple dosimeter that is easy to 
fabricate which could potentially provide additional safeguards during clinical 
radiotherapy. 
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The unique properties associated with the size and shape of gold nanoparticles has 
facilitated its widespread use in chemical and biological sensing253. We have recently 
pioneered the development of a sensor based on the formation of gold nanoparticles from 
its colorless precursor salt solution upon exposure to therapeutic levels of radiation162, 229, 
256. Although this is a powerful approach, it is limited in its translational due to the use of 
toxic functional components like cationic surfactants279. In order to relieve concerns 
regarding potential toxicity during handling and application over a patient, we have 
developed the first biocompatible sensor to detect radiation by employing amino acids to 
perform a similar function as that of the cationic surfactant. We have also employed the 
developed sensor to detect prescribed dose delivered to a canine patient which is a first 
based on our understanding of the literature.  
8.2 Materials and Methods 
 
Materials. Gold (III) chloride trihydrate (HAuCl4, 3H2O), 20 natural amino acids, 
glutathione, β-alanine, m-Fluoro-DL-phenylalanine, 5-aminovaleric acid, L-ornithine 
monohydrochloride were purchased from Sigma-Aldrich. N-Acetyl-L-cysteine was 
purchased from Fisher chemicals. 4-aminobutyric acid was purchased from Acros 
organics. D-Valine, D-Aspartic acid, D-Leucine, D-Threonine, D-Aspartame and D-
Phenylalanine were purchased from Alfa-Aesar. All chemicals were used as received from 
the manufacturer without additional purification. MilliQ water (18.2 MΩ-cm) was used as 
a solvent unless otherwise specified.  
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Sample Preparation for Primary Screening. For the primary screening, 30µL of 10 mM 
amino acids were mixed with 30µL of 1 mM HAuCl4·3H2O. To this mixture 940µL MilliQ 
water (18.2 MΩ-cm) was added and the final pH of the precursor solution was around ~6. 
Samples were prepared at Banner-MD Anderson Cancer Center, Gilbert, AZ prior to 
radiation. 
 
Irradiation of Samples. A Varian TrueBeam linear accelerator was used to irradiate 
samples at a dose rate of 600 MU/min with a 6MeV photon energy at Banner-MD 
Anderson Cancer Center, Gilbert, AZ. The final delivered dose to samples are mentioned 
in the manuscript and in their respective figure captions. After irradiation the samples were 
transported back to Arizona State University in Tempe, AZ for analysis.  
 
Absorbance Spectroscopy to Evaluate the Primary Screen. UV-Visible absorbance 
profiles of the samples were measured using a BioTek Synergy 2 plate reader. Absorbance 
values from 150 µL of each sample were measured from 300 to 900 nm with a step size of 
10 nm in a 96 well plate. Nanopure water (18.2 MΩcm) was used as a blank in all cases. 
The absorbance value was further offset by subtracting A900. The maximum absorbance 
between 500 and 600nm was used to determine the as a pseudo indicator to characterize 
the yield of nanoparticles.  
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Hydrogel synthesis for radiation experiments. L-(-)-Phenylalanine (25 µL of 25 mM) 
was incubated with gold (III) chloride trihydrate (30 µL of 10 mM) for 15 mins in 
Eppendorf tubes. In the meantime, a clear solution of 1 % w/v agarose is prepared through 
heating. This heated liquid agarose (750 µL) was mixed with the gold-phenylalanine 
mixture. From this resulting mixture, 700 µL was allowed to set in prefabricated circular 
molds (~1.5 cm diameter & ~3 mm thickness). Prior to irradiation, 400 µL of 10 mM L-(-
)-Tryptophan is incubated on the preformed hydrogel to diffuse into the gel for five mins. 
These transparent hydrogel discs were used for subsequent irradiation studies. Glutathione 
(700 µL of 5 mM) was incubated on the irradiated gels after 10mins upon completion of 
radiation. Absorbance was recorded 1 hour after radiation exposure. 
 
Irradiation of Hydrogels. A Varian Truebeam linear accelerator radiation therapy system 
at the Banner M.D. Anderson Cancer Center in Gilbert, AZ delivering a 6 MeV photon 
beam was used for irradiation at a dose rate of 600 MU/min. The samples were irradiated 
with doses of 1, 2, 3, 4, 5, 6 and 7.5 Gy.  
 
Absorbance Spectroscopy to Evaluate the Hydrogel Nanosensor. A BioTek Synergy 2 
plate reader was used to measure the absorbance profiles for all irradiated and control gel 
samples. Absorbance was recorded between 300 nm and 990 nm with a step size of 10 nm. 
The characteristic plasmonic absorption peak observed at 530 nm is used to identify the 
presence of gold nanoparticles.  
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Generation of Calibration Curve using UV-Visible Absorbance. To generate the 
calibration curve, the absorbance at 530nm is subtracted from the absorbance at 990nm 
from the previously generated UV-Visible spectrum. The final absorbance of the non-
irradiated hydrogel (0Gy) is further offset from itself and the absorbance of the irradiated 
hydrogels. These final absorbance values are plotted as a function of radiation dose and is 
used to generate the calibration curve.  
 
NMR Spectroscopy. NMR samples were prepared by dissolving the corresponding amino 
acid (L-alanine, L-phenylalanine, D-phenylalanine) and Gold (III) chloride trihydrate salt 
in 1:1 DMSO-D6 and D2O mixture. Final concentration of the pure amino acid solution 
used for 1H NMR spectra was 0.78 mM. The final concentration used for 1H NMR for the 
mixture of amino acid and chloroauric acid was 0.78 mM and 0.37 mM respectively. A 
Varian 500 MHz NMR instrument was employed in these studies to collect 1H NMR data.  
 
Sample preparation for Transmission Electron Microscopy. 1,2-propane diol 
(chaotropic agent) was added to the hydrogels and dissolved by heating to 80 °C for 15 
minutes. This mixture was centrifuged at 4000 rpm for 10 mins. The supernatant was 
removed and was further dispersed in MilliQ water. The transmission electron microscopy 
samples were prepared by drop casting this solution onto the TEM grids. The samples were 
air dried overnight and visualized using a CM200-FEG instrument operating at 200 kV in 
the LeRoy Eyring Center for Solid State Sciences at ASU. 
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Cell culture using BJ5ta Human fibroblast cell line. BJ5ta human fibroblast cells were 
used to assess the toxicity levels of the irradiated and non-irradiated gel sensors. Cells were 
sub-cultured in DMEM containing 10% fetal calf serum from a cryo-stock, until they were 
at least 70%–80% confluent. 3 mL trypsin was added to detach the cells from the surface 
of the culture flask. Culture flasks were further incubated at 37 °C for five minutes and cell 
detachment was verified under the microscope. Once the cells were detached, 7 mL DMEM 
was added to dilute trypsin and were transferred to a sterile centrifuge tube. The tube was 
centrifuged at 800 rpm for 5 minutes followed by dilution with culture medium to attain a 
desired cell density. Quantification was achieved using a hemocytometer. 24-well plates 
containing non-irradiated and irradiated (at 5 Gy) gels were seeded with above cell 
suspension, resulting in 100,000 cells in each well. Pure agarose gels were used as a control 
for determining the toxicity of our nanosensor. The plates with cells were incubated at 37 
°C in a humidified atmosphere (5% CO2/95% O2) for 24 hours. After 24 hours standard 
procedures for live-dead assay and XTT assay were followed to quantify the cytotoxicity.  
 
Evaluation of Hydrogel Toxicity Using Live-Dead Assay. 5µL calcein and 20µL 
ethidium homodimer-1 to 10ml of cell culture media. After 24 hours of cell seeding, the 
cell culture media from the well plate is removed and replaced with 1ml of the Live/Dead 
assay mixture. The cells were incubated for 1 hour.  After staining, samples were washed 
and observed using Evos FL Auto Live Cell Imaging System.  
.  
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 Evaluation of Hydrogel Toxicity Using XTT Assay. After 24 hours, the cells were 
transferred to a sterile tube. The tube was centrifuged at 800 rpm for 5 minutes and the 
culture medium was removed and replaced with serum free media. XTT labeling mixture 
was added to the serum free media and incubated for 4 hours prior to analysis. The 
absorbance at 475 and 660nm was determined using a plate reader (Bio-Tek Synergy 2). 
The value of A475 – A660 was evaluated. The relative cell viability was calculated from 
test/control x 100% where test and control are the offset absorbance values of the agarose 
hydrogel containing the gold-amino acid mixture and pure agarose hydrogel.    
 
Gel Dosimetry in an Anthropomorphic Thorax Phantom. All phantom experiments 
were carried out at the Banner M.D. Anderson Cancer Center in Gilbert, AZ. A CIRS tissue 
equivalent thorax phantom was aligned on a Philips RT CT table with aligning lasers. The 
hydrogel nanosensor is positioned in the middle of the radiation field and a known dose of 
3 Gy dose was delivered to the skin of the phantom. The change in color post-irradiation 
is evaluated using UV-Visible spectroscopy. The final absorbance values are calculated as 
previously mentioned and the radiation delivered is predicted using the calibration curve.  
 
Institutional Animal Care and Use Committee (IACUC). Prior to canine experiments, 
the experimental protocol that would be performed on the canine patient was documented 
and approved by ASU’s IACUC. A consent form approved by ASU’s IACUC was signed 
by the pet owner prior to any experiment conducted.  
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Canine experiments. A canine patient being treated using radiotherapy was selected in the 
pilot study. A fractional dose of 3 Gy was delivered each day to the region being treated. 
A 1.5cm bolus is placed on top of the patient. Our gel nanosensor was placed on top of the 
bolus and exposed to the prescribed ionizing radiation dose from a Varian Trilogy linear 
accelerator radiation therapy system. All canine experiments were performed at the 
Arizona Veterinary Oncology Center in Gilbert, AZ (approx. 14 miles distance from ASU) 
with owner’s approval. Similar to the placement of the hydrogel nanosensor, a 
NanoDOT™ was also placed on top of the bolus. The NanoDOT™ was used to evaluate 
the performance of our hydrogel sensor. The change in color post-irradiation is evaluated 
using UV-Visible spectroscopy. The final absorbance values are calculated as previously 
mentioned and the radiation delivered is predicted using the calibration curve.  
 
Image Processing. All images were acquired using an Iphone 7S plus camera under 
suitable lighting and automatic settings. The images were cropped to the desired size for 
representation. No further editing was carried out on the pictures reported here. 
 
Statistical Analyses. All irradiation experiments were carried out a minimum of three 
times independently unless otherwise mentioned. The results are expressed as mean ± 
standard deviation. All the calculations were carried out using Microsoft Excel 2016. 
8.3 Results and Discussion 
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Facile radiation sensors are required to ensure the accurate delivery of high radiation dose 
to the target region whilst minimizing radiation to the healthy surrounding tissue. Here, we 
show the development of a biocompatible plasmonic hydrogel based nanosensor as a 
simple colorimetric reporter for therapeutic levels of ionizing radiation. Prior to the 
development of the hydrogel nanosensor, a library of 32 amino acids and their derivatives 
were screened for their gold nanoparticle formation efficacy in order to identify the lead 
amino acid which would then be later used to develop the nanosensor. The preliminary 
screen was carried out with HAuCl4: amino acid (Molar ratio of 1:10) at a radiation dose 
325 Gy (Figure 8.1). In the current system reduction of Au3+ ions to Au0 occurs through a 
free radical mechanism. Ionizing radiation (X-Rays) splits water into three major free 
radical components namely H., OH. and e-aq. These short-lived solvated electrons and 
hydrogen free radicals facilitate the reduction processes to Au0. Successful reduction to 
Au0 followed by nucleation and growth leads to mature nanoparticles stabilized by amino 
acids. Upon exposure to irradiation, the nanoparticle yields were measured 2 hours and 6 
hours post irradiation and were compared with control experiments (0Gy) to establish 
increased nanoparticle formation.  
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Among the screened amino acids, tryptophan readily reduces chloroaurate ions to gold 
nanoparticles in the absence of irradiation. The reduction propensity of tryptophan involves 
oxidation of the indole moiety leading to spontaneous reduction of metal ions280. A 
significant increase in absorbance is not observed upon incidence of ionizing radiation 
suggesting that the bulk of the reduction is carried out by tryptophan. Cysteine, methionine, 
N-acetyl cysteine and glutathione form an important class of amino acids containing a thiol 
or thioether functional group in the side chain281. Choloroaurate ions being soft lewis acids 
show high affinity towards ligands containing a sulfur donor atom. This allows for the 
Figure 8.1 Maximum absorbance proportional to concentration of gold nanoparticles 
following irradiation of 325 Gy measured at discrete time intervals. Black: 0 Gy and 2 
hours post irradiation, Black diagonal stripes: 325 Gy and 2 hours post irradiation, Dark 
Yellow: 0 Gy and 6 hours post irradiation, Dark Yellow Horizontal stripes 325 Gy and 6 
hours post irradiation.   
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formation of a stable metal complex. Histidine similarly forms a stable metal complex 
through their α-amino nitrogen282. We expect the complexation of these amino acids with 
choloraurate ions to decrease the redox potential making the metallo-complex inactive 
towards the radiolysis generated reducing species112. Positively charged amino acids 
(arginine and lysine) do not exhibit nanoparticle formation tendency in the presence of 
ionizing radiation. We hypothesize that these positively charged ligands do not effectively 
chelate the metal center due to charge repulsion and a certain degree of complexation is 
required to initiate the reduction process in the presence of ionizing radiation112.  
 
Radiotherapy involves complex treatment plans to deliver curative levels of radiation to 
the target (2-5Gy) and simultaneously reduce radiation induced toxicity to healthy tissues. 
The potential benefit of these are improvement in survival rates and quality of life post 
treatment. Poor treatment planning and delivery could lead to an opposite adverse outcome. 
There is a need for a robust dose verification system, which can be fabricated in house 
requiring minimal training to operate. Towards this effort, we propose a sensor that changes 
color upon exposure to ionizing radiation and the intensity of color developed will 
qualitatively and quantitatively report for the intensity of radiation dose. Five amino acids 
including phenylalanine, aspartic acid, valine, leucine and threonine were identified as lead 
candidates from the screen and were evaluated for their ability to template gold 
nanoparticles at lower radiation levels (0, 5, 25, 50, 100 and 200Gy) (Figure 8.2 A). 
Among these five lead amino acid candidates, phenylalanine exhibited the highest 
nanoparticle templating efficacy and synergistic effects were not observed when 
phenylalanine was employed in concert with other leads amino acids or as a dipeptide 
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(aspartame) (Figure 8.2 B). Phenylalanine was chosen as the lead candidate to facilitate 
the development of the hydrogel nanosensor. To facilitate handling and application 
concerns associated with liquid sensor systems, phenylalanine was integrated in an agarose 
hydrogel matrix prior to irradiation. Irradiation of the gold alone hydrogel or the gold-
phenylalanine hydrogel with 7.5Gy displayed minimal tendency to form gold nanoparticles 
based on the absence of the characteristic maroon/pink color associated with gold 
nanoparticles (Figure 8.3). To facilitate reduction in the presence of ionizing radiation, 
tryptophan that could reduce and template gold nanoparticles spontaneously was 
supplemented externally to the gold-phenylalanine hydrogel. Interestingly, in the presence 
of phenylalanine, gold nanoparticle formation tendency is hindered when compared to the 
only gold hydrogel control. We deliberate that in such quasi-equilibrium conditions, 
therapeutic levels of ionizing radiation would be sufficient to reduce chloroauric acid to 
gold nanoparticles. Indeed, the appearance of the maroon/pink color associated with gold 
nanoparticles upon exposure to 7.5Gy suggests the use of the hydrogel as a colorimetric 
sensor for detection of therapeutic levels of ionizing radiation. All these results taken 
together, we rationalize the need for Au (III), phenylalanine and tryptophan. 
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A 
 
B 
 
Figure 8.2 (A). Maximum absorbance as a function of radiation dose for the lead amino 
acids. Gold stripes: valine (V), Gold solid: leucine (L), black wavy: phenylalanine (F), 
black brick: aspartic acid (D), black diagonal: threonine. (B). Maximum absorbance as a 
function of radiation dose. Amino acids employed for the study Phenylalanine (F), aspartic 
acid (D), valine (V), leucine (L), threonine and Aspartame (FD). All absorbance 
measurements were carried out 2 hours post irradiation. 
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We carried out experiments to investigate delayed nanoparticle kinetics in the presence of 
phenylalanine. We hypothesized that the electron rich phenyl side chain of phenylalanine 
is involved in electrostatic interaction with the indole moiety of tryptophan, responsible for 
the spontaneous reduction of chloroaurate ions. To evaluate the role of the phenyl ring in 
protecting gold ions against spontaneous reduction in the presence of tryptophan glycine, 
(L)-phenylalanine, (D)-phenylalanine and (L)-alanine were incorporated in an agarose 
matrix along with chloroauric acid. In the presence of chloroauric acid alone and hydrogels 
 
0 Gy 7.5 Gy 
Figure 8.3 Representative images of the agarose hydrogel containing various combinations 
of Au3+, L-Phenylalanine and Tryptophan following irradiation with 0 Gy and 7.5 Gy. Each 
hydrogel has the following combination, Au3+ + Tryptophan (Top Left), Au3+ + 
Phenylalanine (Top Right), Only Au (Bottom Left) and Au3+ + Phenylalanine + Tryptophan 
(Bottom Right). There is a clear visual change in the system containing all three 
components in case of 7.5 Gy and no change in color in the absence of radiation. These 
indicate the requirement of tryptophan for irradiation induced gold nanoparticles 
formation. The Au3+ tryptophan system forms gold nanoparticles spontaneously in the 
absence of radiation (0Gy). 
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containing glycine-chloroauric acid and (L)-alanine-chloroauric acid, tryptophan was 
adequate to reduce Au(III) to nanoparticles within 10 minutes (Figure 8.4). This is can be 
visually observed through the development of a pink color from the previously colorless 
hydrogel. However in the presence of a phenyl ring containing amino acids there is a 
noticeable delay in color development (20 mins). To investigate further the presence of a 
free phenyl ring in the presence of chloroaurate ions, we probed L-phenylalanine and a 
mixture of L-phenylalanine and chloroaurate ions through 1H NMR. (Figure 8.5 A and 
8.5 B). The absence of peak shifts in the side chain phenyl protons coupled with downfield 
shifts in the chiral proton(H-α) and CH2 protons(H-β) indicate minimal interaction between 
the phenyl ring and chloroaurate ions. Similar peak shifts were observed in structurally 
similar molecules to phenylalanine including alanine and D-phenylalanine (Figure 8.5 C-
8.5 F). These results taken together suggest the presence of a free phenyl ring, which could 
potentially inhibit spontaneous nanoparticle formation in the presence of tryptophan. 
Additionally, the gold-phenylalanine-tryptophan hydrogel was incubated with glutathione 
post-irradiation to sequester the unreacted gold ions through the formation of stable-metal 
complex inhibiting spontaneous nanoparticle formation in the absence of radiation (Figure 
8.6, 8.7). This formulation would constitute the plasmonic nanosensor for further 
experiments. 
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    A      B     C                 D    E 
0 min  
 
   
2 min 
 
 
4 min 
 
 
10 min 
 
 
20 min 
 
 
30 min 
Figure 8.4 Optical images of agarose hydrogel containing mixtures of chloroauric acid 
with (A) no additive, (B) glycine, (C) alanine, (D) D-phenylalanine, and (E) L-
phenylalanine. After addition of tryptophan, a visual change in color is observed within 4 
minutes in case of hydrogels containing no amino acid and amino acids without a phenyl 
ring i.e. in A, B, C. In the presence of amino acids containing the phenyl ring, a faint visual 
change in color is observed after 20 minutes (D and E).  
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7.007.057.107.157.207.257.307.357.40
f1 (ppm)
(A) L-Phenylalanine 
(B) Chloroauric acid + L-Phenylalanine 
(D) Chloroauric acid + D-Phenylalanine 
(C) D-Phenylalanine 
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Figure 8.5 1HNMR spectra between pure amino acids and a mixture of amino acid and 
chloroauric acid. 1H NMR spectra of (A) pure (L)-phenylalanine, which indicates a 
multiplet peak at ∂7.22 ppm for phenyl ring protons; a doublet of doublet peak at ∂3.68 
ppm for the chiral proton (H-α) and two doublet of doublet peaks at ∂3.10 ppm & ∂2.89 
ppm for the diastereotopic CH2 protons (H-β), (B) a mixture of L-phenylalanine with 
chloroauric acid, which shows a downfield shift in the chiral proton (H-α) to ∂3.95 ppm as 
a triplet and CH2 proton (H-β) peaks appear at ∂3.11 & ∂3.01 ppm merged with each other. 
Minimal peak shifts is observed for the side chain phenyl ring protons (at ∂7.22 ppm),  (C) 
pure D-phenylalanine, which indicates a multiplet peak at ∂7.22 ppm for phenyl ring 
protons; a doublet of doublet peak at ∂3.66 ppm for the chiral proton (H-α) and two doublet 
of doublet peaks at ∂3.11 ppm & ∂2.89 ppm for the diastereotopic CH2 protons (H-β), (D) 
a mixture of D-phenylalanine with chloroauric acid, which indicates a downfield shift in 
the chiral proton (H-α) to ∂4.01 ppm as a triplet and CH2 proton (H-β) peaks appear at ∂3.11 
& ∂3.04 ppm merged with each other. Minimal peak shifts are observed for the side chain 
phenyl ring protons (at ∂7.23 ppm), (E) pure L-alanine, which indicates a quartet peak at 
∂3.47 ppm for the chiral proton (H-α) and a doublet peak at ∂1.28 ppm for the methyl 
protons,  (F) a mixture of L-alanine with chloroauric acid, which indicates a downfield 
shift in the chiral proton (H-α) and the methyl proton peak to ∂3.78 ppm and ∂1.35 ppm are 
observed respectively. These results indicate preferential interaction to the amine and 
carboxylate moieties and minimal interaction of chloroaurate ions with the phenyl ring. 
 
 
(E) L-Alanine 
(F) Chloroauric acid + L-Alanine 
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Figure 8.6 Absorbance profiles of the hydrogel nanosensor as a function of time (A) 
without and (B) with glutathione incubation. Significant differences were observed after 
one day in all cases indicating the need of glutathione supplementation for inhibiting gold 
nanoparticle growth. (C) Optical images are shown illustrating the increase in intensity of 
the developed maroon color over time in the absence of glutathione incubation (D) No such 
increase in intensity of the radiation-induced maroon color was observed after incubation 
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with glutathione. A two-way paired Student’s t-test was performed and p-values < 0.05, 
considered statistically significant, are denoted with an asterisk (*) on the respective 
column.  
 
 
 
Figure 8.7 Effect of radiation post glutathione addition. Hydrogel nanosensors exposed to 
0Gy and 5Gy were incubated with glutathione prior to an additional exposure of 10Gy. 
The absorbance exposed to a single treatment of radiation (solid gold bars), absorbance 
value after 1hour post irradiation with 10 Gy (bars with horizontal gold stripes) and 
absorbance value after 24 hours post irradiation with 10Gy (bars with diagonal gold 
stripes). Visually, no changes in the hydrogel nanosensor were observed and no 
significant differences were detected when comparing the mean absorbance values 
indicating the sequestering of unreacted gold ions by glutathione inhibiting further gold 
nanoparticle growth. A two-way paired Student’s t-test was performed and p-values < 
0.05, considered statistically significant, are denoted with an asterisk (*) on the respective 
column.  
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The precursor nanosensor hydrogel were irradiated with various levels of therapeutically 
relevant radiation doses. This resulted in the formation of gold nanoparticles rendering a 
pink color to the hydrogel (Figure 8.8). Exposure to ionizing radiation results in the 
formation of free radicals including e-aq and H. which aids in the reduction of Au(III) to 
Au(0). Further nucleation and growth leads to formation of clusters which over time mature 
and lead to the formation of gold nanoparticles. Gold nanoparticles generated upon 
radiolysis are likely to be stabilized by amino acids in the system. The intensity of color 
developed in the hydrogel is dependent on the concentration of the gold nanoparticles 
which is directly associated with the intensity of the prescribed radiation dose. The increase 
in color is directly proportional to the increased generation of free radicals at higher doses. 
Morphology and size of the nanoparticles generated in the hydrogel sensor irradiated with 
2 and 7.5 Gy were evaluated through transmission electron microscopy (Figure 8.9). 
Quasi-spherical nanoparticles were observed in both the 2 and 7.5 Gy condition with an 
average size of 34.2 ± 9.7 nm and 21.6 ± 3.6 nm correspondingly. Interestingly we also 
noticed the presence of smaller nanoparticles in the non-irradiated control (1.8 ± 1.5 nm). 
The small size of nanoparticles is in agreement with the absence of a plasmon peak in the 
absorbance spectrum266.  
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     0 Gy             1 Gy              2 Gy            3 Gy   
 
    4 Gy               5 Gy              6 Gy           7.5 Gy 
Figure 8.8 Optical images of hydrogels irradiated radiation doses used routinely in clinical 
fractionated radiotherapy. The radiation dose corresponding to the visual color change is 
indicated below each image in gray (Gy).  
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The change in color of the irradiated hydrogels was visible to the naked eye as early as 10 
minutes while higher levels of radiation (4-7.5 Gy) required only <5 mins.  This increase 
in color in the irradiated hydrogels were quantified based on a simple, bench top UV-vis 
spectrophotometer (Figure 8.10 A). The earliest time point where we quantified the change 
in color was 1 hr. A typical spectral peak between 500 nm and 600 nm is used as an index 
to demonstrate the existence of gold nanoparticles. To further quantify the nanoparticle 
concentration with different radiation dose levels, the peak absorbance at 530 nm was 
plotted as a function of radiation dose (Figure 8.10 B). A linear calibration curve was 
obtained between 1-6 Gy. These radiation levels are employed during conventional and 
hypofractionated radiation therapy. Post-irradiation stability over a period of 7 days was 
monitored under natural lighting and at room temperature (Figure 8.11). No significant 
differences in absorbance were observed after a week demonstrating post-irradiation 
stability unlike conventional dosimeters where fading of the output over time and during 
readout is observed.  
 
Figure 8.9 Representative transmission electron microscopy (TEM) images of gold 
nanoparticles formed at (A) 0 Gy (left, scale bar of 5 nm), (B) 2 Gy (middle, scale bar of 
50 nm) and (C) 7.5 Gy (right, scale bar of 100 nm). The average nanoparticle size varies 
from 1.8 ± 1.5 for 0 Gy, 34.2 ± 9.7 for 2 Gy and 21.6 ± 3.6 for 7.5 Gy. 
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The efficacy of our sensor was determined by delivering a dose of 5 Gy (not used to 
generate the calibration curve). The color change was quantified and based on the 
calibration curve, the predicted dose was 5.32 ± 0.24 Gy with an error percentage of 6.4%. 
With the increase in complexity of radiation delivery techniques, localized radiation 
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Figure 8.10 (A) UV-Vis absorption spectra of the control (0 Gy) gels and gels irradiated 
with different doses of X-ray radiation. (B) Maximum absorbance vs. radiation dose which 
serves as the calibration curve for the sensor at various therapeutic doses of radiation
between 0 Gy and 6 Gy. 
 
Figure 8.11 Post irradiation stability of the hydrogel sensor irradiated with 5 Gy. No 
significant changes in the absorbance profile observed for at least a week. Insets display 
demonstrate no significant visual change over time corroborating the stability of the 
absorbance profile.   
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injuries are common and the skin is the first organ affected due to ionizing radiation. There 
is a need to monitor the dose prescribed to the skin. To demonstrate the efficacy of our 
biocompatible hydrogel nanosensor, we placed the hydrogel nanosensor disc on the surface 
of an anthropomorphic phantom mimicking the thorax of an adult human (Figure 8.12). A 
prescribed dose of 3 Gy was delivered the skin surface and the change in color was 
recorded. Based on the calibration curve, our nanosensor hydrogel discs predicted a dose 
of 3.03 ± 0.47 Gy with an error percentage of 1%.   
 
 
 
 
 
 
 
 
 
To demonstrate feasibility and applicability for potential clinical use, we used a live canine 
patient as a model to verify the efficacy of the sensor. Ahead of the use on live canine 
patients, we ensured the biocompatibility of the sensor by carrying out XTT and live dead 
assay (Figure 8.13). We found no change in cell viability when compared to the pure 
Figure 8.12 (A) Digital image of the hydrogel sensor (positioned in the intersection of the 
green lasers) on top of an anthropomorphic thorax phantom. The phantom was treated with 
a dose of 3 Gy, Optical image of the hydrogel sensor on the surface of the phantom prior 
to irradiation (0 Gy) and post irradiation. 
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agarose hydrogel. The use of low concentration gold salt and biocompatible templating 
agents provide strong support to the biocompatible nature of the functional components of 
the hydrogel nanosensor. We further investigated the translational capability of our 
biocompatible hydrogel nanosensor to verify the dose delivered to a canine patient. The 
prescribed surface dose to the canine was 1.34 Gy (Figure 18). Hydrogel nanosensor discs 
were placed on the surface of the bolus to record the surface dose. Upon execution of the 
treatment plan the hydrogel discs were removed and the absorbance relating to the distinct 
color change was recorded. Based on the previously generated calibration curve, the dose 
was estimated to be 1.25 ± 0.34 Gy. Clinically prevalent nanoDot™ reported a prescribed 
dose of 1.29 ± 0.02 Gy with an error percentage of 3.7%. Other clinical dosimeters like 
TLDs have a 5% error which is comparable to the 6.7% error of the hydrogel nanosensor. 
NanoDOT™ and the TLDs are prone to loss of readout signal and more cumbersome to 
operate making the hydrogel nanosensor an easier adaption into the clinic. As far we know, 
this is the first reported molecular and nanoscale sensor that has been used to verify the 
dose delivered to an actual patient. The ease of production, operation and measurement of 
its distinct color change along with its radiation dose resolution, indicates tremendous 
potential of the nanosensor to be widely used in the clinic. 
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Pure agarose Sensor with 0 Gy Sensor with 5 Gy 
100% 135 ± 15 % 133 ± 8 % 
Figure 8.13 Live/Dead® cell viability assay showing live BJ5ta human fibroblast cell line 
stained with calcein-AM (green) and dead cells with EthD-1(red). Cells were seeded on 
the 0 Gy and  5 Gy hydrogel post irradiation (≈2hours). Absence of significant dead cells 
when compared to the (A) agarose control indicate the biocompatibility of the functional 
components of the sensor. All images have scale bar of 400 µm.  Cell viability was 
quantified using XTT and no significant changes were observed. 
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8.4 Conclusions 
To our knowledge, this is the first demonstration of a colorimetric biocompatible molecular 
and nanoscale radiation sensor. The formation of gold nanoparticles in response to ionizing 
radiation is qualitatively visualized through a distinct color change and quantitatively 
measured using a simple UV-vis spectrophotometer. The developed sensor demonstrated 
the ability to detect therapeutic levels of ionizing radiation and present a linear response 
between 1-6 Gy commonly used during conventional and hypofractionated radiotherapy. 
The nanosensor was accurately able to predict the prescribed radiation dose to an 
anthropomorphic phantom and a live canine patient. The efficacy of the hydrogel 
nanosensor was comparable to clinical dosimeters. The fabrication of a hydrogel-based 
sensor would facilitate adaptation into various shapes, which could potentially result in 
personalized dosimetry based on anatomical variation on the patient. We anticipate that 
this new sensor could accelerate and lead to development of next generation radiation 
sensors assisting physicists and clinicians in providing valuable information regarding the 
prescribed dose to the patient. 
  
Figure 8.14 (A). Representative image of the experimental setup for the radiotherapy 
treatment of canine patient, (B). Images of NanodotTM OSLD and the hydrogel sensor 
placed on the canine patient (top right) show the gel prior to irradiation (0 Gy) and post 
irradiation with 1.34 Gy (bottom right). The change in color was quantified using UV-Vis 
spectrophotometer and the gel nanosensor calibration predicted a dose of 1.25 ± 0.34 Gy, 
which was an error of 6.7% compared to the planned dose. 
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Chapter 9 CONCLUSION AND FUTURE PERSPECTIVES 
 
9.1 Conclusion  
 
The purpose of the research conducted upto this point has revolved around the development 
of a novel plasmonic nanosensor that can be effectively be employed in the clinic to 
qualitatively and quantitatively predict the radiation dose delivered to patients undergoing 
radiotherapy. To this end we have: 1) developed the first gold nanoparticle based sensor to 
detect therapeutic levels of ionizing radiation, 2) to enable safe handling, the second 
generation gold nanoparticle based sensor was developed in a biocompatible hydrogel, 3) 
the applicability to detect high energy photons, protons and electrons was demonstrated, 4) 
improved the capability of the hydrogel sensor to qualitatively and quantitively predict 
dose in a two-dimensional space, 5) Finally, to reduce the toxicity of the hydrogel 
nanosensor, a completely novel amino acid based nanosensor was developed. The 
following framework represents the work that I believe is required for the evolution in the 
technology.  
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9.2 Future Perspectives  
Future Direction 1. A Proof of Concept Nanotechnology Based Gel Dosimeter for In 
Vivo Use in Brachytherapy 
 
Introduction  
Brachytherapy is a procedure that involves the use of radioactive isotopes to treat cancer.283 
The radioactive source is generally placed temporarily or permanently inside the patient to 
induce radiation damage to cancerous cells while maintaining the viability of healthy 
cells.284 The current technology employed is to use 3D imaging-based dose calculations to 
predict the dose delivered to organs at risk(OAR)285 However, organ movement between 
imaging and treatment and dose calculation uncertainties result in unpredictability 
requiring the need for in vivo dosimetry.285 The motivation will be to assess the radiation 
dose delivered to organs at risk (OAR) by direct measurements using the hydrogel 
nanosensor as described previously. As a proof of concept, the capability of the hydrogel 
nanosensor in detecting and predicting radiation dose delivered through a radioactive 
isotope, an 192Ir source is shown.  
Experimental  
 
Materials. Molecular biology grade agarose, L-ascorbic acid (AA), gold(III) chloride 
trihydrate (HAuCl4.3H2O) and myristyltrimethylammonium bromide(C14TAB)(≥99%) 
were acquired from Sigma-Aldrich. The chemicals were employed in the study with no 
further processing or purification. The solvent employed in the study was MilliQ water 
(18.2 MΩ.cm).  
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Hydrogel Nanosensor Preparation for Valencia Applicator. To fabricate a hydrogel 
nanosensor a petri dish with a glass bottom mold with a diameter of ≈1 cm and thickness 
of 0.5 mm is used. Briefly, 600 µL of a 50 mM stock solution of C14TAB was prepared 
and mixed with 30 µL of 10 mM HAuCl4 in a 1.7 mL microcentrifuge tubes. From this 
mixture, 100 µL was removed prior to the addition of heated 2% (w/v) liquid molecular 
grade agarose (500 µL). From this mixture, 500 µL was removed and poured into the 
molds. The excess liquid was removed from the sides before the setting of the gel (10-
15secs). The gels were then incubated in 10 mM Ascorbic Acid (500µL) for 1 minute on 
the hydrogel nanosensor resulting in translucent hydrogels.  
 
X-ray irradiation. Experiments for irradiations related to the Valencia applicator were 
conducted at the Banner-MD Anderson Cancer Center in Gilbert. The radiation source 
employed was an 192Ir source.  
 
Absorbance Spectroscopy. The absorbance spectra for the non-irradiated and the 
irradiated hydrogel nanosensor were obtained using a BioTek Synergy™ 2 plate reader. 
Absorbance values were measured from 300 nm to 990 nm with a step size of 10 nm. 
MilliQ water was used as blank for all experiments. To normalize the absorbance spectra 
for further analysis, the absorbance at 990nm was subtracted from the absorbance of all 
wavelengths. The maximum absorbance between 500 and 600nm wavelength is used as a 
measure of intensity in the change in color. To ensure that the 0 Gy absorbance is 0, the 
absorbance value corresponding to 0 Gy is subtracted from all the irradiated absorbance 
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values. This is plotted as a function of radiation dose to generate the calibration curve which 
is used to determine unknown radiation doses. 
 
Image Acquisition. All images were acquired using an iPhone 8. Furthermore, images 
were cropped to the required size and no further editing or post processing of the images 
was carried out.  
 
Statistical Analysis. All experiments were performed in quintuples unless otherwise 
specified. Data analysis for all independent experiments was performed using Microsoft 
Excel. Data reported in the manuscript are represented as mean ± one standard deviation. 
 
RESULTS AND DISCUSSION 
 
High dose rate brachytherapy is operated widely in the treatment of skin lesions. Several 
applicator designs including the Valencia applicator have been introduced in order to 
deliver a homogenous absorbed radiation dose to the cancerous lesion and avoid radiation 
leakage to the healthy tissue.286 As a proof of concept, we have developed an accessory to 
the Valencia applicator that could be mounted instead of the cap and could potentially be 
used to monitor the delivered radiation dose (Figure 1). Irradiation of the hydrogel 
nanosensor with different doses of ionizing radiation with a 192Ir source resulted in the 
formation of gold nanoparticles rendering a change in color from translucent to 
pink/maroon. The intensity of color developed is dependent on the yield of gold 
nanoparticles, which in turn is directly proportional to the intensity of ionizing radiation. 
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Increasing the intensity of ionizing radiation results in an increased generation of reducing 
free radical species which can further facilitate additional reduction of Au(I) to Au(0). The 
change in color in the hydrogel nanosensor after exposure to ionizing radiation was visible 
as early as 10 minutes. The change in color was further quantified using UV-Visible 
spectroscopy 1-hour post-irradiation. A characteristic spectral peak between 500 and 
600nm is observed for all the irradiated hydrogel nanosensors. The maximum absorbance 
was plotted as a function of the radiation dose from 0-4 Gy to obtain a linear calibration 
curve with an equation (y= 0.012 x X; y = maximum absorbance between 500-600nm and 
X = radiation dose in Gy). An known radiation dose of 2.25Gy (not employed in generating 
the calibration curve) is employed to determine the efficacy of the hydrogel nanosensor in 
predicting the radiation dose. The use of the calibration curve resulted in a prediction of 
1.96 ± 0.23Gy for a dose of 2.25 Gy.  
 
In the future, the effect of various dose rates due to radioactive decay of the isotope on the 
signal (absorbance) of the hydrogel nanosensor has to be verified. The technology can be 
extended to other applicators (Leipzig) and other applicators designed to treat other organs 
of interest (prostate).    
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Figure 9.1 Schematic illustrating the fabrication technique and potential applicability of 
the Valencia applicator.  
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Figure 9.2 Images of the hydrogel nanosensor following exposure to various levels of 
ionizing radiation from an 192Ir source. Images were acquired 1-hour post-irradiation. 
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Figure 9.3 (A) Plot of absorbance as a function of radiation dose and (B) Maximum 
absorbance response between 500 and 600nm versus radiation dose 1-hour post-irradiation.  
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Future Direction 2. Three-dimensional radiation dosimetry using plasmonic hydrogel 
nanosensors 
 
Introduction 
 
Modern radiotherapy involves delivery of high levels of ionizing radiation to the target 
volume while simultaneously minimizing the dose delivered to the surrounding healthy 
tissue287. With the introduction of sophisticated treatment delivery modalities like intensity 
modulated radiation therapy(IMRT), volumetrically modulated arc therapy(VMAT) and 
stereotactic radiosurgery (SRS), control over the total dose distributed in an ideal three-
dimensional (3D) shape is conceivable288. These treatment techniques involve delivery of 
high levels of ionizing radiation with steep dose gradients near the target volume making 
them highly susceptible to errors289. In addition, any deviation during the complex 
movement of the multileaf collimator and gantry will affect the accuracy of the delivered 
treatment plan289. To accommodate these new treatment modalities, quality assurance of 
the patient’s treatment plan is recommended, and verification of the treatment plan is 
essential prior to treating patients. There is still a pressing need for a practical 3D dosimetry 
system, convenient for clinical use, and with the accuracy and resolution to enable 
comprehensive verification of the complex dose distributions typical of modern radiation 
therapy.  
 
To aid in the measurement of 3D dose distributions, various 3D gels have been fabricated 
as a potential solution to this challenge. Fricke ferrous sulfate dosimeters are easy to 
fabricate and use but suffer from poor post-irradiation stability post due to ion diffusion 
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which eventually erases topographical dose profiles290. Polymer gel dosimetry were 
developed to overcome post-irradiation instability but requires upwards of 40 hours from 
fabrication to imaging making routine employment labor intensive and time-consuming291. 
The fabrication and the diffusion concerns were overcome with the development of solid 
radiochromic dosimeters292. These dosimeters are easy to handle and mold into various 
shapes depending on the application. But current dyes incorporated within the solid 
radiochromic dosimeters are prone to post-irradiation photo bleaching293. These limitations 
within existing systems warrant further development of a simple yet robust 3D dosimeters 
that can potentially assist physicists and clinicians in generating safe and effective 
treatment plans to improve patient safety and post quality of life.  
 
Nanotechnology-enabled sensors provide new solutions towards detection of ionizing 
radiation with increased selectivity and sensitivity224. We have previously developed a 
colorimetric sensor wherein ionizing radiation facilitates the generation of gold 
nanoparticles from its ionic precursor solutions. To achieve easy handling and to overcome 
any application concerns, we incorporated the precursor solution in agarose hydrogels. 
Furthermore, we illustrate the robust performance of the hydrogel nanosensor to 
qualitatively and quantitatively determine topographical radiation dose profiles and its 
clinical translation by demonstrating its efficacy in determining radiation dose delivered to 
live canine patients. Here, we illustrate the capability of the hydrogel nanosensor to detect 
radiation dose profiles in 3D which represents a significant step forward in the field of 3D 
dosimetry. To our knowledge, no such nanoscale technologies exist which can detect 
radiation dose profiles in all three dimensions.  
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Experimental  
Materials. Hydrogen tetrachloroaurate trihydrate (HAuCl4.3H2O), 
myristyltrimethylammonium bromide (C14TAB) (99%), L-ascorbic Acid and molecular 
biology grade agarose were acquired from Sigma-Aldrich. No further purification of the 
chemicals was carried out. MilliQ water (18.2 MΩ.cm) was used as solvent for all 
experiments conducted. 
Preparation of three-dimensional (3D) Hydrogel Nanosensor. Stock solutions of 
C14TAB (75mM), Ascorbic acid (10mM) and hydrogen tetrachloroaurate (10mM) was 
prepared. This constitutes Part A of the hydrogel nanosensor mixture. Simultaneously 1% 
w/v agarose was heated in a microwave until a clear solution was observed. This constitutes 
Part B of the hydrogel nanosensor mixture. Equal parts by volume of both Part A and Part 
B are mixed to fabricate the final 3D hydrogel nanosensor. For example, to prepare a 3D 
hydrogel nanosensor with a final volume of 30ml, the volumes of each the individual 
components in part A are determined by the following equation.   
30uL of 10mM HAuCl4 x C + 600uL of 75mM C14TAB x C + 60uL of AA x C = 15 mL 
C = 21.7 
The surfactant is added to hydrogen tetrachloroaurate initially and left undisturbed for 5 
minutes prior to the addition of ascorbic acid. To this mixture the liquid agarose (Part B) 
at 40°C is added and allowed to gel at room temperature prior to irradiation experiments.  
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Irradiation Experiments. Experiments for irradiations were carried out at Banner-MD 
Anderson Cancer Center in Gilbert. The radiation source employed was a 6MV photon 
beam at a dose rate of 100MU per minute.  
 
 Results and Discussion  
Here, we demonstrate the ability of the hydrogel nanosensor to qualitatively and 
quantitatively determine radiation dose delivery in 3D. As a proof of concept, we verified 
the ability of the 3D hydrogel nanosensor to qualitatively retain spatial dose information 
post-irradiation. 30mL of the hydrogel nanosensor was allowed in set in 50 ml centrifuge 
tubes prior to irradiation (Figure 1). A clear translucent hydrogel is observed when the 
tubes are not exposed to radiation and remains stable over the course of 3 days. Exposing 
the tubes to 2 and 5Gy results in the hydrogel nanosensor displaying colors with varying 
intensity of maroon/pink. This increment in color is likely due to the increase in the number 
of free radicals with increasing radiation dose resulting in a higher yield of nanoparticles. 
To visualize post irradiation diffusion and/or photo bleaching, one of the tubes was 
irradiated with both 2 and 5Gy transversely with minimal diffusion or post-irradiation 
photobleaching observed over time. To ensure no diffusion arises over time along the 
sagittal plane, one of the tubes was exposed to a 5 Gy dose. Similar stability profile is 
observed indicating post-irradiation stability of the hydrogel nanosensor.   
 
In the future, the change in color in these three-dimensional hydrogel nanosensors will be 
required to be quantifiable. We propose the use of an Optical Computed Tomography 
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(OCT) scanner. This technique will involve the use of data obtained from the transmitted 
and attenuated light beams to reconstruct a volumetric model of the irradiated regions. The 
development of 3D dosimeters which are easy to fabricate and use simple optical scanning 
measurements would better assist clinicians during patient treatment to determine the 
effectiveness of the treatment plan and ensure patient safety. 
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t = 2 hours      t = 1 day 
 
t = 3 days   
 
Figure 9.4 Digital images of hydrogel nanosensor exposed to four different radiation 
conditions. From Left. 0 Gy (No Radiation Control), Half the hydrogel nanosensor exposed 
to 2 Gy horizontally, Half the hydrogel nanosensor exposed to 5 Gy horizontally, Top one 
third exposed to 2 Gy and the bottom one third exposed to 5 Gy while the middle section 
remains not exposed to radiation and 5 Gy radiation delivered vertically. These images 
illustrate minimal post-irradiation fadeout diffusion over the course of 72 hours.  
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